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SUMMARY
The work described in this thesis concerns the microbial 
degradation of 4-alkylpyrocatechols by the bacterium Pseudomonas 
putida and a mutant of the fungus Aspergillus niger. The aim was to 
extend current studies on the methylmuconate pathways by exploring the 
size and shape of the active sites in the dioxygenase and cycloisomerase 
enzymes in P. putida and A. niger, and the methylmuconolactone 
methyl-isomerase enzyme in Rhodococcus rhodocrous N75.
(1) A range of 4-alkylpyrocatechols was synthesised and tested as 
substrates for the enzymes in P. putida. Each pyrocatechol was fed to a 
culture of the organism, with 4-methylpyrocatechol being fed in parallel 
as a control. The % yields of 4-alkylmuconolacatones depended upon the 
alkyl group as follows: Me, 46; Et, 46; Pr, 31; Prn, 14; allyl, 10; Bu“, 
trace; Bu, 0%. Thus, the ethyl and isopropyl groups, having chains of 
two carbons, clearly fit well the active sites of both the dioxygenase and 
cycloisomerase enzymes, even though the latter group is much wider. 
However, the bulkier tert-butyl group is not accommodated by the 
dioxygenase. The three-carbon chains of the propyl and allyl groups are 
less well accommodated than the shorter chains, although useful yields 
of the 4-alkylmuconolactones were obtainable. However, 4- 
butylpyrocatechol was metabolised to only a small extent. When the 
methyl group was replaced by the electron-withdrawing 4-
I
trifluoromethyl group, no products of dioxygenase cleavage were 
observed.
(2) It is known that the dioxygenase and cycloisomerase enzymes 
present in A. niger are not as effective at dissimilating 4- 
methylpyrocatechol as P. putida. This was exaggerated with bulkier side 
chains, exemplified by 4-isopropylpyrocatechol being converted to 3- 
isopropylmuconolactone in trace quantities and 4-n-propylpyrocatechol 
failing to produce any enzymic metabolites.
(3) The enzymic 4-alkylmuconolactones prepared with cultures of 
P. putida were tested as substrates for the methylmuconolactone 
isomerase in R. rhodocrous N75. The rate of isomerisation to the 3- 
alkylmuconolactones decreased with increasing size of the alkyl group 
as follows: methyl > ethyl > isopropyl > propyl > allyl.
n
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CHAPTER 1 INTRODUCTION
Aromatic compounds are degraded by certain species of bacteria 
and fungi. Naturally-occurring benzene derivatives are metabolised in 
the first instance to either pyrocatechol (1) or protocatechuic acid (2). 
Unnatural benzenoid compounds that have been passed into the 
environment as pollutants present micro-organisms with a challenge. In 
order to utilize these benzene derivatives as a source of carbon and 
energy, bacteria and fungi must either adapt their existing pathways for 
the assimilation of simple substrates, or evolve new enzymic routes to 
cope with the new compounds. Compounds whose biodegradation 
pathways have been studied include benzene-derivatives with a variety 
of different substituents - alkyl, acyl, carboxyl, halo, amino, hydroxy, 
alkoxy, nitro and sulfonyl.
COOHA
^ V ^ O H
OH
(1) (2)
1.1 Background
A multitude of aromatic substances is initially metabolised by 
micro-organisms to pyrocatechol (1) and its derivatives, which become 
substrates for reactions which cleave the aromatic ring. The non- 
aromatic products of this cleavage are then metabolised via a variety of 
pathways.
1
Pyrocatechol (1), protocatechuic acid (2) and a variety of other 
pyrocatechol derivatives are a point of secondary metabolic divergence 
during the microbial assimilation of aromatic compounds. Two main 
pathways exist for the assimilation of these compounds by cleavage of 
the benzene ring: ortho cleavage (cleavage of the carbon-carbon bond 
between the vicinal hydroxy groups) and meta cleavage (cleavage of a 
carbon-carbon bond adjacent to the vicinal hydroxy groups) (Scheme 1). 
Orthofission leads to the formation of muconic acids (3), and then to 
further metabolism in a branch of the 3-oxoadipate pathway. Meta 
fission of the aromatic nucleus gives a 2-hydroxymuconic semialdehyde 
derivative (4) which is assimilated in a separate pathway.1 In general, a 
single species or strain will entertain only one pathway or the other. In 
Pseudomonas acidovorans and testosteroni, for example, protocatechuic 
acid (2) and its biochemical precursors are metabolised via the meta- 
cleavage pathway,2 while the ortho-cleavage route is employed by all 
other Pseudomonas species for this compound.3 However, in certain 
bacteria, both pathways can occur for assimilation of different primary 
substrates. The metabolically tangential nature of these pathways is 
maintained due to the specific induction of each set of enzymes in each 
process.4'7
2
Schem e 1
ortho cleavage X
♦  — *  COOH
HOOC 
OH
(1) X=H (3)
(2) X=COOH
XA meta cleavage x
COOHK
OH
OH 0HC
OH
(4)
The ring cleavages are oxidative and are mediated by oxygenases. 
These enzymes utilize oxygen as a substrate, and therefore the 
assimilation of aromatic substrates is an aerobic process, and cannot 
operate anaerobically.9,10 Also, despite the reduction of oxygen in the 
initial reactions of aromatic substrate degradation, this does not lead 
directly to the generation of ATP and the production of energy. This 
appears to be limited to the subsequent breakdown of the aliphatic 
metabolites in the tricarboxylic acid cycle.1
As Stanier found with the bacterium Pseudomonas putida,n the 
enzymes of the 3-oxoadipate pathway are inducible, that is their 
synthesis in microorganisms is controlled by the presence of particular 
metabolites from the pathway. The nature of this regulation has been 
studied in many microbial genera, at both the physiological and genetic 
levels.
3
1.1.1 Formation of Pyrocatechols
In 1947, Evans12 identified pyrocatechol (1) as having 
accumulated during the growth of the bacterium Acinetobacter 
calcoaceticus13 on phenol (5), and benzoic (6) and p-hydroxybenzoic (7) 
acids (Scheme 2). With the bacterium Pseudomonas putida, Stanier and 
Sleeper14 established that pyrocatechol was an intermediate from benzoic 
acid oxidation.
Fungi also produced pyrocatechol from aromatic precursors. 
Trichosporon cutaneum fungi converted phenol (5) into pyrocatechol (1) 
and resorcinol (8) into 1,2,4-benzenetriol (9) (Scheme 2).15
Scheme 2
X wA A
X Y Z
(5) H OH H (1) ii
£
(6) c o 2h H H (9)
OII£
(7) C 0 2H OH H
(8) OH H OH
The formation of pyrocatechols occurs by dioxygenation of the 
benzene (10) nucleus followed by a dehydrogenation. In the bacterium 
Moraxella B, isotope experiments proved that the oxygenase enzyme 
incorporated both oxygen atoms from dioxygen. NADH was generated
4
during the course of the dehydrogenation of the isolable intermediate cis-
16
1,2-dihydroxydihydrobenzene (11) in cell-free extracts (Scheme 3). 
Similarly, the degradation of benzoic acid (6) by Arthrobacter 
globiformis was by dioxygenation to cis-l,2-dihydroxy-1,2-dihydro- 
benzoic acid (12), followed by dehydrogenation and decarboxylation to
17
pyrocatechol (1) (Scheme 3).
Scheme 3
(10) X = H 
(6) X = C 0 2H
(11) X = H
(12) X = C 0 2H
OH
OH
NADH
(1)
1.2 Meta Cleavage
Meta-cleavage of pyrocatechol (1) was discovered in 1959 by 
Dagley and Stopher.18 A species of Pseudomonas was isolated 
containing a pyrocatechol-2,3-oxygenase enzyme,19 which cleaved the 
aromatic ring between carbons 2 and 3, giving 2-hydroxymuconic 
semialdehyde (13). A similar enzyme was observed in another 
pseudomonad, and termed meta-oxygenase.20 Steps in the meta-cleavage 
pathway were elucidated by Dagley and Gibson21 and further modified 
by Bayly and Dagley.22 Following initial conversion of pyrocatechol (1) 
into 2-hydroxymuconic semialdehyde (13), a hydrolytic cleavage of 
formate occurs giving 2-oxopent-4-enoic acid (14) (Scheme 4). This is
5
hydrated to 4-hydroxy-2-oxopentanoic acid (15), prior to cleavage to 
acetaldehyde (16) and pyruvic acid (17).23 A similar sequence degrades 
protocatechuic acid (2), to formic acid and two molecules of pyruvic 
acid (17), and also various alkylpyrocatechols. However, the enzymes of 
the pathway are different for the conversion of pyrocatechol (1) and 
protocatechuic acid (2).
Scheme 4
COOH COOHi /  \  (cleavage /  \  /
 *  OHC
OH
(1) (13) (14)
OH
O
I CH3CHO   \  /
''""XOOH \
O
(17) (16) (15)
COOH
A variation of the sequence involving an oxidation by an NAD- 
dependent dehydrogenase was reported by Nishizuka in 1962.24 2- 
Hydroxymuconic semialdehyde (13) was oxidised to 2-hydroxy-cw,c/.s- 
muconic acid (18) (Scheme 5), with carbon dioxide being expelled from 
this molecule instead of formic acid to give the corresponding 2- 
oxopent-4-enoic acid (14) as was formed in the formate-expulsion route. 
This is then degraded as before. The dehydrogenase and a tautomerase
6
which effect the decarboxylation were found to be induced at the same 
time as the 2,3-oxygenase enzyme in Azotobacter and Pseudomonas 
genera.25,26 The hydrolase in the formate-producing step of the previous 
pathway was not induced, suggesting that it is non-specific. Since the 
pathway in Scheme 5 requires a specific tautomerase whereas that in 
Scheme 4 a non-specific hydrolase, it may be that the latter pathway is 
more common in bacteria.
Scheme 5
f , COOH / = ^  COOH
OHC (   ► HOOC
OH OH
(13) (18)
-COs
COOH<
O
(14)
1.3 Ortho Cleavage
Orr/zo-cleavage of pyrocatechol (1) involves initial conversion of 
pyrocatechol (1) into cis,cis-muconic acid (19). Cyclisation occurs 
giving muconolactone (20) (Scheme 6). This lactone undergoes 
isomerisation to 3-oxoadipic acid enol lactone (21), prior to hydrolysis to 
3-oxoadipic acid (22). This molecule then enters the tricarboxylic acid
7
cycle and is converted into acetic acid (23) and succinic acid (24). 
Details of these transformations are discussed in the subsequent sections 
of this chapter.
Scheme 6
ortho
cleavage HOOC
COOH
OH
(1) (19)
HOOC HOOC
O
(21) (20)
HOOC
V \ COOH CH3C O O H  + h q q c j  C 0 0 H
(22) (23) (24)
1.3.1 Formation of cis,cis-Muconic Acids
The initial ortho-cleavage of pyrocatechol by a partially purified 
enzyme from a Pseudomonas species gave muconic acid (19),27
8
identified as the cis,cis- isomer following synthesis of cis,cis- (19), 
cis,trans- (25), and trans,trans-muconic acids (26).28,29 Oxidation of 
pyrocatechol (1) to cis,cis-muconic acid (19) (Scheme 7) in bacteria has
30 31
been observed in whole cells of a Pseudomonas, Acinetobacter hvoffi,
32
Corynebacterium and cell-free extracts of Klebsiella aero genes NCTC 
418.33 Muconic acid was also formed in fungi, such as whole cells of the
34,35
yeast strains Rhodotorula rubra IFO 0892 and 1101.
H2OC
c o 2h r
h2o c
(19)
c o 2h
(25)
(26)
Scheme 7
HgOC
c o 2h
(1) (19)
Meta fission has also been observed (see Scheme 4). For instance, whole 
cells and cell-free extracts of an Acinetobacter oxidized pyrocatechol (1)
30
to 2-hydroxymuconic semialdehyde (13) (Scheme 8). The occurrence
9
of the two types of cleavage appears to be mutually exclusive, and tends 
to depend on the substrate. In strains of Pseudomonas putida, 
pyrocatechol from benzoic acid underwent ortho cleavage while 
pyrocatechols produced from o- (27) and p-cresol (28) underwent meta
4
cleavage. By use of both nonmetabolizable mducers and blocked 
mutants, it was found that the enzymes of the meta pathway were 
induced by the primary substrate, cresol or phenol, or analogues.
Scheme 8
(1)
OHCr\
(13)
c o 2h
OH
CH?
V
OH
(27) (28)
The control and regulation of the enzymes has been widely 
studied. For example, Bird and Cain36 found that cis,cis-muconic acid
(19) was the product inducer of catechol 1,2-oxygenase in Pseudomonas 
aeruginosa. Both cis,cis-muconic acid and pyrocatechol induced the 
enzyme under aerobic conditions, but it was postulated that this was 
probably due to the endogenous formation of cis,cis-muconic acid.
10
Several other compounds are degraded via pyrocatechols, for
37
example naphthalene (29) by Pseudomonas putida, benzoic, p-toluic
38
(30), and m-toluic (31) acids by Gordona rubra N657, and benzene, 
benzoic acid, o-cresol, guaiacol (32), phenol, protocatechuic acid (2),
39
and salicylic acid (33) by a Rhizobium species. Catechol 1,2- 
dioxygenase was present in the crude extracts and c/s.m-muconic acid 
was identified in the spent cultures.
(29)
CH3
/ \
V
c o2h
(30)
A
c o 2h
(31)
OCH?
OH
(32)
C02HA
OH
OH
(2)
c o 2h
OH
(33)
1.3.2 Formation of Muconolactones
(+)-Muconolactone (20), formed by the cyclisation of cis,cis- 
muconic acid (19) (Scheme 9), has been observed several times in 
bacteria, such as in cell-free extracts of Klebsiella aero genes NCTC
33 16
418 and a strain of Moraxella B, and whole cells of Acinetobacter
11
Jl
Iwoffi, a strain of Pseudomonas, a Corynebacterium species and 
Arthrobacter globiformis,17
In fungi, formation of muconolactone (20) was studied using 
whole cells of the yeast strains of Rhodotorula rubra IFO 0892 and
3435 4Q
1101, Rhodotorula glutinis, and recently in the deuteromycetous 
fungus Penicilliumfrequentans Bi 7/2.41
Scheme 9
HOOC ^  Lactonising
COOH Enzyme
(19)
Muconolactone (20) is not an intermediate in the meta pathway. 
For example, whole cells and cell-free extracts of an Acinetobacter 
which degraded pyrocatechol by meta fission did not degrade cis,cis-
30
muconic acid (19). (+)-Muconolactone (20) was shown to be the 
product of the effect of a lactonizing enzyme (muconate cycloisomerase)
42 43on cis,cis-mucomc acid. Ornston investigated the isolation, 
purification, optimum activity pH range and molecular weight of the 
muconate lactonizing enzyme from Pseudomonas putida A. 3.12. The 
X-ray crystal structure of muconate cycloisomerase from Pseudomonas 
putida has been reported.44 The manganese (Il)-dependent enzyme has
31,39
also been reported in other bacteria.
HOOC.
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The stereoselectivity of the enzyme has been studied in bacteria 
and fungi. Muconate-lactonizing enzyme from Trichosporon cutaneum 
was purified 50-fold.15Both this enzyme and chloromuconate 
cycloisomerase (Section 1.6) from Pseudomonas species B 13 converted 
cis,cis-muconic acid to (4S)-(+)-muconolactone (20) by a syn 
lactonization, determined from *H NMR measurements (Scheme 9).45 
The stereochemistry of the transformation was identical to that observed 
with muconate lactonizing enzyme from Pseudomonas putida *
The amino acid sequence determined for the cis,cis-muconate 
lactonizing enzyme from Trichosporon cutaneum fungi did not exhibit 
any similarity to that of the muconate lactonizing enzyme from 
Pseudomonas putida.45 It did, however, exhibit moderate sequence 
similarity with 3-carboxy-cw,cw-muconate lactonizing enzyme from the 
fungus Neurospora crassa, which catalyzed a stereochemically-identical 
lactonization reaction with 3-carboxymuconic acid (Section 1.4). Syn 
cyclization of cis,cis-muconic acid has also been shown to form the (4S)- 
(+)-muconolactone in Aspergillus niger41
The catalytic mechanism of muconate cycloisomerase was 
investigated by computer modelling. Manganese (II) and a lysine residue 
were proposed to provide electrophilic stabilization of the enol/enolate
44
intermediate that forms during the course of the reaction. In 
Pseudomonas aeruginosa the enzyme was induced by c/s,c/£-muconic
• j  36acid.
13
1.3.3 Formation of 3-Oxoadipic Acid
In both bacteria and fungi, (4S)-(+)-muconolactone (20) is 
isomerised to 3-oxoadipic acid enol lactone (21), and this lactone is 
hydrolysed enzymically to 3-oxoadipic acid (22) (Scheme 10).
.  hoo c-w Q - . 0
(20) (21)
/  V COOH
HOOC ) ---- /
O
(22)
The conversion of (4S)-(+)-muconolactone (20) into 3-oxoadipic acid 
enol lactone (21) has been observed from the action of an isomerase 
enzyme in cell-free microbial extracts,5 and in the degradation of benzoic 
acid by Arthrobacter globiformis.11 However the transformation did not 
occur when the meta pathway was induced in an A cin e to b a c terThe 
enzyme responsible for enol lactone formation, (45)-(+)-muconolactone 
isomerase, was induced by cis,cis-muconic acid in Pseudomonas 
aeruginosa.36,4 3-Oxoadipic acid enol lactone (21) was also identified as
Scheme 10
HOOC
14
a product of fungal degradation of phenol, by the yeast strains of 
Rhodotorula rubra IFO 0892 and 1102.34,35
Muconolactone isomerase has been isolated and characterised, in 
terms of molecular weight and optimum activity pH range, from 
Pseudomonas putida A.3.12.43 The crystal structure of the Pseudomonas 
putida enzyme showed a large central cavity,48’49 and it was similar in 
structure to the same enzyme from Alcaligenes eutrophus JMP134.50 
This enzyme showed high activity with (4S)-(+)-muconolactone (20) as 
substrate.
The stereochemical course of the enzymic reaction was 
determined, by performing the reverse reaction in deuterium oxide. A 
2,5-dideuterio-3-oxoadipic acid enol lactone (34) of defined 
stereochemistry was converted into 2,5-dideuteriomuconolactone (35) 
(Scheme 11). This could only happen by a 1,3-shift of hydrogen across 
one side of the enol lactone (34).69
Scheme 11
H
COOHCOOH
(34) (35)
Since Evans12 identified a keto acid (later identified as 3-oxoadipic acid 
(22)51) as having accumulated during the growth of the bacterium 
Acinetobacter calcoaceticus13 on phenol and benzoic and p-
15
hydroxybenzoic acids, 3-oxoadipic acid has also been identified several 
times from the breakdown of pyrocatechols.
A hydrolase enzyme was also identified, converting the enol 
lactone (21) into 3-oxoadipic acid (22).3 In bacterial cell-free extracts 
only the cis,cis-isomer of muconic acid was converted into 3-oxoadipic 
acid,52,53 as was (45)-(+)-muconolactone (20).54 Conversion of (4S)-(+)- 
muconolactone into 3-oxoadipic acid has been also been found in
3037 31
Pseudomonas and Acinetobacter Iwoffi. Klebsiella aero genes NCTC 
418 adapted to benzoic acid and p-hydroxybenzoic acid oxidized
33
pyrocatechol to 3-oxoadipic acid. 3-Oxoadipic acid enol lactone and 3- 
oxoadipic acid were formed in the degradation of benzoic acid by 
Arthrobacter globiformis,17 Neither substance is formed by the meta 
pathway, exemplified by the fact that whole cells and cell-free extracts 
of an Acinetobacter did not degrade (4S)-(+)-muconolactone or 3- 
oxoadipic acid while the meta pathway was induced.30 (4S)-(+)- 
Muconolactone isomerase and 3-oxoadipic acid enol lactone hydrolase
36.4
in Pseudomonas aeruginosa were induced by cis,cis-muconic acid.
In fungi, formation of 3-oxoadipic acid (22) from phenol was 
studied using whole cells in the yeast strains of Rhodotorula rubra IFO 
0892 and 1101.3435 3-Oxoadipic acid was produced from muconolactone
(20) by the crude cell free extract34 and whole cells55 of Rhodotorula 
rubra IFO 0892 and 1101.
The purification, optimum activity pH range and molecular 
weights of 3-oxoadipic acid enol-lactone hydrolase from Pseudomonas 
putida A. 3.12 have been studied.43 3-Oxoadipic acid enol lactone
16
hydrolase from Pseudomonas cepacia has also been purified to apparent 
homogeneity and characterized.56
Katagiri and Hayaishi57 established that 3-oxoadipic acid was 
converted into the corresponding coenzyme-A ester prior to its cleavage 
to give the co-A thioesters of succinic acid (24) and acetic acid (23).
1.4 Degradation of Protocatechuic Acid
As indicated in the previous section, both fungi and bacteria 
assimilate pyrocatechol via the same intermediates, whether by the ortho 
or meta pathways. 4-Substituted pyrocatechols which undergo ortho 
cleavage, by analogy, might be expected to be assimilated through 3- 
substituted muconic acids. These unsymmetrical muconic acids give rise 
to two possible modes of cyclisation to muconolactones. The pathways 
of degradation of protocatechuic acid are found to be different in 
bacteria and fungi.
Ortho-cleavage of protocatechuic acid (2) involves initial 
conversion of protocatechuic acid (2) into 3-coiboxy-cis,cis-mucomc 
acid (36). In bacteria, cyclisation occurs giving 4-carboxymuconolactone
(37) (Scheme 12). This lactone undergoes isomerisation and decarboxyl­
ation to 3-oxoadipic acid enol lactone (21), prior to hydrolysis to 3- 
oxoadipic acid (22). However, in fungi cyclisation occurs giving 3- 
carboxymuconolactone (38) (Scheme 12). This lactone undergoes 
isomerisation to 4-carboxy-3-oxoadipic acid enol lactone (39). The enol 
lactone (39) is then hydrolysed to 4-carboxy-3-oxoadipic acid (40), 
which is decarboxylated to give 3-oxoadipic acid (22). Details of these 
differences in bacteria and fungi are outlined in this section.
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1.4.1 Formation of 3-Carboxy-cw,cis-muconic Acid (36) 
Protocatechuic acid (2) accumulated from the oxidation of phenol,
and benzoic and p-hydroxybenzoic acids12 by Acinetobacter 
calcoaceticus,13 and the oxidation of p-hydroxybenzoic acid by 
Pseudomonas putida.14 The immediate product of o/t/zo-cleavage of 
protocatechuic acid (2) by a partially purified oxygenase (Scheme 13) 
was identified as 3-carboxy-c/s,c/s-muconic acid (36) in 1954.58
Scheme 13
ho2c v^ . oh
(2) (36)
Cain et a t9 found that certain fungi oxidised p-hydroxybenzoic 
acid and protocatechuic acid but not pyrocatechol. These fungi 
possessed a protocatechuate-3,4-oxygenase enzyme and accumulated 3- 
carboxymuconic acid (36) as the product of protocatechuic acid 
oxidation. The same transformation was observed in Neurospora 
species In Rhodotorula, the enzyme was found to be competitively
59
inhibited by pyrocatechol.
1.4.2 Formation of 3-Carboxymuconolactone (38) and 4- 
Carboxymuconolactone (37)
Bacteria cyclise 3-substituted muconic acids to 4-substituted 
muconolactones.1 In particular, 3-caiboxy-c/s,c/s-muconic acid (36) was
HoOC
C02H
J
c o 2h
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converted enzymically into 4-carboxymuconolactone (37) (Scheme 14) 
by enzymes isolated from Pseudomonas.3 Omston studied the isolation, 
purification, optimum activity pH range and molecular weight of 3-
However, 3-carboxymuconic acid (36) was converted by fungi 
(for example Neurospora species60) into 3-carboxymuconolactone (38) 
(Scheme 14), which was isolated and characterized. In contrast, none of 
the fungi produced the corresponding bacterial intermediate 4- 
carboxymuconolactone (37). The lactonizing enzymes of Rhodotorula 
and Neurospora crassa were characterised.59
Scheme 14
43
carboxymuconic acid lactonizing enzyme from P. putida A. 3.12.
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In 1975, Kirby et a l61 showed that the reaction catalysed by this 
enzyme from the fungus Neurospora crassa proceeded by syn-addition
to the C-4-C-5 double bond61 to give (S)-(-)-3-carboxymuconolactone
(38) (Scheme 15). The absolute configuration of the lactone was 
determined by ozonolysis to give (S)-malic (L-malic) acid (41).62 3- 
Carboxy-ds,cLS-muconic acid lactonizing enzyme from Neurospora 
crassa exhibited moderate sequence similarity with the cis,cis-muconic 
acid lactonizing enzyme from the fungus Trichosporon cutaneum,45 
which catalyzed a stereochemically-identical lactonization reaction with 
muconic acid (Section 1.3).
Scheme 15
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Non-enzymic, oxidative ring scission of protocatechuic acid (2) 
with 15-20% sulphuric acid-free peracetic acid gave only 3-carboxy- 
muconolactone (38).63 3-Carboxy-c/s,c/,s-muconic acid (36) was not 
isolated from the reaction.
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1.4.3 Assimilation of 3-Carboxymuconolactone and 4-
Carboxymuconolactone 
In bacteria, 4-carboxymuconolactone (37) is decarboxylated with 
a concommitant double bond isomerisation, giving 3-oxoadipic acid 
enol-lactone (21) (Scheme 16). This is then hydrolysed as in the 
degradation of muconolactone. 4-Carboxymuconolactone (37) was 
transformed into this enol-lactone (21) by enzymes isolated from 
Pseudomonas species.3 Ornston studied the isolation, purification, 
optimum activity pH range and molecular weight of 4- 
carboxymuconolactone decarboxylase from Pseudomonas putida A.
Scheme 16
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3-Oxoadipic acid enol lactone (21), therefore, was found to be 
common to both pyrocatechol and protocatechuic acid metabolism in 
bacteria in general, with all other genera studied exhibiting no diversity 
from the pathways observed in Pseudomonas,64'66
However, fungi operate a different pathway involving instead 3- 
carboxymuconolactone (38). Fungi did not degrade 4- 
carboxymuconolactone (37) or 3-oxoadipic acid enol lactone (21) at 
significant rates, and thus they differed radically from bacteria. In 
bacteria, 3-oxoadipic acid enol lactone was the precursor of 3-oxoadipic
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acid in all strains examined.59 Nevertheless, 3-oxoadipic acid was found 
in the metabolites from protocatechuic acid by crude cell-free extracts of 
the yeast Rhodotorula rubra IFO 0892 and 1101.35’67 Furthermore, 3- 
carboxymuconolactone (38) was converted into 3-oxoadipic acid by 
Neurospora species.60 However, both chemically and enzymically 
prepared 3-carboxymuconolactone (38) could not be converted into 3- 
oxoadipic acid by bacterial extracts.58,60 Again, this stark contrast 
between the Neurospora fungi and bacteria was found to be a 
characteristic of all fungal genera studied.59
3 -Carboxy-4-carboxymethy 1-4-hydroxycrotonolactone hydrolase, 
responsible for the conversion of 3-carboxymuconolactone (38) to 3- 
oxoadipic acid in Aspergillus niger, was purified 250-fold.68 4- 
Carboxymuconolactone (37) did not act as substrate, but 3-oxoadipate 
enol lactone (21) and muconolactone (20) were hydrolysed slowly. All 
the lactones acted as competitive inhibitors. Evidence suggested an 
active-site thiol group in the enzyme and the presence of a tightly bound 
divalent metal ion.
Thus the product of 3-carboxymuconolactone metabolism by 
fungal extracts was 3-oxoadipic acid, and evidence for a CoA-bound 
derivative of this metabolite was found during further metabolism of the 
keto acid.59
A strain of Penicillium formed pyruvic acid (17) from 
protocatechuic acid (2), but not via 3-oxoadipic acid (22), suggesting the 
existence also of a meta-type ring cleavage among fungi.59
In 1979, a paper by Hill et a l68 showed with deuterium-labelling 
studies that the conversion of 3-carboxymuconolactone to 3-oxoadipic 
acid, catalyzed by a cell-free preparation from Neurospora crassa,
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involved an intramolecular 1,3-suprafacial hydrogen-shift consistent 
with an initial, ally lie isomerization of the substrate (Scheme 17). The 
stereochemical course of the reaction catalyzed by 4- 
carboxymuconolactone decarboxylase was also determined.69
Schem e 17
This was confirmed when the degradation of 3-carboxymuconolactone
(38) to 3-oxoadipic acid by the multifunctional enzyme complex of 
Neurospora was studied. The overall transformation was found from 
deuterium labelling studies to involve an intramolecular, suprafacial 1,3-
shift of hydrogen from C-4 in the lactone to C-5 in the oxoadipic acid. 
Thus, it was demonstrated that the pathway in fungi involves the
formation of 4-carboxy-3-oxoadipic acid enol lactone (39), by the 1,3-
hydrogen migration, and subsequent hydrolysis of this lactone gives the
4-carboxy-3-oxoadipic acid (40). It is at this point in the fungal pathway
that decarboxylation occurs, yielding 3-oxoadipic acid (22) (Scheme 18).
HOOC HOOC P
HOOC fungi HOOC
(42) (43)
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1.5 Ortho  C leavage O f M ethylpyrocatechols
O/t/jo-cleavage of 4-methylpyrocatechol (44) involves initial 
conversion of 4-methylpyrocatechol (44) into 3-methyl-c/s,c/s-muconic 
acid (45). In fungi, cyclisation occurs giving 3-methylmuconolactone
(46) (Scheme 19). This lactone undergoes isomerisation and hydrolysis 
to 4-methy 1-3-oxoadipic acid (47), which is metabolised further. In 
bacteria, cyclisation of (45) occurs giving 4-methylmuconolactone (48) 
(Scheme 19). This lactone cannot undergo isomerisation like that of 
muconolactone (20) or 4-carboxymuconolactone (37). Thus, it is 
resistant to further metabolism. However, certain specialised bacteria 
have acquired the capability to convert the bacterial lactone (48) into the 
fungal lactone (46), thereby overcoming the block to further metabolism. 
Details of these different pathways in bacteria and fungi are outlined in 
this section.
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1.5.1 Formation of Methylpyrocatechols and Methylmuconic 
Acids
Substituted muconic acids were prepared from the corresponding 
pyrocatechols using pyrocatechase II from Pseudomonas species B13.70
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Pyrocatechol- 1,2-oxygenase was isolated from Gordona rubra N657 and 
incubated with 4-methylpyrocatechol (44) to form 3-methyl-cis,cis- 
muconic acid (45) (Scheme 20).38
Scheme 20
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4-Methylpyrocatechol was detected as a metabolite from the 
metabolism of cresols by Trichosporon cutaneum WY 2-2, suggesting 
that an additional hydroxy group was introduced into the aromatic ring 
without oxidation of the methyl group itself.71 WY 2-2 possessed a 
dioxygenase enzyme which had the same substrate specificity 
irrespective of the growth substrate used, and which converted 4- 
methylpyrocatechol (44) into 3-methylmuconic acid (45) (Scheme 20) 
and 3-methylpyrocatechol (49) into 2-methylmuconic acid (50) (Scheme
2 1).72 Several other Trichosporon and Candida strains possessed a 
pyrocatechol-1,2-dioxygenase which in some cases showed higher 
specificity for 4-methylpyrocatechol than for pyrocatechol.
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Scheme 21
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Enzymes in Nocardia rubra N75 also metabolized 4- 
methylpyrocatechol and 3-methyl-cw,c/5-muconic acid.38
The deuteromycetous fungus Penicilliumfrequentans Bi 7/2 
produced 3-methylmuconic acid from substrates such as phenol, p-
Similar to the regiochemical difference in cyclisation of 3- 
carboxy-c/s,c/s-muconic acid, fungi and bacteria produce regioisomeric 
lactones from methyl-substituted muconic acids.
In 1966, Erlebach73 noted that biological decomposition of 3- 
methylmuconic acid at pH 5 gave a variety of organic acids.
Further to this, various microbial catabolites were isolated from 
Trichosporon cutaneum including (4S)-(-)-3-methylmuconolactone (46) 
and (-)-3-oxo-4-methyladipic acid (47).74
cresol, anisole and benzoic acid, but the oxidation appeared unspecific.41
1.5.2 Formation of Methylmuconolactones
Me Me
HOOCHOOC
COOH
(46) (47)
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A notable feature of this sequence is the formation of 3- 
methylmuconolactone (46), which was readily metabolized. This was in 
contrast to the analogous reaction in bacteria giving the dead-end 
compound 4-methylmuconolactone (48), which could not be 
enzymically degraded and at the time was thought to render the 3- 
oxoadipate pathway unavailable for methyl-substituted bacterial sources 
of carbon that are catabolized by way of 4-methylpyrocatechol (Scheme
22). For example, ortho cleavage of the intermediate 4- 
methylpyrocatechol led to 4-methylmuconolactone as dead-end product 
in cells of Bacillus pumilus. This bacterium was also able to cooxidize 
m- as well as o-cresol to 3-methylpyrocatechol, which underwent ortho 
cleavage to the dead-end product 2-methylmuconolactone. After 
adaptation of the cells to m- and o-cresol, 3-methylpyrocatechol 
underwent meta instead of ortho cleavage.75 Utilisation of p-cresol as 
sole carbon source occurred by the oxidation of the methyl substituent 
and ortho cleavage of the resulting protocatechuic acid (Section 1.4).
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In some cases, bacteria are able to produce both 3- and 4- 
methylmuconolactones. Thus, the product formed from 4- 
methylpyrocatechol by enzymes in Nocardia rubra N75 was a mixture 
of these isomeric lactones.38 In 1985, Pieper et a l76 showed that 
Alcaligenes eutrophus JMP134 produced both 4-methylmuconolactone
(48) and 3-methylmuconolactone (46) as products of the cyclisation of
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3-methylmuconic acid (45). 4-Methy 1-3-oxoadipic acid (47) was also 
identified, as the hydrolysis product of 3-methylmuconolactone. 3- 
Methy 1-cis,cis-muconic acid from Pseudomonas species B 13 was also 
found to cycloisomerize non-enzymically in slightly acidic solutions.70
The formation of 4-methyl-3-oxoadipic acid (47) from 4- 
methylpyrocatechol (44) was investigated by Bruce and Cain77 in 
Rhodococcus ruber N75, Rhodococcus corallinus N657, Rhodococcus 
rhodochrous N5, and Rhodococcus strains BCN1, BCN2,and 4PH1.
1.5.3 Stereochemistry of the 3-Methyl-cis,cw-muconic Acid 
Cyclisation
In 1989 Kirby and co-workers78 demonstrated that the enzyme- 
catalyzed cyclization of 3-methyl-c/s,c/s-muconic acid (45) proceeded 
by syn addition of carboxyl groups to double bonds to form (4S)-3- 
methylmuconolactone (46) in the fungus Aspergillus niger and (4S)-4- 
methylmuconolactone (48) in the bacterium Pseudomonas putida 
(Scheme 22).
To establish the absolute configuration of each lactone, this group 
first resolved synthetic (±)-3-methylmuconolactone (51) via fractional 
crystallisation of the (£)-(-)-1-phenylethylammonium salts (Scheme
23).79’80 X-Ray crystallographic analysis of these salts established the 
absolute configuration of each enantiomeric 3-methylmuconolactone. 
The (S)-(-)-3-methylmuconolactone (46) was then shown to be identical 
to the lactone from the fungus Aspergillus niger. To establish the 
absolute configuration of the bacterial 4-methyl lactone (48), the (£)-(-)-
3-methylmuconolactone (46) was converted with bromine into the
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bromo dilactone (53). This was reduced with tributyltin hydride to give 
the (-)-l-methylmuconodilactone (54) (Scheme 24). With aqueous 
sodium hydroxide, the dilactone (54) gave (S)-(+)-4- 
methylmuconolactone (48), which was found to be identical to the 
lactone from bacteria, together with (S)-(-)-3-methylmuconolactone. 
The absolute configuration of the bromo dilactone (53) was determined 
by X-ray diffraction, exploiting the bromine as a heavy atom, thereby 
confirming the absolute configurations of both the fungal (46) and 
bacterial (48) muconolactones.80
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Kirby and co-workers demonstrated in experiments with the 
deuteriated 4-methylpyrocatechol (55) that the product of its enzymic 
oxygenation, deuteriated 3-methyl-cw,c/s-muconic acid (56), underwent 
enzymic cyclization by syn addition of carboxy groups to distal double 
bonds to form the (S)-4-methylmuconolactone (57) in the bacterium 
Pseudomonas putida and the (S)-3-methylmuconolactone (58) in the 
fungus Aspergillus niger (Scheme 25). Similarly, syn cyclization of the 
unsubstituted c/^c/s-muconic acid was shown to occur in Aspergillus 
niger to form the (S)-muconolactone (Section 1.3).
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1.5.4 Isomerisation of 4-Methylmuconolactone to 3-
Methylmuconolactone
The conversion of 4-methylmuconolactone (48) to 3- 
methylmuconolactone (46) by a new enzyme from Rhodococcus species 
was described (Scheme 26).77 The novel enzyme 4-methylbut-2- 
enelactone methyl-isomerase was detected in, and purified to 
electrophoretic homogeneity from, Rhodococcus rhodocrous N75, a 
nocardioform actinomycete, by Bruce et al.81 The new isomerase was 
highly specific with respect to its lactone substrate. Of the methyl- 
substituted lactones, (4S)-(+)-4-methylmuconolactone (48) and a 
possible isomerization reaction intermediate (-)-1-methyl-3,7-dioxo-2,6- 
dioxabicyclo[3.3.0]octane (54) were accepted as substrates. Only the
(45)-(-)-3-methylmuconolactone (46) was produced. Some other lactone
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analogs acted as competitive inhibitors. Kinetic data showed that 
dilactone (54) was isomerised faster than the lactone (48). It was 
suggested that the isomerization did not involve actual methyl migration, 
but proceeded via the 1-methyldilactone (54).
Scheme 26
Me
CL JQ  M eX T ' CO,H
(48)
methyl isomerase HOOC
(46)
Me
O- ‘
O
O 
H
(54)
In an independent study, a similar lactone isomerase, transforming 
the lactone (48) into the lactone (46), was purified from Pseudomonas 
species B13 derivative FR1, carrying the plasmid-encoded isomerase 
gene cloned from Alcaligenes eutrophus JMP 134.82 Again, in addition to
4-methylmuconolactone, the dilactone (54), was a substrate for the 
enzyme, but this time kinetic data showed that it could not be a free 
reaction intermediate. Thus, the monolactone (48) was transformed 
faster than the dilactone (54) into the product (46). Isomeric, methyl- 
substituted muconolactones were neither substrates nor inhibitors.82
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1.5.5 Non-Enzymic Formation of 4-MethylpyrocatechoI
Metabolites
Several of the previously-mentioned metabolites have been 
isolated and their properties studied in chemical oxidations of methyl- 
substituted phenols, catechols, quinones and derivatives.80,83'86 
In addition to the syntheses already cited in Section 1.5.3,80 3- 
methylmuconolactone (51) and 4-methylmuconolactone (60) were 
formed from the peroxyacetic acid-mediated oxidation of p-cresol, 4- 
methylpyrocatechol and 4-methyl-o-benzoquinone (59) (Scheme 27).85 3- 
Methyl-2-c/1s-4-rran5-muconic acid (61) was also identified as a product 
of these reactions.
Scheme 27
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2-Methoxy-4-methylphenol (62) was converted into 4-methyl-o- 
benzoquinone (59) by treatment with alkaline hydrogen peroxide.83 The
quinone (59) was further oxidised to 3-mcthy\-2-cis-4-trans-muconic 
acid (61) and eventually converted into oxalic (63), acetic (23), 
methylmaleic (64) and methylfumaric (65) acids (Scheme 28).
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1.6 Ortho Cleavage of Halopyrocatechols
1.6.1 Formation of Halopyrocatechols and Halomuconic 
Acids
Several aromatic compounds are converted microbially in the first 
instance into halogenated derivatives of pyrocatechol. In the study of the 
degradation of chloropyrocatechols, it was found that the cleavage of the 
benzene ring of some derivatives was mediated by 1,2-dioxygenases from 
bacteria.87'89 These enzymes were specific for mono- and 
dichloropyrocatechols. Orr/zo-cleavage of 3-chloropyrocatechol (66) gave
2-chloro-c/s,c/s-muconic acid (67) (Scheme 29), while 4- 
chloropyrocatechol (68) gave 3-chloro-c/s,c/s-muconic acid (69) (Scheme 
30).70 Enzymes purified from Arthrobacter species also converted 4- 
chloropyrocatechol into 3-chloro-c/.s,c/.s-muconate.90
Scheme 29 
Cl
(66)
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3-Chlorophenol and 4-chlorophenol were degraded by a yeast 
strain, Rhodotorula glutinis, with a stoichiometric release of chloride 
ions. 4-Chloropyrocatechol was observed as a product of the
degradation.40 2-Chlorophenol was degraded less.
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In Pseudomonas species B13, two separate dioxygenase enzymes 
appeared to be induced for the assimilation of pyrocatechols and 
chloropyrocatechols. Pyrocatechase I was specific for the cleavage of 
pyrocatechol, while pyrocatechase II cleaved chloropyrocatechols.88,89 
Substituted muconic acids were prepared from the corresponding 
pyrocatechols by pyrocatechase II from Pseudomonas species B 13 for 
comparison of their stabilities under different pH conditions.70 The 
enzyme was more active for 4-chloropyrocatechol than 3-chloro- and 3,5- 
dichloro-pyrocatechol (70). Both enzymes were found in Pseudomonas 
derivatives and in Alcaligenes species.91,92
Cell-free extracts from Pseudomonas species strain B 13 were 
found to completely degrade 3,5-dichlorocatechol (70). The proposed
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route of assimilation involved cleavage to 2,4-dichloro-ds,c/s-muconic 
acid (71) (Scheme 31).93 Enzymes from cell-free extracts of 
Pseudomonas species strain NCIB 934094 effected the transformation of 
(70) to (71), as did enzymes from Arthrobacter.95
Scheme 31
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Similarly, cell-free extracts of Pseudomonas species strain NCIB 9340 
gave the 2-methyl-4-chloromuconic acid (73) from 3-methyl-5- 
chloropyrocatechol (72) (Scheme 32).94
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2-Chloro-4-methylphenoxyacetic acid (74) was not a growth 
substrate for Alcaligenes eutrophus JMP 134 and JMP 134-1, but it was
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transformed enzymically into 2-chloro-4-methyl-cw,cw-muconic acid (75) 
(Scheme 33).%
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Halophenols have also been co-metabolically degraded and partly 
dehalogenated by the deuteromycetous fungus Penicilliumfrequentans Bi
3-Substituted cis,cis-mucomc acids cycloisomerized readily in 
slightly acidic solutions to give the corresponding 3-substituted
of chloromuconic acid gave geometrical isomers of 4-carboxymethylene- 
but-2-en-4-olide. With Pseudomonas species strain B 13, 2-chloro-c/.s,c/1s- 
muconic acid (56) yielded /rarts-4-carboxymethylenebut-2-en-4-olide 
(77), a process thought to occur by ^//-elimination from 5- 
chloromuconolactone (76) (Scheme 34).
1.6.2 Formation of Halomuconolactones
muconolactones. 70 However, enzymic cyclisation of the two regioisomers
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Earlier, 4-chloropyrocatechol had been found to be degraded by bacterial
muconic acid (69) gave czs-4-carboxymethylenebut-2-en-4-olide (79), 
postulated to arise from anf/-elimination from the initially-formed 4- 
chloromuconolactone (78) (Scheme 35).
Both cis- and trans-isomers of the diene lactone (79) were 
substrates for a hydrolase enzyme which converted them into 
maleylacetic acid (80).98 Maleylacetic acid is not a direct entry point into 
the 3-oxoadipate pathway, but in some cases can be converted into 3- 
oxoadipic acid or its subsequent metabolites.93
enzymes to 4-carboxymethylenebut-2-en-4-olide.97 3-Chlor o-c is,c is -
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The cyclisation of muconic and chloromuconic acids was also 
found to be effected by two different enzyme types. Cycloisomerase type 
I was induced during the degradation of benzoic acid (the precursor of 
pyrocatechol) and was specific for cis,cis-muconic acid itself. 
Cycloisomerase type II was induced in response to the assimilation of 3- 
chlorobenzoic acid, and had relaxed specificity, utilising cis,cis-muconic 
acid, 2-chloro-c/s,czs-muconic acid (67) and 3-chloro-cis,cis-muconic 
acid (69) as substrates. Unlike the pyrocatechases, only one enzyme was 
present in each bacterial strain.98 3-Carboxy-c/s,c/s-muconate cyclase
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was inhibited by the cis,cis-, cis,trans- and trans,trans- isomers of 3- 
chloromuconic acid, none of which being a substrate of the enzyme. 99 
Cell-free extracts from Pseudomonas species strain B 13 were 
found to effect cyclisation of 2,4-dichloromuconic acid (71) to cis-2- 
chloro-4-carboxymethylenebut-2-en-4-olide (81),93 as were cell-free 
extracts of Pseudomonas species strain NCIB 9340 94 (Scheme 36) and a 
lactonizing enzyme from Arthrobacter. 95 Conversion of this product into 
maleylacetic acid (80) and 2-chloromaleylacetic acid (82) was also 
observed.93,94
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Dichloromuconate cycloisomerase from Alcaligenes eutrophus JMP 134 
was purified and characterised. 100 The specificity of the enzyme was 
demonstrated by the observed low activities with cis,cis-muconic and
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monochloro-cis,cis-m\icomc acids, whereas it exhibited high activity with 
2,4-dichloro-c/£,c/s-muconic acid (71). All of these chlorinated 
compounds were found to be biological precursors of both 2- 
chloromaleylacetic acid (82) and maleylacetic acid (80). Maleylacetic 
acid was formed by the degradation of 4-chloropyrocatechol by 
Pseudomonas species.101 Similarly, cell-free extracts of Pseudomonas 
species strain NCIB 9340 converted 2-methyl-4-chloromuconic acid (73) 
into 2-methyl-4-carboxymethylenebut-2-en-4-olide (83) and 2- 
methylmaleylacetic acid (84) (Scheme 37).94
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2-Chloro-4-methyl-c/^,cw muconic acid (75) was converted by 
enzymic cycloisomerization in Alcaligenes eutrophus JMP 134 and JMP
134-1 into 2-chloro-4-methylmuconolactone (85), which was a dead-end 
metabolite (Scheme 38).96
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C
/
COOH c o 2h
HOOC /
CH3' CH3
(75) (85)
Non-enzymic cycloisomerization of 2-chloro-4-methyl-c/s,c/s-muconic 
acid (75) gave both diastereomers of 5-chloro-3-methylmuconolactone
(86) (Scheme 39). Lactones with a chloro substituent on the 4- 
carboxymethyl side chain were stable under both physiological and acidic 
conditions.96
Scheme 39
2-Chloro-ds,ds-muconic acid (67) was stable under slightly acidic 
conditions and was isolated as a crystalline compound. However 
cycloisomerization did occur in 75% sulphuric acid to yield 2-
COOH
HOOC
(75) (86)
46
chloromuconolactone (87), while isomerisation to the cis,trans form (88) 
occurred with heating at pH 1 (Scheme 40).70
Scheme 40
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The conversion of 2-chloro-c/s,c/s-muconic acid (67) by muconate 
cycloisomerase from Pseudomonas putida PRS2000, Acinetobacter 
calcoaceticus ADP1 and Pseudomonas species strain B 13 yielded two 
products, identified as 2-chloro- (87) and 5-chloro-muconolactone (76) 
(Scheme 4 1).102 Cyclisation by the enzyme from Pseudomonas putida 
gave initially 2-chloromuconolactone (87) as the major product, while 5- 
chloromuconolactone (76) dominated after prolonged incubation. Both 
chloromuconolactones were stable at physiological pH.
H2SO4
(87)
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It was postulated that the chloromuconate cycloisomerases must 
have evolved the capability to cleave the carbon-chlorine bond during 
their divergence from normal muconate cycloisomerases, since the former 
enzymes of Pseudomonas species strain B 13 and Alcaligenes eutrophus 
JMP 134 had been shown previously to produce the trans-dienelactone 
(77) from 2-chloro-c/s,ds-muconic acid.102
Scheme 41
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Muconate cycloisomerase and chloromuconate cycloisomerase 
from Rhodococcus erythropolis 1CP cells were purified and 
characterized.103 Both enzymes discriminated between the two possible 
directions of 2-chloro-c/s,c/s-muconic acid (67) cycloisomerization and 
converted this substrate into 5-chloromuconolactone (76) only (Scheme
41). Unlike the chloromuconate cycloisomerases of gram-negative 
bacteria, the corresponding Rhodococcus erythropolis enzyme was 
unable to catalyze elimination of chloride from (+)-5-
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chloromuconolactone (76). Moreover, in being unable to produce (+)-2- 
chloromuconolactone (87), the two cycloisomerases of Rhodococcus 
erythropolis 1CP differed significantly from the known muconate and 
chloromuconate cycloisomerases of gram-negative strains.
In 1995, Vollmer and Schloemann104 studied the conversion of 2- 
chloro- cis,cis -muconic acid (67) into the trans-diene lactone (trans-4- 
carboxymethylenebut-2-en-4-olide) (77) by purified preparations of the 
pJP4-, and pAC27-encoded chloromuconate cycloisomerases from 
Alcaligenes eutrophus and Escherichia coli DH1, respectively (Scheme
42). (+)-2-Chloro- (87) and (+)-5-chloro-muconolactone (76) also gave 
//*«AZ5-4-carboxymethylenebut-2-en-4-olide (77) with these enzyme 
preparations. Thus, in common with other chloromuconate 
cycloisomerases, the pJP4- and pAC27-encoded versions were able to 
catalyze chloride elimination from (+)-5-chloromuconolactone. However 
the ability to eliminate chloride from (+)-2-chloromuconolactone 
differentiated these enzymes from other groups of cycloisomerases.104
Scheme 42
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2-Fluoro-cis,cis-muconic acid (89) was stable under slightly acidic 
conditions, but was isomerized to the cis,trans form (90) by heating at pH 
1 (Scheme 43).70 Also, it was not cycloisomerized by crude extracts or 
cycloisomerase II preparations from Pseudomonas. 70
Scheme 43
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However, the simultaneous presence of partially purified preparations of 
pyrocatechol 1,2-dioxygenase from Pseudomonas cepacia and muconate 
cycloisomerase from Alcaligenes eutrophus 335 converted 4- 
fluoropyrocatechol (91) into (+)-4-fluoromuconolactone (93) (Scheme 
44).105 (+)-4-Fluoromuconolactone (93) was also shown to be the only 
major product formed from 3-fluoro-cis,c/s -muconic acid (92) by the 
action of muconate cycloisomerases from Alcaligenes eutrophus 335, 
Alcaligenes eutrophus JMP134, and Pseudomonas cepacia as well as by 
the action of dichloromuconate cycloisomerase from Alcaligenes 
eutrophus JMP 134 (Scheme 44). This suggested that dichloromuconate 
cycloisomerase, like the muconate cycloisomerases, catalyzed primarily a 
cycloisomerization reaction. Only in the case of chloro- and bromo- 
substituted substrates was a dehalogenation observed at this stage.105
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4-Fluoromuconolactone (93) decomposed non-enzymically at pH 
7, mainly to maleylacetic acid (80), which then decarboxylated to give 
c/s-acetylacrylic acid (94) (Scheme 45). Significant amounts of an 
unidentified compound were also formed, but hydrogen fluoride 
elimination to yield the two, isomeric diene lactones was negligible.105 
However, the non-enzymic reactions proceeded slowly and an enzymic 
conversion of 4-fluoromuconolactone in vivo was assumed. Participation 
of diene lactone hydrolases in this reaction was indicated by their 
induction during growth of various strains on 4-fluorobenzoic acid. 
However, experiments with cell extracts of Pseudomonas putida A3.12 
suggested that at least one other hydrolytic enzyme was able to contribute 
to the 4-fluoromuconolactone conversion.105
51
Scheme 45
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Other halogenated muconolactones have been less well studied. It 
was found that 2-chloro-3 -methylmuconolactone (95) was dechlorinated 
within 8 days in sludge from a lignin bleachery, whereas 4-methyl-5- 
chloromuconolactone monomethyl ester (96) did not undergo biological 
dechlorination, perhaps because it structurally-similar to 4- 
methylmuconolactone (50), a dead-end intermediate of the bacterial 
ortho-cleavage pathway.106
Cl Me
(95) (96)
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1.6.3 Stereochemistry of Halomuconolactones
Muconolactone isomerase of Alcaligenes eutrophus JMP 134, 
which normally catalyses isomerisation to the enol lactone (21) (see 
Section 1.3.3), catalyzed dechlorination of (AR,5R)- (97) and (4R,5S)-5- 
chloro-3-methyl-muconolactone (99) and (4#,5S)-5-chloromuconolactone 
(101) to give principally the 3-methyl-rraAzs- (98) and 3-methyl-c/s-diene 
lactone (100) and a 3:1 mixture of cis- (79) and trans-diene lactones (77), 
respectively.50 The major products all arose by sy/7-elimination of HC1 
(Scheme 46).107 The stereochemistry of the four stereoisomers of 5- 
chloro-3-methylmuconolactone was deduced from NMR data, stability 
data, and from comparison with authentic (4R,5S)-5- 
chloromuconolactone.107
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The enzyme was proposed to have a structure similar to that of 
muconolactone isomerase of Pseudomonas putida and a high degree of 
sequence similarity with other muconolactone isomerases was observed. 
It had a high activity with (4S)-muconolactone, although (4R,5S)-5- 
chloromuconolactone (101) was the preferred substrate. The (4S,5S)~ 
lactone (102) was an inhibitor of (4/?,5tf)-5-chloro-3- 
methylmuconolactone (97) dehydrochlorination. Methyl substitution of 
the substrate resulted in a higher affinity for the enzyme, but a drastically 
lower velocity, resulting in a lower specificity constant.50
Me
(102)
The absolute stereochemical courses of the cis,cis-muconic acid 
lactonizing enzyme from Trichosporon cutaneum and the chloromuconic 
acid cycloisomerase from Pseudomonas species B 13 have also been 
determined.45 The regiochemistry of cyclization of 3-halo-c/s,c/s-muconic 
acids by the enzyme from Trichosporon cutaneum and by the enzyme 
from Pseudomonas species B 13 have been shown to differ in a halogen 
substituent-dependent manner, suggesting a different active site 
architecture of the two enzymes. The results parallelled those observed 
by Pieken and Kozarich108 for the nonenzymic lactonization of the 3- 
halomuconates at pH 1-6 and in concentrated HC1, respectively 
(Section 1.6.4).
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1.6.4 Non-Enzymic Formation of Halomuconic Acids and
Halomuconolactones
Dimethyl 3-halo-cw,cw-muconates (105) were prepared by Pieken 
and Kozarich109 from 4-halopyrocatechols (103) by oxidation to the 
intermediate o-quinones (104) with sodium periodate, and subsequent 
oxidative cleavage with lead tetraacetate in the presence of methanol 
(Scheme 47). Alkaline hydrolysis of the dimethyl 3-halo-czs,a^- 
muconates (105) yielded acid-sensitive disodium salts of 3-halo-cis,cis- 
muconates (106). The authors examined the lactonization of cis,cis-3- 
fluoromuconate and its chloro and bromo analogs under acidic 
conditions.108
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At pH 0 cis ,cis-3-fhiovomucomc acid gave 4-fluoromuconolactone 
(107), while cis,cis-3-chlowmucomc acid and cis,cis-3-bromomucomc 
acid gave 3-halomuconolactones (108) (Scheme 48). At pH 1-6,4- 
carboxymethylenebut-2-en-4-olide (77) formed in all cases. At pH 3.2 
and below, czs,c/s-3-chloromuconic acid and cis,cis-3-bromomucomc 
acid also isomerised to the 3-ha\o~2-cis-4-trans-muconic acids (109) as 
additional products (Scheme 49).
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1.6.5 Degradation of Trifluoromethylpyrocatechols
The assimilation of trifluoromethyl-substituted aromatic 
compounds is especially interesting. The trifluoromethyl group has found 
widespread application in the biochemical and pharmaceutical industry in 
increasing the persistance and resistance to biological breakdown of the 
compounds into which it is incorporated. These properties are usually 
attributed to the fact that the trifluoromethyl group is not much more 
sterically-demanding than a methyl group, whereas it is much more 
electron-withdrawing. It was planned in the present work to synthesise 
and feed trifluoromethylated compounds to the organisms under 
investigation, for comparison with the alkyl analogues.
Both 3- and 4-trifluoromethylbenzoic acid have been subjected to 
degradation by bacteria, resulting in a common dead-end product, 2-
hydroxy-6-oxo-7,7,7-trifluorohepta-2,4-dienoic acid (113).n °
3-Trifluoromethylbenzoic acid (110) was metabolised in Pseudomonas 
putida mt-2 by c/s-dioxygenation, followed by dehydrogenation and
decarboxylation to 3-trifluoromethylpyrocatechol (112).111 This was then
112
cleaved to the dead-end product (113) by meta-fission (Scheme 50).
The cleavage by pyrocatechol-2,3-dioxygenase in Pseudomonas putida 
was strongly inhibited by the electronegative substituent, and it was not
observed at all in Rhodococcus rubropertincus.m
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4-Trifluoromethylbenzoic acid (114) was dioxygenated to the cis- 
2,3-dihydroxy compound (115) in Pseudomonas putida, which was then
113
transformed into 2,3-dihydroxy-4-trifluoromethylbenzoic acid (116). 
Meta cleavage produced 3-carboxy-2-hydroxy-6-oxo-7,7,7- 
trifluorohepta-2,4-dienoic acid (117) (Scheme 51), which was 
decarboxylated to 2-hydroxy-6-oxo-7,7,7-trifluorohepta-2,4-dienoic acid
(113). The meta cleavage was found to be retarded by electron
113
withdrawal. The decarboxylation was not affected by the 
trifluoromethyl group, but the hydrolysis of the product to (118) was
113
affected. This was accounted for in that the acid (113) showed strong
CF3
.OH
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112
binding to the hydrolase enzyme, but negligible turnover. However, the
acid (113) has been found to be further degraded by light.
110
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CHAPTER 2 RESULTS AND DISCUSSION
A major aim of the research described in this thesis was to explore 
the ability of micro-organisms to convert alkylpyrocatechols, other than 
4-methylpyrocatechol, into the corresponding, chiral 
alkylmuconolactones. In this way, information about the substrate 
specificity, and hence active site geometry, of the pyrocatechase, 
(dioxygenase) and cycloisomerase enzymes would be obtained and it 
might also prove possible to develop useful microbial syntheses of the 
chiral lactones on a preparative scale. To this end, literature routes to 
pyrocatechols were surveyed and, where necessary, modified for the 
present purposes.
2.1 Synthesis of Pyrocatechols
Appropriate methods were required to produce a variety of 4- 
substituted pyrocatechols, for testing as substrates for dioxygenase 
enzymes in bacteria and fungi. Of the pyrocatechol targets, only 4- 
methyl- (44) and 4-ethyl-pyrocatechol (119) were commercially available. 
The methyl derivative was used as a control for each experiment with 
other alkylpyrocatechols. 4-Isopropyl- (120) and 4-trifluoromethyl- 
pyrocatechol (121) were not commercially available, but it was believed 
that these compounds could be obtained from the corresponding phenols, 
which were available from commercial sources.
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Both 4-propylphenol (122) and eugenol (123) could be utilised as 
starting materials to prepare 4-propylpyrocatechol (124), although 
eugenol had the advantage of having the correct substitution pattern 
already in place, and also served as a precursor for 4-allylpyrocatechol 
(125) (Scheme 52). For the synthesis of 4-fz-butylpyrocatechol (126), the 
corresponding phenol was not available, but again a compound with the 
correct substitution pattern, 4-butyrylpyrocatechol (127), was accessible, 
supplied by Prof. R. B. Cain (Scheme 53).
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Similarly, it was thought that 3-chloro-5-methylpyrocatechol (128) 
could be synthesised either from 4-methylphenol (28) or from vanillin 
(129), which had the oxygen substituents already in place (Scheme 54).
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When 4-substituted phenols were available, several potential 
methods were known for the synthesis of the corresponding 
pyrocatechols.114,115
Elbs persulfate oxidation116 involves the introduction of a sulfate 
group ortho to a phenolic hydroxy group, the product of which (131) can 
then be hydrolysed to a pyrocatechol (132) (Scheme 55).117,118 
Formylation ortho to the hydroxy group of a phenol allows oxidation of 
the resultant salicylaldehyde (133) by a Dakin reaction,119 which can be 
performed with sodium percarbonate.120 The resulting phenyl formate
(134) can again be hydrolysed to a pyrocatechol (132). Another method 
of furnishing an acyloxy-substituted phenol which can be easily converted 
into a pyrocatechol utilises the reaction of benzoyl peroxide with 4- 
substituted phenols.121,122 This gives o-hydroxyphenyl benzoate esters
(135), which are hydrolysed to pyrocatechols (Scheme 55).
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Pyrocatechols can also be obtained indirectly by reduction of quinones
(136) (Scheme 56). Quinones can be formed in a variety of ways123 from 
4-substituted phenols (130), including the use of Fremy’s salt 
[(KOsS)2NO] (Teuber reaction),124,125,126 chromic acid,127 thallium 
trifluoroacetate128 and diphenyldiselenic anhydride.129 Reduction of the 
resultant quinones (136) can be effected with a variety of reagents,130 
such as sodium dithionite, diethyl hydroxylamine, sodium borohydride,
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trimethyl phosphite, zinc and acetic acid or potassium iodide in acetic 
acid.
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Some of the methods outlined above have been employed in the syntheses 
detailed in this work.
2.1.1 Synthesis of 4-Isopropylpyrocatechol (120)
Treatment of a phenol with a dibenzoyl peroxide is believed to give 
an intermediate phenyl benzoyl peroxide, which rearranges to give an Co- 
hydroxy )phenyl ester, and this can be hydrolysed to a pyrocatechol.115 
Following the recommended general method,131 4-isopropylphenol (137) 
was treated with dibenzoyl peroxide in chloroform at reflux for 6 h 
(Scheme 57), resulting in the formation of 2-benzoyloxy-5- 
isopropylphenol (138), which was isolated in 20 % yield following 
chromatographic separation. Cleavage of this ester group with aqueous 
sodium hydroxide under an inert atmosphere at ambient temperature for 
18 hours gave 4-isopropylpyrocatechol (120), which was purified by 
distillation, giving an isolated yield of 33 %.
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The low yields associated with this first route to 4- 
isopropylpyrocatechol prompted investigation into another synthetic 
route. The formation of the desired product by reduction of the 
corresponding ortho-quinone (139) appeared attractive. Fremy’s salt, 
potassium nitrosodisulfonate132 was the oxidant of choice for the 
formation of this quinone from 4-isopropylphenol.124,133 Thus, addition of 
an ethereal solution of 4-isopropylphenol (137) to a pH-buffered, cooled 
aqueous solution of potassium nitrosodisulfonate produced a highly 
coloured solution (Scheme 58). Following work-up, orange crystals were 
isolated, but analysis by XH NMR showed this material to be a complex 
mixture.
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However, it was felt that this route would benefit if isolation of the o- 
quinone intermediate (139) was not attempted, but that it be generated 
and reacted in situ. o-Benzoquinones are known to undergo Diels-Alder 
dimerisation. Therefore, a chloroform solution of 4-isopropyl-o- 
benzoquinone (139) was formed as indicated above (Scheme 58). 
Treatment of this solution with potassium iodide in glacial acetic acid134 
effected a colour change from deep red to purple, indicating that the 
quinone had been reduced and that the iodide had been oxidised to 
iodine. Washing with sodium bisulfite reduced the iodine to iodide again 
prior to isolation of the resultant 4-isopropylcatechol (120) in 36 % yield 
after column chromatography (Scheme 59). The product had a melting 
point of 75-76 °C, which agreed with the literature value.135
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2.1.2 Synthesis of 4-ethylpyrocatechol (119)
4-Ethylpyrocatechol (119) was initially produced from 4- 
ethylphenol (140). Later, supplies became available commercially 
(Lancaster Synthesis). Again, oxidation of the phenol with Fremy’s salt 
(potassium nitrosodisulfonate) gave the corresponding 4-ethyl-o-quinone
(141), which was not isolated but reduced in situ with potassium iodide 
(Scheme 60). Distillation and chromatography were required to separate 
the product from the starting phenol. 4-Ethylpyrocatechol (119) was 
isolated as white crystals in 33 % yield. The melting point of the product 
was 38-39°C, and agreed with that reported in the literature.136
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2.1.3 Synthesis of 4-aIIyIpyrocatechol (125) and 4-n-propyl- 
pyrocatechol (124)
The commercial availability of eugenol (123) made this compound 
a desirable starting material for the synthesis of both 4-allylpyrocatechol 
(125) and 4-Ai-propylpyrocatechol (124). Both routes required the 
cleavage of the phenolic ether. Several reagents are known for this 
transformation,130,137,138,139 including hydrogen bromide,140 
iodotrimethylsilane141 and Lewis acids.142 Cleavage of the methyl ether in 
eugenol was attempted with aluminium trichloride with pyridine in 
dichloromethane at reflux,143 followed by acid hydrolysis of the 
aluminium complex formed (Scheme 61). This sequence yielded 4- 
allylpyrocatechol (125) in 26 % after chromatography, while 26 % of the 
starting eugenol was also recovered. The mass spectrum of 4- 
allylpyrocatechol (125) showed the molecular ion at m/z = 150.0673 
(C9H10O2 requires M, 150.0681). Catalytic hydrogenation of the double 
bond of the 4-allyl group was then effected with 10 % palladium on 
carbon as catalyst, in ethanol for 90 minutes. Distillation of the crude 
product furnished the desired 4-^-propylpyrocatechol (124) in 93 % yield, 
with a melting point of 59-60°C, which agreed with the literature value.144
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The low yield of methyl ether cleavage with aluminium trichloride 
prompted investigation of an alternative reagent. Boron tribromide is 
often recommended for the cleavage of aryl methyl ethers.145 A 
dichloromethane solution of eugenol (123) at -78 °C was treated with 
boron tribromide (Scheme 62).137 The mixture was allowed to come to 
room temperature and stirred for 24 horns, then quenched with diethyl 
ether and hydrolysed with water. The major product, isolated in 40 % 
yield, was a brown gum, identified as 4-(2-bromoprop-l-yl)pyrocatechol
(142). The !H NMR spectrum of this product showed a multiplet for a 
single proton at 5 4.11-4.28 ppm, assigned to the bromomethine group. It 
is suspected that this compound results from the hydrobromination in the 
acidic work-up of the allyl double bond in the initially-formed 4- 
allylcatechol.146
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In order to avoid the bromination side reactions during the Lewis 
acid-mediated ether cleavage, reversal of the order of this and the 
hydrogenation step was attempted. Thus, hydrogenation of eugenol (123)
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at atmospheric pressure was accomplished over carbon-supported 
palladium in ethanol at ambient temperature (Scheme 63). 2-Methoxy-4- 
/i-propylphenol (143) was formed completely after 4 hours, distilling to 
give a clear oil in 91 % yield. Cleavage of the methyl ether was then 
effected with boron tribromide to give 4-rt-propylpyrocateehol (124) in 
90 % yield after distillation.
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2.1.4 Synthesis of 4-n-butyIpyrocatechol (126)
Clemmensen reduction147,148 of the readily available 4- 
butyrylbenzene-l,2-diol (127) provided ready access to 4-n- 
butylpyrocatechol (126). A zinc-mercury amalgam149 was prepared by 
mixing acid-washed zinc powder with mercuric chloride in water 
(Scheme 64). The resulting amalgam was slurried with aqueous acid and 
an ethanol solution solution of the ketone (127) for 12 hours at reflux.150 
Distillation of the resultant product gave 4-/i-butylpyrocatechol (126) in 
51 % yield as a colourless oil which crystallised on standing. The 
compound had a melting point of 39-41 °C, which agreed with the 
literature value.151
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2.1.5 Synthesis of 3-chloro-5-methylcatechol (128)
It was of interest in this project to observe the effect of chlorination 
of the aromatic substrates on their cleavage by bacterial dioxygenases. 
Also, interesting stereochemical deductions could be made from the 
cyclisation of the expected muconic acids (Section 1.6). 3-Chloro-5- 
methylpyrocatechol (128) was desired for comparison with 4- 
methylpyrocatechol, and a route to this compound was developed. 
Vanillin (129) was chlorinated with chlorine gas in glacial acetic acid at 
ambient temperature (Scheme 65).152 The product crystallised from the 
solution, and was recrystallised from acetic acid to give 3-chlorovanillin
(144) as a white solid in 87 % isolated yield. This material was then 
hydrogenated in acidified ethanol in the presence of 10 % palladium on 
carbon as catalyst. A 51 % yield of 2-chloro-6-methoxy-4-methylphenol
(145) was obtained as an oil. Cleavage of the methyl ether was effected 
with anhydrous aluminium trichloride and pyridine in dichloromethane at
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reflux for 24 hours.143 Acidification and work-up gave equal amounts of
3-chloro-5-methylpyrocatechol (128) and the starting methyl ether (145), 
which were separated by chromatography to yield the desired pyro- 
catechol in 22 %. The mass spectrum of the product showed molecular 
ions at mlz =160 and 158 in a 1:3 ratio, while the XH NMR spectrum 
showed the presence of the methyl group at 5 2.21 ppm.
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Again, the low yield in the final step of this route was undesirable. 
A possible alternative route to 3-chloro-5-methylpyrocatechol involved o- 
chlorination of fused p-cresol (28). Treatment of this phenol with neat
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sulfuryl chloride and warming the mixture to 50 °C gave 2-chloro-4- 
methylphenol (146) as an oil, after alkaline work-up.153 Purification by 
distillation furnished the desired product in 62 % yield (Scheme 66). 
Oxidation of 2-chloro-4-methylphenol (146) with potassium 
nitrosodisulfonate in a buffered solution, followed by potassium iodide- 
mediated reduction of the quinone intermediate in chloroform yielded a 
mixture of products. After chromatography and distillation, a 34 % yield 
of 3-chloro-5-methylpyrocatechol (128) was obtained as an off-white 
solid.
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2.1.6 Synthesis of 4-trifluoromethyIpyrocatechol (121)
The influence of the trifluoromethyl group on the cleavage and 
subsequent enzymic reactions of some pyrocatechols has already been 
outlined (Section 1.6.5). Trifluoromethyl-substituted aromatic compounds 
are becoming increasingly widespread pollutants. Their resistance to 
biodegradation in mammals is useful in the pharmaceutical industry, but 
causes problems in the environment. It was therefore of interest to 
investigate the hitherto unexplored degradation of 4-trifluoromethyl- 
pyrocatechol by bacteria, in comparison to the sterically-similar 4-methyl 
analogue.
Attempts to synthesise 4-trifluoromethylpyrocatechol (121) proved 
very difficult. Oxidation of 4-trifluoromethylphenol (147) to the 
corresponding benzoquinone with Fremy’s salt and reduction with 
potassium iodide failed to give the desired pyrocatechol, with starting 
material being recovered quantitatively. Attempted oxidation of this 
phenol (147) with benzoyl peroxide also failed to change the starting 
material (Scheme 67). Presumably, the powerful electron-withdrawing 
effect of the trifluoromethyl group prevented electrophilic attack by either 
reagent.
Scheme 67
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Instead, activation of the ring towards nucleophilic attack was expected in 
a route to 4-trifluoromethylpyrocatechol (121) from the commercially 
available 4-chloro-3-nitro-1 -trifluoromethylbenzene (148). This 
compound was treated with powdered sodium hydroxide in dimethyl 
sulfoxide for 24 hours at ambient temperature.154 Acidification to pH 1 
and extraction with ether gave 2-nitro-4-trifluoromethylphenol (149) in 87 
% yield as a red oil (Scheme 68). Hydrogenation of the nitro group was 
effected with hydrogen gas over Raney nickel in ethanol at ambient 
temperature.155 The resultant 2-amino-4-trifluoromethylphenol (150) was 
crystallised from toluene as an off-white solid in 76 % yield. The same 
compound was also obtained from the nitrophenol (149), by hydrogen 
transfer from formic acid, catalysed by 10 % palladium on carbon,156 at 
100 °C and acidic work-up. 2-Amino-4-trifluoromethylphenol (150) was 
converted into 4-trifluoromethylpyrocatechol (121) by treatment with 
acidified sodium periodate at ambient temperature in acetic acid.134 This 
oxidised the amino phenol to the corresponding o-quinone mono-imine, 
and then hydrolysed the imine group. The resultant o-quinone was 
reduced with potassium iodide in acetic acid to the desired 4- 
trifluoromethylpyrocatechol (121), isolated in 17 % yield as a colourless 
oil after distillation. Sodium bisulfite was used to reduce the iodine 
formed to iodide ion. This new pyrocatechol was characterised by NMR 
spectroscopy. The 13C NMR spectrum showed a quartet at 5 124.0 
assigned to the trifluoromethyl group, while the NMR spectrum 
showed a broad singlet for two OH protons at 5 6.52 ppm which were 
exchanged for deuterium on shaking with D2O. The high resolution mass
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spectrum for (121) gave a value for the molecular ion of 178.0241 
(C7H5O2F3 requires Af, 178.0242)
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CF
OoN
Cl
(148)
HO'
OH
NaOH
DMSO
A
OH
(149)
H2
Raney Ni 
EtOH
1 . HCI, Nal04  
AcOH
2. Kl, AcOH
3. NaHS03 OH
(121) (150)
2.2 Synthesis of Metabolic Intermediates
In order to investigate the muconolactone methyl isomerase 
enzyme, which overcomes the metabolic dead-end in the bacterial 
assimilation of 4-methylpyrocatechol (Section 1.5), several targets were 
identified as possible racemic substrates or inhibitors for the enzyme of
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Rhodococcus rhodocrous. These included (±)-3-alkylmuconolactones, 
e.g. (126), and (±)-l-alkylmuconodilaclones, e.g. (154).
3-AJkyl-cis-cis muconic acids were thought to be useful precursors 
to these lactones and they could also be used to examine the substrate 
specificity of the cycloisomerase enzyme in Pseudomonas putida, which 
converts these muconic acids to 4-substituted muconolactones.
Thus, investigations were carried out into potential synthetic routes 
to 3-alkyl-c/s,c/.s-niuconic acids or their derivatives. A possible route 
involved the oxidative cleavage of oquinones, which can be formed from 
pyrocatechols or as mentioned previously (Section 2.1). Oxidation of 
pyrocatechols to o-quinones has been executed with a variety of 
reagents,157 including chromium trioxide, iron (IE) salts, silver oxide,158 
silver carbonate on Celite159 and eerie ammonium nitrate.160 The o- 
quinones could then be cleaved to cis,cis-muconic acid derivatives with 
peracids161 or an oxidised cobaltocene adduct.162 A direct preparation of 
alkylmuconolactones from o-nitrophenols in hot sulfuric acid is also 
known.163
2.2.1 Synthesis of (±)-3-Isopropylmuconolactone (152) and 
(±)-l-isopropyImuconoldilactone (154)
4-Isopropylphenol (137) was nitrated at the 2-position when kept 
in a solution of concentrated nitric acid in acetic acid at 20 °C for 15 
minutes (Scheme 69).163 4-Isopropyl-2-nitrophenol (151) was isolated in 
59 % yield after chromatography and distillation, with the remaining 41 
% consisting mainly of the starting phenol. Treatment of 4-isopropyl-2- 
nitrophenol with concentrated sulphuric acid at 110-115 °C for 2.5 hours
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cleaved the carbon-carbon bond between the hydroxy group and the nitro 
group, and hydrolysed the carbon-nitrogen bond. Recyclisation then 
occurred to give the racemic 3-isopropylmuconolactone (152) in 56 % 
isolated yield. 164 This new lactone showed a band in the IR spectrum at 
1746 cm'1, which is characteristic of the carbonyl group in an cxp- 
unsaturated 5-membered ring lactone. The high resolution mass spectrum 
for (152) gave a value for the molecular ion of 184.0735 (C9H12O4  
requires Af, 184.0736). Bromolactonisation was performed on this 
muconolactone with bromine in the presence of base, followed by 
bisulfite washes to remove excess bromine. 165 (±)-8 -Bromo-l- 
isopropylmuconodilactone (153) was isolated as a brown gum in 87 % 
yield. The NMR spectrum of the product showed a single proton at 6  
4.55 ppm, indicating that it was bonded to the carbon bearing the bromine 
atom. The high resolution mass spectrum for (153) gave values for the 
molecular ions of 263.9816 and 261.9839 (CpHnO^Br requires Af, 
263.9821, and CpH^O^Br requires Af, 261.9841). Reduction of the 
bromodilactone was accomplished with tributylstannane in benzene at 30- 
40 °C in the presence of azoisobutylnitrile as radical initiator, 165 
furnishing (±)-l-isopropylmuconodilactone (154) in 22 % isolated yield. 
The high resolution mass spectrum for the new dilactone (154) gave a 
value for the molecular ion of 184.0738 (C9H12O4 requires Af, 184.0736), 
while two carbonyl carbons were observed at 6  172.8 and 173.0 in the 
13C NMR spectrum.
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Thus, this route was successfully used to give the racemic 3- 
isopropylmuconolactone and the racemic 1-isopropylmucondilactone. It 
was hoped that it could also be used to give other racemic 3- 
alkylmuconolactones and dilactones. Thus, 2-chloro-4-methylphenol 
(146) was converted into 2-chloro-4-methyl-6-nitrophenol with nitric acid 
in acetic acid at 0 °C without agitation (Scheme 70). The desired product 
was isolated in 61 % yield after addition of water gave a yellow
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precipitate. However, treatment of this nitrophenol with hot, concentrated 
sulfuric acid gave only intractable mixtures.
Scheme 70
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Cleavage of 2-nitro-4-trifluoromethylphenol (149) in this manner 
gave mainly starting material and 3-trifluoromethylmuconolactone was 
not isolated from the reaction.
2.2.2 Synthesis of alkylmuconolcatones by oxidation of
corresponding 0-quinones with monoperphthalic acid
As a model study for this route, racemic 3-methylmuconolactone 
(51) and 1-methylmuconodilactone (158) were synthesised from 4- 
methylpyrocatechol (44) (Scheme 71) following the published methods.80
4-Methylpyrocatechol was oxidised with a suspension of silver oxide in 
ether.166 Careful removal of the solvent by low temperature distillation 
gave 4-methyl-o-benzoquinone (59), in 71 % yield as red-brown crystals. 
The quinone was then treated with monoperphthalic acid, prepared from 
phthalic anhydride and aqueous alkaline hydrogen peroxide,167 in ether 
for 24 hours.168 3-Methylmuconic anhydride (156) was isolated and was
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then cleaved in aqueous base to form disodium 3-mQ\hy\-2-cis-4-trans- 
muconate (157).168
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3-Methylmuconolactone (51) was obtained by heating the salt (157) 
under reflux in hydrochloric acid.169 The racemic 3-methylmuconolactone 
was isolated and converted with bromine and aqueous base in 
dichloromethane165 into the racemic 1 -methyl-8-bromomuconodilactone 
(158), obtained as a white solid in 87 % yield. Treatment of this 
compound with tributylstannane in benzene, warmed in the presence of 
azoisobutylnitrile,170 replaced the bromine atom with hydrogen, to give 
racemic 1-methylmuconodilactone (159) as a white crystalline solid in 22 
% yield.
Silver oxide,171 prepared from the action of sodium hydroxide on 
silver nitrate solution, oxidised 4-isopropylcatechol (120) in dry ether in 
the presence of anhydrous magnesium sulfate and in the absence of light.
4-Isopropyl-o-benzoquinone (139) was produced in 71 % yield as a deep 
red oil (Scheme 72), but it decomposed on storage. The lR  NMR 
spectrum of (139) showed three protons in the alkene region at 5 6.07,
6.27 and 6.94 ppm. The 13C NMR spectrum showed the presence of two 
quinone carbonyls at 5 179.6 and 180.1.
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However, attempted Baeyer-Villiger oxidation of this quinone to the 
corresponding 3-isopropyl-cz\s,c/s-muconic acid anhydride, with 
monoperphthalic acid, resulted in intractable tars, and the route was not 
pursued further.
It was intended that 3-chloro-5-methylpyrocatechol be used as a 
precursor to 3-methyl-5-chloromuconolactone, for *H NMR studies, with 
deuterium labelling, into the stereochemistry of enzymic cyclisation. To 
this end, 3-chloro-5-methylpyrocatechol was oxidised with silver oxide in 
ether to give 3-chloro-5-methyl-o-quinone (160), isolated as a red oil in 
40 % yield (Scheme 73). The 13C NMR spectrum of (160) showed the 
presence of two carbonyl groups at 5 173.3 and 179.9 ppm. However, 
attempted Baeyer-Villiger oxidation of this quinone to the corresponding
2-chloro-4-methyl-cz's,cz's-muconic acid anhydride, using monoperphthalic 
acid, again resulted in intractable tars.
Scheme 73
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2.3 METABOLISM OF 4-ALKYLPYROCATECHOLS
2.3.1 In Pseudomonas putida
Once the 4-alkylpyrocatechols shown in Figure 1, had been 
successfully synthesised, they were fed along with commercially 
available 4-t-butylpyrocatechol (161) to cultures of Pseudomonas putida. 
The feeding of 4-methylpyrocatechol (44) was used as a control each 
time.
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These compounds were fed for the following reasons 
(Scheme 74):
1. To test the capability of the dioxygenase and cycloisomerase enzymes 
in Pseudomonas putida cultures to use these compounds, and the derived 
muconic acids, as substrates, for the biosynthesis of the corresponding 
muconolactones. This would give insight into the shape and size of the 
enzymes active sites by showing which groups are easily 
accommodated.
2. If the corresponding 4-alkylmuconolactone was formed, this would be 
converted into the corresponding dilactone, and both compounds would 
be tested as substrates for methylmuconolactone methyl isomerase of 
Rhodococcus rhodocrous N75.
Scheme 74
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hours, to 3 day old cultures of Pseudomonas putida. The entire culture 
medium was combined together 24 hours after the last feeding and 
adjusted to pH 7.5 and extracted with ether, to extract any non-acidic 
material present in the broth which included any pyrocatechol that had 
not been cleaved by the dioxygenase enzyme. The ether extracts were 
analysed by *H NMR spectroscopy. The culture medium was then 
adjusted to pH 2.5 and extracted with ether. These ether extracts 
contained any muconolactones that had been produced by the organism. 
An area of concern was the quantification of substrate specificity of the 
enzymes for each pyrocatechol. Proof was required that the enzymes 
were being produced and working effectively each time. To overcome 
this problem, 4-methylpyrocatechol was fed in parallel each time to 
demonstrate that the bacterial and fungal enzymes were operating 
consistently throughout the feeding experiments.
2.3.1.1 Metabolism of 4-IsopropylpyrocatechoI (120)
4-Isopropylpyrocatechol (120) was the first in the series of 4- 
alkylpyrocatechols that was fed to Pseudomonas putida. The culture 
medium was combined and adjusted to pH 7.5 with sodium hydroxide 
solution. The entire culture medium was extracted with ether, dried and 
concentrated to give a dark brown oil which was analysed by *H NMR 
spectroscopy. This showed that small quantities of unreacted 4- 
isopropylpyrocatechol (120) had been recovered. Acidification, 
extraction into ether and evaporation of the ether gave a red-brown gum. 
The total extract was analysed by *H NMR spectroscopy in (CD3)2CO to 
ensure that all the extract had fully dissolved. The *H NMR spectrum
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showed doublets ( /  5.8 Hz) at 5 6.12 and 7.76, corresponding to the 
vinylic protons (2- and 3-H), confirming that 4-isopropylmuconolactone
(165) was the major product. The minor metabolites 3- 
isopropylmuconolactone (152) and 3-isopropyl-2-pyrone-5-carboxylic 
acid (166) were also present. 3-Isopropylmuconolactone (152) was 
identified by comparison of its spectrum with that of the synthetic 
racemate. In particular, signals were observed at 5.40 (ddd, J  8.6, 3.6 
and 1.7 Hz) and 5 5.86 (s with fine splitting) for 4-H and 2-H 
respectively. 3-Isopropyl-2-pyrone-5-carboxylic acid (166) was 
tentatively identified by singlets with fine splitting at 6 7.14 and 6.30 
corresponding to the vinylic protons (Scheme 75). The corresponding 
te/t-butyl derivative, which had been isolated from the bacterial 
degradation of 4-terf-butylpyrocatechol, gave similar signals. (See 
Section 2.3.1.6, page 110).
The total extract was separated on 20 x 20 cm silica plates using 
diisopropyl ether : formic acid : water (200:7:3) as eluent. Examination 
of the TLC plate by UV light and development with iodine vapour 
showed approximately 20 separate bands. Each band was removed, 
stirred with acetone for several hours and filtered. The filtrate was 
evaporated and the residue was dissolved in ether and washed with water 
to remove any formic acid present, dried over sodium sulphate and then 
evaporated under reduced pressure. The extract from each band was 
examined by *H NMR spectroscopy. 4-Isopropylmuconolactone (165),
Rf 0.4, and 3-isopropylmuconolactone (152), R¥ 0.2, were obtained as off 
- white oils, which failed to crystallise. Examination of the other bands 
showed few !H NMR signals and none which corresponded to any 
possible metabolites.
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4-Isopropylmuconolactone (165) was isolated as an oil,
[a]D + 21 ° (c, 0.7 in methanol). The IR spectrum showed the carbonyl 
absorption at 1745 cm 1 and the high resolution mass spectrum gave a 
molecular weight of 184.0751 in good agreement with a theoretical 
value of 184.0736 for C9H120 4. The !H NMR spectrum showed the 
characteristic doublet of doublets for the vinyl protons at 5 6.12 and 6 
7.76 with J  5.8 Hz, while the AB quartet corresponding to 5-methylene 
protons was observed at 5 2.79 and 2.97 with J  15.9 Hz.
The absolute configurations of (S)-muconolactone (20), (S)-3- 
methylmuconolactone (48), (S)-4-methylmuconolactone (50) and (S)-3- 
carboxymuconolactone (38) have all been determined unambiguously. 
Although it was likely that the cycloisomerase of Pseudomonas putida
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would produce the new 4-alkylmuconolactone with the same absolute 
stereochemistry, this point was checked by comparing the CD spectra 
(measured by Professor N.C. Price, Stirling University) of the known 
and new derivatives.
It was found 173 that the muconolactones having hydrogen at C-4 
all showed positive Cotton effects (CEs) near 200 nm, corresponding to 
the strong, UV, n - n  absorptions, and negative CEs at longer 
wavelength, corresponding to weak n - n  absorptions not normally 
detectable in the UV spectra. A similar conclusion for other butenolides 
has recently be reported 174. As expected, the positive CE, near 200 nm, 
for 4-methylmuconolactone was much less well defined, since the two 
groups at the chiral centre now have similar sizes and polarisabilities. 
Nevertheless, the negative CE (at 220 nm) was still apparent. It was of 
interest therefore to observe the effect of the larger, isopropyl group at 
C-4.
The amorphous 4-isopropylmuconolactone (165) was accurately 
weighed and the CD spectrum run in acetonitrile. The same solution was 
used directly to measure the UV spectrum. No CE peak was observable 
near 200 nm, although the curve was still positive in this region (Figure 
2). Unexpectedly, a strong negative CE was observed at 217 nm, 
presumably arising from an n - n transition. It is not clear why this CE is 
stronger than the negative CEs of the other muconolactones. Whether 
fortuitously or not, the CE curve shows the same change in sign, positive 
to negative, with increasing wavelength characteristic of all the other 
muconolactones with the absolute configuration. The UV spectrum 
showed the strong absorption expected for a butenolide, 204 nm (£  
7330)
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Figure 2 CD Spectrum of 4-AIkylmuconolactones
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(I) 2-Methylmuconolactone, (II) 3-Methylmuconolactone (48),
(HI) 4-Methylmuconolactone (50) and (IV) 4-Isopropylmuconolactone (165)
3-Isopropylmuconolactone (152) was also isolated as an oil and 
identified by comparison of its spectrum with that of the synthetic 
racemate. In particular, signals were obtained as a multiplet at 5 5.35 - 
5.45 and 5 5.86 (s, with fine splitting) for 4-H and 2-H, respectively. An 
IR absorption band was observed at 1720 cm'1 and a molecular weight of 
184.0722, (C9H120 4 requires M, 184.0736). The 3- 
isopropylmuconolactone did not give any significant optical rotation and 
is thought to be formed from the non-enzymic cyclisation of the 3- 
isopropylmuconic acid (167) formed in vivo from 4-
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isopropylpyrocatechol (Scheme 76). The absence of any signals for 3- 
isopropyl-c/^fraAzs-muconic acid in the total extract showed that the 
cycloisomerase enzyme had efficiently cyclised the 3-isopropyl-c/.s,c/s- 
muconic acid. It is known that 3-methyl-cw,c/s,-muconic acid isomerises 
readily, non-enzymically to the cis,trans isomer at pH 7 .80
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(+)-4-isopropylmuconolactone (165) was then converted into the 
corresponding 1-isopropylmuconodilactone (168) via l-isopropyl-4- 
bromomuconodilactone (169) which was required as a potential substrate 
for the cycloisomerase enzyme of Rhodococcus rhodocrous N75 
(Scheme 77).
Scheme 77
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The lactone (165) was treated with bromine and sodium hydrogen 
carbonate in a two phase, water-dichloromethane system to give the 1- 
isopropyl-4-bromomuconodilactone (169) in high yield (91%) with an 
[a]D - 49 0 (c, 0.6 in methanol). The rH NMR spectrum of this product 
showed singlets at 6 4.49 and 5.08 expected for the trans protons 4-H 
and 5-H respectively, which have a torsion angle of 90 °. This 
bromodilactone (169) was treated at room temperature with tributyltin 
hydride, the reaction being initiated by warming with azoisobutrylnitrile, 
to give 1-isopropylmuconodilactone (168) as an oil with [a]D- 117 0 (c, 
0.3 in methanol). This dilactone (168) was characterised by the IR 
carbonyl stretching band at 1788 cm'1. The high resolution mass 
spectrum gave a value for the molecular ion of 184.0746, (C9H120 4 
requires M, 184.0736).
As mentioned previously, 4-methylpyrocatechol (44) was fed 
during each feeding experiment as a control to ensure that the organism
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was functioning effectively. The 4-methylpyrocatechol (44) was fed in 
the same manner as described for 4-isopropylpyrocatechol (120). At pH 
7.5 the ether extracts contained only trace quantities of the 4- 
methylpyrocatechol (44), whereas large quantities were recovered when 
the organism was not functioning effectively. At pH 2.5, the ether 
extracts were evaporated to give an off-white, oily solid. This oily solid 
would not dissolve fully in (CD3)2CO or CDC13 to enable the total extract 
to be examined by *H NMR. Therefore a portion of the total extract was 
dissolved in (CD3)2SO. In this way, the major component was identified 
as 4-methylmuconolactone (50). Also observed were quantities of 3- 
methylmuconolactone (51) and 3-methyl-2-cis-4-trans-muconic acid 
(157) (Scheme 78). Surprisingly, none of the corresponding cis-trans- 
isopropylmuconic acid was detected in the preceding experiment.
3-Methyl-2-c/s-4-rrafts-muconic acid (157) was separated from 
the 4- and 3-methylmuconolactones (50) and (51) by centriffugiation 
with acetone. This muconic acid (157) was obtained as a white 
crystalline solid, m.p. 176-177 °C. The JH NMR spectrum showed the 
characteristic doublets at 5 6.15 and 8.45 with /  16 Hz corresponding to 
the trans vinylic protons, while the cis proton gave a singlet at 5 5.96. 
Once this acid had been removed, the rest of the extract was purified by 
preparative TLC using the same method and conditions as for the 
products from 4-isopropylpyrocatechol (120). On examination of the 
TLC plates by UV light and after development with iodine vapour, 
approximately 10 bands were observed. Each of the bands were 
extracted as before and the extracts examined by *H NMR spectroscopy. 
Scheme 78
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Pseudomonas
putida
(50)
CH3HOOC
+
(51)
+ /  
HOOC
CH3
\
COOH
(157)
4-Methylmuconolactone (50), tfF0.4, and 3-methylmuconolactone (51), 
Rf 0.2, were isolated successfully as white gums. Examination of the 
other bands showed few JH NMR signals and none which corresponded 
to any possible metabolites. (5)-4-Methylmuconolactone (50) had [a]D + 
31 0 (c, 0.9 in methanol). This agrees with a literature value of [a]D + 32 
0 (c, 10.0 in H20 ).74 In some literature references the (S)-4- 
methylmuconolactone (50) was successfully isolated as a white 
crystalline solid, m.p 49-51 °C.175 However the optical rotation has the 
same value irrespective of the physical form. Once again, 3- 
methylmuconolactone (51) did not have an optical rotation and was 
thought to be formed from the non-enzymic cyclisation of 3-methyl-2- 
cis-4-trans-muconic acid (157) formed in vivo from 4- 
methylpyrocatechol (44).
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As a trial for the conversion of the 4-isopropylmuconolactone 
(165) into the corresponding dilactone (168), cyclisation of 4- 
methylmuconolactone (50) was attempted first (Scheme 79). (S)-4- 
Methylmuconolactone (50) was treated with bromine as before to give 
the l-methyl-4-bromomuconodilactone (170) as a white crystalline solid 
with m.p 123-124 °C with [a]D - 68 ° (c, 0.9 in methanol). This 
bromodilactone was converted into the dilactone by debromination as 
before to produce 1-methylmuconodilactone (54) as a white crystalline 
compound with m.p 108-109 °C and [a]D - 132 0 (c, 0.2 in methanol),
175which is m agreement with literature values.
Scheme 79
CH
O
O
COOH 2. Na2 S 2 0 3
(50)
(170)
OO
H
(54)
The feeding of 4-isopropylpyrocatechol (120) to Pseudomonas 
putida was carried out on several occasions to determine the 
reproducibility of the experiment and to accumulate enough material to 
use as a substrate for Rhodococcus rhodocrous N75. Each time, 4- 
methylpyrocatechol (44) was fed as a control, which was important as on 
several occasions during this period it was found that the organism was 
not working effectively. Lower levels of enzymically oxidised products
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were produced and consequently larger quantities of unreacted 
pyrocatechols were recovered. Thus, 4-methylpyrocatechol served as an 
effective indicator of the efficiency of the organism.
2.3.1.1.1 Quantification of Metabolites by NMR Spectroscopy 
A concern in the execution of the feeding experiments was the 
accurate quantification of the different metabolites produced. This was 
previously measured directly by the amount of metabolite recovered 
from preparative TLC. To assess the accuracy of quantification by 
preparative TLC, quantitative NMR measurements were carried out on 
the total metabolites extracted at pH 2.5. Thus an aliquot of the total 
extract was evaporated, completely dried and then weighed. This aliquot 
was dissolved in an appropriate deuteriated solvent and the NMR 
spectrum was recorded. An known quantity of iodoform (CHI3) was 
added to act as an internal standard for the proton integrals. The weight 
of CHI3 was approximately equal to that of the 4-substituted 
muconolactone present. The NMR spectrum of this mixture, when 
integrated allowed absolute quantities of the metabolites to be 
calculated. Iodoform proved to be an excellent compound for use as an 
internal standard as it has a high molecular weight per proton and is 
soluble in all the deuteriated solvents tested. By this quantatitive method, 
4-isopropylmuconolactone (165) was found to be formed from the 
corresponding pyrocatechol in 31 % yield. Similarly, the yields of 3- 
isopropylmuconolactone (152) and 3-isopropyl-2-pyrone-5-carboxylic 
acid (166) were 6 and 5 %, respectively. These figures are consistent 
with those obtained by direct weighing of the metabolites after 
separation by preparative TLC, carried out on the same extract.
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Quantitative NMR measurements were also carried out on a 
portion of the total material extracted at pH 2.5 from the feeding of 4- 
methylpyrocatechol (44) to Pseudomonas putida. Thus, 4- 
methylmuconolactone (50) was obtained in 46 % yield. This agrees with 
previously reported results.162 3-Methylmuconolactone (51) was 
produced in 6 % yield, and 3-methy\-2-cis-4-trans-mucomc acid (157) in 
15 % yield. Previous experiments with 4-methylpyrocatechol in 
Pseudomonas putida had not detected 3-methyl-2-c/s-4-rraA2.s-niuconic 
acid (157).162 This is probably because the muconic acid is completely 
insoluble in the normal CDCl3and (CD3)2CO, the solvents previously 
used for examining these extracts.
In conclusion quantitative NMR measurements agree well with 
weighing after separation, but are more direct and not subject to losses 
during preparative TLC. Preparatitive TLC is an adequate method for 
quantification of some metabolites e.g. 4 and 3- substituted 
muconolactones. However some metabolites e.g. 3- substituted 
- cis,trans- muconic acids are lost during TLC and consequently cannot 
be quantified. The results of the feeding experiments with 4- 
isopropylpyrocatechol (120) are shown in Table 1 on page 99.
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2.3.1.2 Metabolism of 4-EthyIpyrocatechol (119)
4-Ethylpyrocatechol (119) has been fed on several previous 
occasions to Pseudomonas putida with different quantities of metabolites 
produced each time.165,172 It was therefore necessary to accurately 
quantify the amounts of metabolites produced using quantitative *H 
NMR measurements and using 4-methylpyrocatechol (44) as a control to 
ensure the organism was functioning effectively.
Unmetabolised 4-ethylpyrocatechol (119) was extracted at pH 7.5. 
The ether extracts of the medium at pH 2.5 were evaporated in vacuo to 
give a mid-brown, oily solid. The !H NMR in (CD3)2CO showed the 
presence of three metabolites. 4-Ethylmuconolactone (171) was the 
major metabolite, showing a characteristic doublet of doublets at 5 6.05 
and 7.56 ( /  5.7 Hz) for 2- and 3-H. 3-Ethylmuconolactone (172) was 
identified by the characteristic signals at 5 5.19 - 5.25 (multiplet, 4-H) 
and 5 5.80 (s, 2-H). This product had been detected by :H NMR 
spectroscopy before but had not been isolated.165 Also observed was 3- 
ethyl-2-c/s-4-rrarts-muconic acid (171) with characteristic doublets at 5
6.27 and 8.66 ( /  15.7 Hz) corresponding to the protons on the trans 
double bond, and a singlet at 5 6.02 for the proton of the cis double bond 
(Scheme 80). As 4-ethylmuconolactone (171) had been previously 
isolated and characterised it was not necessary to purify the extract by 
TLC.172 Quantification was instead executed by XH NMR spectroscopy 
using iodoform as an internal standard.
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Scheme 80
ACH2CH3
OH
(119)
Pseudomonas
putida
COOH
HOOC CH2CH3 CH-P.H
+ COOH
HOOC
O
(171) (172) (173)
Quantitative NMR measurements on the total metabolites 
extracted at pH 2.5 showed conversion of 4-ethylpyrocatechol (119) into 
4-ethylmuconolactone (171) in 46 % yield. 3-Ethylmuconolactone (172) 
and 3-ethyl-2-c is-4-trans-muconic acid (173) were formed in 7 and 6 % 
yield respectively. These results are in broad agreement with work 
previously carried out for 4-ethylmuconolactone, although no figures 
were available for the conversion into 3-ethylmuconolactone (172) and 
there was no indication that 3-ethy l-2-c is-4-trans-muconic acid (173) 
was present.165,172 The results of the feeding data for this experiment with 
4-ethylpyrocatechol (119) are shown in Table 4 on page 109.
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23.1.3 Metabolism of 4-AIIyIpyrocatechoI (125)
Since 4-isopropylpyrocatechol (120) was efficiently metabolised 
by Pseudomonas putida it was of interest to find if the organism would 
accommodate a longer chain length in the 4- position of pyrocatechol. It 
was decided to feed 4-allylpyrocatechol (125) to the organism as 
outlined previously. Unreacted 4-allylpyrocatechol (125) was recovered 
during the ether extracts of the culture medium at pH 7.5. At pH 2.5, the 
ether extracts were evaporated in vacuo to give a dark brown gum. The 
total extract was examined by *H NMR spectroscopy, giving a complex 
spectrum partly due to the vinyl protons on the allyl group having shifts 
comparable to the vinyl protons in the muconolactone. 4- 
Allylmuconolactone (174) was observed as one of the major metabolites 
with the characteristic doublet of doublets at 5 6.11 and 7.74 ( /  5.7 Hz). 
Also observed were the characteristic signals for the olefinic protons due 
to 3-ally\-2-cis-4-trans-muconic acid (175), namely a doublet of doublets 
at 6 6.29 and 8.64 ( /  16.2 Hz), and a singlet at 6 6.02. 3- 
Allylmuconolactone could not be observed in the JH NMR of the total 
extract at pH 2.5 (Scheme 81).
The total extract was then purified by preparative TLC using the 
same procedure as 4-isopropylpyrocatechol (120). 4-Allylmuconolactone 
(174) was isolated as a viscous gum with an [a]D + 10 ° (c, 0.5 in 
methanol). 3-Allyl-2-cis-4-trans-mucomc acid (175) and 3- 
allylmuconolactone were not isolated although (175) was detected in the 
lH NMR spectrum of the total extract at pH 2.5.
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Scheme 81
Pseudomonas
putida
COOH
OH
OH
(125)
O
COOH
HOOC
(174) (175)
It was found that the solid gum 4-allylmuconolactone (174) 
spontaneously cyclised upon storage at ambient temperature to give (-)-
1-allylmuconodilactone (176), a white crystalline compound with m.p 
114-115 °C and [a]D - 82 0 (c, 0.3 in methanol) (Scheme 82). As the 
allylmuconodilactone had been obtained this way there was no 
requirement to attempt its synthesis via the bromodilactone, with the 
concomitant problem of bromination of the ally lie double bond.
Scheme 82
y S  Cyclisation
^  O. ? upon storage at R.T
° ~ o ^  ------------------------------ ■
COOH
(174) (176)
The results of the feeding experiments with 4-allylpyrocatechol (125) are 
shown in Table 3 on page 104.
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2.3.1.4 Metabolism of 4-PropyIpyrocatechol (124)
To further investigate the effect of the size of the hydrocarbon 
chain on the 4-position in the degradation of pyrocatechol by 
Pseudomonas putida it was decided to feed 4-propylpyrocatechol (124). 
It was expected that cleavage would occur in the same manner as for 4- 
allylpyrocatechol (125). The unmetabolised 4-propylpyrocatechol (124) 
was recovered at pH 7.5 as usual. The ether extracts of the medium at 
pH 2.5 were evaporated in vacuo to give a dark-brown, tar-like gum. The 
*H NMR spectrum in (CD3)2CO showed 3 metabolites present in equal 
amounts (Scheme 83). 4-Propylmuconolactone (177) was recognised by 
the characteristic doublet of doublets at 6 6.08 and 7.73 (J 5.7 Hz), 
corresponding to 2- and 3-H respectively. 3-Propylmuconolactone (178) 
was also observed by signals at 5.30 (ddd, J  8.5, 3.7 and 1.6 Hz) and 5 
5.86 (s with fine splitting) for 4-H and 2-H respectively. 3-Propyl-2-c/s-
4-fnz/z.s-muconic acid (179) gave doublets at 5 6.25 and 8.63 (J 16.2 Hz) 
from the trans olefinic protons, and the cis olefinic proton gave a singlet 
at 5 5.99.
As the total extract was isolated as a tar-like gum, it was not 
possible to remove the 3-propyl-2-cis-4-trans-mucomc acid (179) by 
suspension in acetone and centrifugation, as was the case with 3-methyl-
2-cis-4-trans-nmconic acid (179). The total extract was instead purified 
by preparative TLC as before.
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Scheme 83
Me
OH
OH
(124)
Pseudomonas
putida
Me
O
COOH
MeHOOC
+ r
HOOC
‘Me
/ %COOH
(177) (178) (179)
4-Propylmuconolactone (177) was obtained as an off-white gum, 
[a]D + 1 1 °  (c, 0.7 in methanol). The JR spectrum showed the carbonyl 
absorption at 1750 cm'1, and a high resolution mass spectrum gave a 
molecular weight of 184.0745 (C9H120 4, requires M, 184.0735).
3-Propylmuconolactone (178) was obtained as a yellow gum, and 
had no optical rotation. Again it was believed to arise from the non- 
enzymic cyclisation of the intermediate 3-propyl-c/^-cw-muconic acid. 
As with the (+)-4-allylmuconolactone it was found that the (+)-4- 
propylmuconolactone (177) cyclised spontaneously upon storage at 
ambient temperature to give the 1-propyldilactone (180) as a gum with 
[a]D - 98 0 (c, 0.5 in methanol) (Scheme 84). This dilactone (180) was
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characterised by the IR carbonyl stretching frequency at 1789 cm'1. The 
high resolution mass spectrum gave a value for the molecular ion of 
184.0728 (C9H120 4, requires M, 184.073. Unfortunately no 3-propyl-2- 
cis-4-trans-muconic acid (179) was recovered. Having acquired the (-)- 
1-propylmuconodilactone, it was not neccessary to synthesise this 
dilactone via the bromodilactone.
Scheme 84
Cyclisation 
upon storage at R.T
COOH
O
H
(177) (180)
The results of these feeding experiments are contained in the 
Table 3 on page 108.
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23.1.5 Metabolism of 4-n-Butylpyrocatechol (126)
Since 4-propylpyrocatechol was less efficiently metabolised than 
the derivatives with shorter alkyl groups, 4-n-butylpyrocatechol (126) 
was tested as a substrate.
Unmetabolised 4-butylpyrocatechol (126) was recovered at pH 
7.5. The total metabolites extracted at pH 2.5 the total were examined by 
JH NMR spectroscopy. This spectrum indicated that the major 
components were 3-butylmuconolactone (181) and 3-butyl-2-cis-4-trans- 
muconic acid (182). Also present were much smaller amounts of 4- 
butylmuconolactone (183). However, the combined amount of 
metabolites was distinctly less than with the foregoing pyrocatechols and 
a larger amount of 4-butylpyrocatechol was recovered (Scheme 85). 
Scheme 85
Me
OH
(126)
Pseudomonas
putidaV
Me Me MeHOOC
COOH
O
+
O
+
HOOC
COOH
(183) (181) (182)
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The *H NMR spectrum indicated that the metabolites (183), (181) 
and (182) were present in a ratio of 1:3:3. As the 4-n- 
butylmuconolactone (183) was present in very small quantities in the 
total extract it was decided not to pursue the separation of these 
components by preparative thin layer chromatography.
The results of this feeding experiment is contained in Table 4 on 
page 114.
2.3.1.6 Metabolism of 4-t-butyIpyrocatechoI (161)
Having fed 4-butylpyrocatechol (126) and discovered that the 
chain length of the 4 carbons is not easily accomodated by the 
dioxygenase enzyme, we decided to feed 4-t-butylpyrocatechol (161) to 
see if the bulkier but shorter (two carbon) group would be more 
acceptable to the organism. 4-t-Butylpyrocatechol (161) was recovered 
from the medium at pH 7.5. The *H NMR spectrum of the metabolites 
extracted at pH 2.5 showed that few products were present. Neither the
4- or 3- substituted t-butylmuconolactones were present, nor was the 3-t- 
butyl-2-c/s-4-rrarts-muconic acid. Several signals were present at 6 7.1 
and 6.2. It was decided to chromatograph this extract in order to identify 
the metabolites present. Preparative TLC using the standard conditions 
gave 3-t-butyl-2-pyrone-5-carboxylic acid (184) as a yellow gum with RF 
0.5. The *H NMR spectrum showed two singlets with fine splitting at 5 
7.24 and 6.33 corresponding to the vinyl protons. The structure (184) 
was established by IR and *H and 13C NMR spectroscopy and accurate 
mass measurement. This product is thought to have been formed via 
meta cleavage rather than ortho cleavage, suggesting that the tertiary
110
butyl group was not accommodated by the 1,2-dioxygenase. Therefore, 
2,3-dioxygenase activity was induced instead (Scheme 86).
Scheme 86
OH
OH
Pseudomonas
putida
OH
OH
(161)
O O '  'COOH
(184)
The results of this feeding experiment are contained in Table 4 on page 
114.
2.3.1.7 Metabolism of 4-Trifluoromethylpyrocatechol (121)
4-Trifluoromethylpyrocatechol (121) was fed to Pseudomonas 
putida to investigate the effect on dioxygenase cleavage of a 
trifluoromethyl group as opposed to a simple methyl group. The 
trifluoromethyl group and methyl group are very similar in size but have
111
very different electronic properties. Thus the Hammett constants, om, are 
+ 0.46 and - 0.06 for CF3 and CH3 respectively.
Unmetabolised 4-trifluoromethylpyrocatechol (121) was 
recovered at pH 7.5. The metabolites extracted at pH 2.5 gave a dark- 
brown tar. The total extract was examined by *H NMR spectroscopy, 
which showed few distingishable proton signals. This extract was then 
chromatographed to identify any metabolites present.
However, preparative TLC using the standard conditions did not yield 
any metabolites. Several bands were extracted but the NMR spectra of 
the extracts showed few proton signals. It was therefore concluded that 
the electron-withdrawing character of the trifluoromethyl group was 
unacceptable to the dioxygenase enzyme.
The results of this feeding experiment are contained in Table 5 on 
page 115.
23.1.8 Metabolism of 3-Chloro-5-methyIpyrocatechol (128)
3-Chloro-5-methylpyrocatechol (128) was fed to Pseudomonas 
putida to examine the effect on ring cleavage of a chlorine in the 3 
position of 4-methylpyrocatechol. It was also hoped that this would lead 
to the formation of 2-chloro-4-methylmuconolactone (185) which could 
then be converted into the corresponding bromodilactone (186) to 
determine the configuration of lactones acquired enzymically from the 
feeding of 2-chloro-4-methylphenoxyacetate to Pseudomonas sp. B13 by 
D.H.Pieper50’96’102 107 (Scheme 87).
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Scheme 87
OHCl
OH
Pseudomonas
putida CH,O
COOH
(128)
CH
(185)
NaHC03 (ac 
Br2, CH2 CI2
(186)
However, 3-chloro-5-methylpyrocatechol (128) was recovered in large 
quantities, thus suggesting that the dioxygenase enzyme did not readily 
accept this pyrocatechol as a substrate. The ether extracts of the medium 
at pH 2.5 gave a dark-brown oil. The total extract was examined by *H 
NMR spectroscopy. Few proton signals present corresponded to any of 
the metabolites expected to have arisen. Preparative TLC did not give 
any metabolites. It was therefore concluded that the dioxygenase enzyme 
of Pseudomonas putida would not accept the chloro derivative (128) as a 
substrate.
The results of this feeding experiment are contained in Table 5 on 
page 115.
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2.3.2 In Aspergillus niger
Several pyrocatechols were fed to an Aspergillus niger mutant 
(that accumulates 3-methylmuconolactone) for the following reasons:
1. 3-Chloro-5 -methylpyrocatechol (128) was fed to elucidate the 
configuration of the 5-chloro-4-methylmuconolactones produced by
-r~» • 50,96,102,107Pieper.
2. 4-Isopropylpyrocatechol (120) and 4-propylpyrocatechol (124), which 
were efficiently metabolised by Pseudomonas putida, were fed as 
possible substrates for the dioxygenase and cycloisomerase enzymes in 
Aspergillus niger.
All the pyrocatechols were fed to cultures of Aspergillus niger. 
The utilization of glucose in the original glucose-salts medium was 
monitored by UV spectrometry and when all the glucose had been 
consumed the substrates were fed in two batches over a period of 24 
hours. The pH of the broth was maintained at pH 5.5 throughout the 
feeding experiment. The contents of the culture flasks were combined 24 
hours after the second feeding and filtered to remove the mycelium. The 
pH was adjusted to 7.2 and extraction with ether was performed to 
remove any non-acidic material. The broth was then adjusted to pH 2.0 
with phosphoric acid and extracted with ether. After this manual 
extraction the broth was then continuously extracted with ether for 48 
hours. As with Pseudomonas putida, 4-methylpyrocatechol was fed as a 
control each time.
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2.3.2.1 Metabolism of 3-ChIoro-5-methylpyrocatechol (128) and 
4-Methylpyrocatechol (44)
3-Chloro-5-methylpyrocatechol (128) was fed to Aspergillus niger 
in an attempt to produce the corresponding ‘fungal’ lactone 5-chloro-3- 
methylmuconolactone (187), in order to assist with the determination of 
the configuration of the lactones isolated in work carried out by Pieper 
(Scheme gg^ 50-96-102-107 ^  structure (187), syn cyclisation onto the usual 
face of the double bond has been assumed.
Scheme 88
OHCl
OH
CHgHOOCAspergill! us 
niger
(187)
O
(188)
Extraction at pH 7.2 gave 3-chloro-5-methylpyrocatechol (128) in 
large amounts. The ether extracts of the medium at pH 2.0 were 
evaporated to give a mid-brown oily solid. After manual extraction of 
the medium at pH 2.0 the remaining aqueous broth was extracted 
continuously with ether for 48 hours. The extracts were dried and
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evaporated to give a further oily solid. Both extracts were examined 
separately by *H NMR spectroscopy, However, neither spectrum showed 
proton signals that corresponded to any likely metabolic products. 
Preparative TLC on both the manual and continuous extract using the 
standard solvent system, of diisopropyl ether: formic acid: water 
(200:7:3), failed to give any metabolites, although some highly coloured 
bands were removed which showed few proton signals when examined 
by *H NMR spectroscopy. 3-Chloro-5-methy lpyrocatechol (128) was fed 
several times to Aspergillus niger, but each time the fungus failed to 
convert any of the pyrocatechol into recognisable metabolites.
4-Methylpyrocatechol (44) was fed as a control each time to 
Aspergillus niger to ensure that the organism was functioning as normal. 
This was particularly important with Aspergillus niger, as on several 
occasions it failed to metabolise 4-methylpyrocatechol (45) and a new 
batch of the organism had to be used. Unmetabolised 4- 
methylpyrocatechol (44) was recovered from the medium at pH 7.2. At 
pH 2.0, manual extraction gave an oily solid. The remaining broth was
i
then continuously extracted with ether. H NMR spectra of both extracts 
showed 3-methylmuconolactone (48) to be present as expected.
Scheme 89
OH
OH
Aspergillus
niger
HOOC
(44) (48)
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Preparative TLC under the standard conditions recovered 3- 
methylmuconolactone (48) as an off-white gum with [a]D- 26 0 (c, 0.3 in 
methanol). However, this rotation is low in comparison to the literature 
value, [a]D- 36 0 (c, 10.9 in water).177 The IR spectrum showed the 
characteristic carbonyl stretching frequency at 1732 cm'1, while high 
resolution mass spectroscopy gave a molecular weight of 156.0419, 
(C7H80 4, requires M, 156.0422).
It was of concern that, after dioxygenase cleavage of the pyrocatechol in 
Aspergillus niger, the resulting cis,cis-mucomc acid would cyclise non- 
enzymically to form the racemic 3-methylmuconolactone (51).
Therefore further confirmation of the functional activity of the enzyme in 
the organism was achieved by conversion of (-)-3-methylmuconolactone 
(48) to the corresponding bromodilactone (53) using the standard 
method.152 Debromination using tributyltin hydride gave the (-)-l- 
methylmuconodilactone (54) with [a]D- 130 ° (c,1.2 in methanol),
175which is in accordance with literature values.
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Scheme 90
ch3HOOC
(48)
1. NaHC03 (aq) 
Br2, CH2 CI2
2. Na2S205
CH.
O
H
CH.
OO
H
(53)
(54)
The results of these feeding experiments are contained in Table 6 
on page 123.
2.3.2.2 Metabolism of 4-IsopropyIpyrocatechol (120)
4-Ethylpyrocatechol (119) had been shown previously into be 
converted into the corresponding ‘fungal’ lactone 3-ethylmuconolactone 
in a modest yield of 7 %.172 It was decided that 4-isopropylpyrocatechol
(120) should be fed to see if the organism could cope with a larger alkyl 
group, of the same chain length (C2) in the 4-position.
Extraction at pH 7.2 gave unmetabolised 4-isopropylpyrocatechol (120). 
The ether extracts of the medium at pH 2.0 were evaporated to give a 
dark brown oily solid. Continuous ether extraction of the aqueous broth 
after this manual extraction produced further quantities of a brown oily
120
solid. !H NMR spectra of both of these extracts showed very small 
quantities of 3-isopropylmuconolactone (189) with characteristic 
NMR signals at 5 5.36 (ddd, J  8.5, 3.9 and 1.6 Hz) and 5.85 (s with fine 
splitting) for 4-H and 2-H respectively. Preparative TLC of both of these 
extracts gave small quantities of 3-isopropylmuconolactone (189) as an 
off-white gum.
Scheme 91
Me. Me
OH
OH
Aspergillus
niger
MeMe.
HOOC
(120) (189)
3-Isopropylmuconolactone (189) was characterised by the IR 
carbonyl stretching frequency at 1757 cm'1. The high resolution mass 
spectrum gave a molecular weight of 184.0727 (C9H120 4 requires M , 
184.0736). Unfortunately, such small quantities of (189) were obtained 
that an accurate [a]D reading could not be obtained. It was therefore not 
determined whether the 3-isopropylmuconolactone (189) was formed by 
the methylmuconolactone cycloisomerase or by non-enzymic 
cyclisation. It can, however, be concluded that the dioxygenase enzyme 
present in Aspergillus niger was capable to some extent of cleaving 4- 
isopropylpyrocatechol (120).
The results of this feeding experiment are shown in Table 6 on 
page 123.
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2.3.2.3 Metabolism of 4-n-Propylpyrocatechol (124)
Although 4-isopropylpyrocatechol (120) was only metabolised to 
a very small extent, 4-n-propylcatechol (124) was fed to complete the 
experiments with the fungus.
4-Propylpyrocatechol (124) was recovered upon manual extraction 
with ether of the medium at pH 7.2. Acidification to pH 2.0 and manual 
ether extraction followed by continuous extraction for 48 hours produced 
black, tar-like solids in small quantities. Both extracts were examined by 
*H NMR spectroscopy, but showed few signals that corresponded to any 
expected metabolites. Attempts were not made to purify these extracts 
by TLC as the *H NMR spectra suggested that no enzymic metabolites 
were present.
The results of this feeding experiment are shown in Table 6 on 
page 123.
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2.3.3 Studies with Rhodococcus rhodocrous N75 (in collaboration
with the University of Newcastle)
The pyrocatechols, 4-alkylmuconolactones (163) and 1- 
alkylmuconodilactones prepared in this study were made available to 
Professor R.B. Cain’s group (University of Newcastle) to test as 
substrates for the enzymes of Rhodococcus rhodocrous N75, as part of a 
continuing, collaborative project on the muconic acid pathways. The 
conversion of the enzymic 4-alkylmuconolactone (163) to 3- 
alkylmuconolactone (190) is shown in Scheme 92.
The bacterium R. rhodocrous N75 has the special ability to 
produce a methylmuconolactone methyl-isomerase, which catalysises 
the isomerisation of 4-methylmuconolactone (50) into 3- 
methylmuconolactone (48) (See Scheme 24, Section 1.5.4). So far, the 
following results have been obtained at Newcastle with the present 
author’s substrates (see Table 7) . 178 Not all the enzymic assays have yet 
been completed.
Scheme 92
COOH
Rhodococcus 
rhodocrous N75 HOOC
O
(163) (190)
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Table 7. Relative activities of the methylmuconolactone methyl- 
isomerase from Rhodococcus rhodocrous N75.
R Relative rates of 
enzyme activity
Methyl 100
Ethyl 34
Isopropyl 22
n-Propyl 12
Allyl 1
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2.3.4 CONCLUSIONS
Pseudomonas putida
Six 4-alkylpyrocatechols(162) were fed, many several times, to 
intact cells of the bacterium in parallel with 4-methylpyrocatechol (44) 
as a control. The aim was to probe the effect of the size and shape of the 
alkyl group on the activity of the two relevant enzymes, the dioxygenase 
(pyrocatechase) and the cycloisomerase (lactonising), acting in 
succession. The yields of the 4-alkylmuconolactones (163) in Table 8 are 
average values from Tables 1-5 for those pyrocatechols fed on more than 
one occasion. Gratifyingly, the average, methyl control conversion 
(46%) was the same as that measured precisely by NMR integration 
with the iodoform standard for the feeding experiments with the 4-ethyl 
and 4-isopropyl - pyrocatechols.
Scheme 93
R
Pseudomonas
putida
COOHOH
(162) (163)
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Table 8. 4-Alkylmuconolactones (162) from 4-alkylpyrocatechols (163) 
in Pseudomonas putida
R Average % Yield of 
Lactone
Methyl 46
Ethyl 46
Isopropyl 31
n-Propyl 14
Allyl 10
n-Butyl trace
t-Butyl -
Since two enzymes are responsible for the production of the 4- 
alkyl lactones, it is not possible to make independent quantitative 
assessments of their individual activities. However, several broad 
conclusions clearly emerge. Thus, the methyl and ethyl derivatives 
behaved the same within experimental error. The yield from 4- 
isopropylpyrocatechol was significantly less, and substantially more 
pyrocatechol was recovered than in the control feedings. A much larger 
drop in yield was observed with the propyl and allyl derivatives, and 
again substantial amounts of the pyrocatechols were recovered. 4- 
Butylpyrocatechol was a very poor substrate (64% recovered) and only 
traces of metabolites were detected. Finally, 4-ter/-butylpyrocatechol 
gave no detectable product of ortho cleavage and 68% of this substrate 
was recovered.
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Two of the pyrocatechols fed to Pseudomonas putida, 4- 
trifluorome thy lpyrocatechol (121) and 3-chloro-5-methy lpyrocatechol 
(128) failed to act as substrates. Clearly 4-trifluoromethylpyrocatechol
(121) was not a substrate for the dioxygenase enzymes, presumably due 
to the electron-deficient nature of the aromatic ring, but we can draw no 
conclusions about the cycloisomerase specificity. That 3-chloro-5- 
methylpyrocatechol (128) also failed to act as substrate for the 
dioxygenase enzyme, perhaps is due to electronic or steric reasons.
The findings can be most simply interpreted in terms of the size 
and shape of the region in the active site of the dioxygenase 
accomodating the 4-alkyl group. Ethyl and isopropyl groups, having 
chains of two carbons, clearly fit well even though the latter is much 
wider. However, the tert-butyl group is too bulky to fit the appropriate 
pocket in the active site. Also, the three-carbon chains of the propyl and 
allyl groups are less well accommodated than the shorter chains of the 
methyl, ethyl and isopropyl groups.
It is not possible to draw detailed conclusions about the 
cycloisomerase. However, the yields of 3-alkylmuconolactones, products 
of non-enzymic cyclisation of the cis, cis-muconic acids, and of the cis, 
trans-muconic acids, metabolically inert products of non-enzymic cis- 
trans isomerism, give some indication of reduced cyclioisomerase 
activity. Broadly, the cyclisomerase tolerates ethyl and isopropyl groups 
well but appears to show less activity, for propyl and allyl groups. 
Interestingly, competitive meta cleavage of the pyrocatechols, leading to 
the pyrone carboxylic acids has been observed for the first time, even 
with 4-methylpyrocatechol.
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From the purely preparative viewpoint, these experiments show 
that optically active 4-alkylmuconolactones having Me, Et and Pr1 
groups can be synthesised in acceptable yields from pyrocatechols. 
Extraction of the crude products with chloroform selectively dissolves 
the 4-alkylpyrocatechols, the other metabolites being less soluble. At 
present, there is no high-yielding, chemical synthesis of even racemic 4- 
alkylmuconolactones, so the microbial synthesis of even the propyl and 
allyl derivatives is the method of choice.
Quantitative assessment of the substrate specificity of the 
cycloisomerase would require a different approach. It would be 
necessary first to synthesise the labile 3-alkyl-cis,cis-mucomc acids as 
their disodium salts. So far, only the methyl derivative has been 
synthesised. Then, measurements of cyclase activity would require 
supplies of at least partially purified enzyme since competitive, non- 
enzymic, cis-trans isomerism of the muconic acids occurs even at pH 7. 
Also it is possible that efficient uptake of the cis-cis-mucomc acids into 
intact cells would not take place; these intermediates are normally 
formed intracellularly. Experiments of this kind are planned for the 
future.
Aspergillus niger
In general, the fungus was not as efficient as the bacteria in 
metabolising 4-alkylpyrocatechols. As with Pseudomonas putida, an 
increase in the length of the 4-alkyl chain of the pyrocatechol reduced 
the yield of the corresponding 3-alkylmuconolactone (Scheme 94) 
(Table 9).
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Scheme 94
Aspergillus HOoc ?
niger \ \
 “  * 0
O
(190)
Table 9. Conversions of 4-alkylpyrocatechols (163) into 3- 
alkylmuconolactones (190) in Aspergilllus Niger.
R % Yield of Lactone
Methyl 11
Ethyl 7
Isopropyl 4
n-Propyl -
Studies with Rhodococcus rhodocrous N75 (in collaboration with the 
University of Newcastle)
The pyrocatechols, 4-alkylmuconolactones and 1- 
alkylmuconodilactones prepared in this study were made available to 
Professor R.B. Cain’s group (University of Newcastle) to test as 
substrates for the enzymes of Rhodococcus rhodocrous N75, as part of a 
continuing, collaborative project on the muconic acid pathways. Not all 
the enzymic assays have yet been completed.
A
OH 
OH
(163)
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The bacterium R. rhodocrous has the special ability to produce a 
methylmuconolactone methyl-isomerase, which catalysis the 
isomerisation of 4-methylmuconolactone (50) into 3- 
methylmuconolactone (48) (See Scheme 24, Section 1.5.4 ). So far, the 
following results have been obtained at Newcastle with the present 
author’s substrates.
Dioxygenase / pyrocatechase. The cleavage of the pyrocatechols (162) 
by cell-free extracts of p-toluate-grown R. rhodocrous N75 was studied 
by measuring the rates of oxygen uptake (Table 7). The dependence of 
rate upon the length and size of the 4-alkyl group corresponded 
remarkably well with that observed with P. putida, with the unexpected 
exception that 4-terr-butylpyrocatechol was cleaved at about the same 
rate as the derivatives with propyl and allyl groups. It appears that the 
‘alkyl pocket’ on the enzyme from Rhodococcus is wider than that on 
the Pseudomonas enzyme, but has approximately the same length.
Methyl-isomerase. The rates of isomerisation of the 4- 
alkylmuconolactones, to give the 3-alkyl isomers, were studied with the 
methyl-isomerase from Rhodococcus (Table 7). These relative rates 
correspond broadly with those tentatively assigned to the cycloisomerase 
from P.putida, with the notable exceptions that the ethyl lactone was 
isomerised significantly more slowly than the methyl standard and the 
allyl derivative was a much poorer substrate than its dihydro form. 
Nevertheless, somewhat similar restrictions apply to the size of the alkyl 
group accommodated by this enzyme with a distinctly different function.
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Scheme 92
P Rhodococcus
rhodocrous N75
\   ►
COOH
(163) (190)
HOOC
Table 7. Relative activities of the methylmuconolactone methyl- 
isomerase from Rhodococcus rhodocrous N75.
R Relative rates of 
enzyme activity
Methyl 100
Ethyl 34
Isopropyl 22
n-Propyl 12
Allyl 1
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CHAPTER 3 EXPERIMENTAL
3.1 GENERAL
Melting points were measured on a Kofler hot-stage apparatus and 
are uncorrected. Boiling points refer to the oven temperature of a Btichi 
GKR-50 Kugelrohr. Infrared (IR) spectra were obtained on a Perkin 
Elmer 580 spectrometer. Nuclear magnetic resonance (NMR) spectra 
were recorded on a Perkin Elmer R32 spectrometer operating at 90 MHz, 
or a Bruker WP200-SY spectrometer operating at 200 MHz (*H) or 50.3 
MHz (13C). The multiplicities of the 13C NMR spectra were determined 
using DEPT spectra with pulse angles of 0 = 90° and 0 = 135°. Mass 
spectra were obtained using A.E.I. MS 12 or 902 spectrometers. 
Elemental analyses were obtained with a Carlo-Erba 1106 elemental 
analyser. Optical rotations were determined on a AA/100 Polarimeter 
(Optical Activity Ltd) at 20°C.
Flash column chromatography was carried out on Merck Kieselgel 
silica HF254 under reduced pressure. Analytical thin layer chromatography 
(TLC) was carried out on precoated Merck Kieselgel silica G F 254. Spots 
were viewed under a UV lamp (254 nm) and developed by iodine vapour. 
Preparative TLC was carried out on 20 x 20 cm Merck Kieselgel silica 
GF254 glass plates of 0.25 mm thickness in diisopropyl ether - formic acid 
- water (100 : 7 : 1).
All solvents were purified by standard techniques. Ether refers to 
diethyl ether.
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3.2 CHEM ICAL SYNTHESIS
3.2.1 4-Isopropylpyrocatechol (120) and Metabolites
4-Benzoyloxy-3-hydroxyisopropylbenzene (138)
A mixture of 4-isopropylphenol (137) (6.8 g, 0.05 mol), benzoyl peroxide 
(12.11 g, 0.05 mmol) and dried chloroform (50 cm3) was heated under 
reflux for 6 h. The mixture was cooled to ambient temperature and the 
resultant brown solution was washed with saturated sodium bicarbonate 
(3 x 50 cm3) until pH of the washes remained alkaline. The chloroform 
layer was dried over sodium sulfate, filtered and evaporated to dryness 
under reduced pressure. The resulting dark brown oil was found to be a 
mixture of the desired ester and unreacted starting material. The mixture 
was purified by column chromatography on basic alumina and elution 
with ethyl acetate : light petrol (b.p. 40-60 °C) (7:3). Kugelrohr 
distillation gave the required ester (138) as an off-white solid gum (2.6 g, 
yield 20 %); vmax(CHCl3) 3027, 2964, 1740, 1268, 1229,1220, 1176, 
1113 and 1024cm 1; 5h(200MHz) (CDC13) 1 .24(6H ,d ,/ 7  H z,M e2), 
2.78 (1H, septet, J 7 Hz, CHMe2), 6.79 - 7.1,7.47 - 7.64 and 8.18- 8.23 
(8H, m, Ar-H); mlz (Found: M+ 256.1097. C16H16O3 requires 256.1099).
4-IsopropylpyrocatechoI (120)
The ester (138) (2.56 g, 10 mmol) was added slowly portionwise with 
stirring to sodium hydroxide (0.8 g, 20 mmol) in water (100 cm3) under 
nitrogen. The solution became dark in colour and was stirred for 16 h. 
The resulting solution was acidified with concentrated hydrochloric acid,
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saturated with sodium chloride and extracted with ether (3 x 100 cm3). 
The extract was dried and evaporated under reduced pressure. Kugelrohr 
distillation gave a pale yellow liquid which crystallised to form the 
desired 4-isopropylpyrocatechol (120) as pale yellow crystals (0.5 g, 
yield 33 %), m.p 76-77 °C (lit.,135 78 °C); vmax(KBr disc) 3431, 3316, 
2957, 1522 and 1286 cm'1; 6H(200 MHz) (CDC13) 1.14 (6H, d, J  10 Hz, 
Me2), 2.72 (1H, septet, J  10 Hz, CHMe2), 5.9 (1H, br.s, OH exch. with 
D20 )  and 6.60-6.79 (3H, m, A r-H ); 6C (50 MHz) (CDC13) 24.1 (Me2),
33.4 (CHMe2), 113.9, 115.6, 119.1 (Ar-H), 141.0 (C-4), 142.7 and 143.2 
(C-l and C-2); mlz 152 (M+) (Found: M+ 152.0821. C9Hi20 2 requires 
152.0837) (Found : C, 71.2; H, 7.65 %. C9Hi20 2 requires C, 71.05; H,
7.9 %).
Potassium Nitrosodisulfonate - Frem y’s S a lt133 
The procedure given by Singh133 was followed with some modifications. 
In a 5L three neck - round bottomed flask was placed distilled water 
(1000 cm3) and crushed ice (500 g), sodium bicarbonate (79.2 g, 0.94 
mol) and sodium nitrite (66 g, 0.96 mol). The mixture was thoroughly 
mixed with a mechanical stirrer and was externally cooled to - 5 °C by a 
mixture of salt and ice. Sulfur dioxide was passed into the mixture 
rapidly, and the temperature was maintained at - 5 °C to - 2 °C. When the 
colour changed to orange - brown (50 min), the passage of sulfur dioxide 
was immediately stopped. The mixture was stirred for an additional 10 
min, during which time it became colourless. Nitrogen was bubbled 
through the solution for 5 min and the solution was adjusted to pH 10.1 
with 18 % ammonium hydroxide (50 cm3). The solution was stirred at -2
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°C for a further 30 min. Potassium permanganate (120 g) in water (360 
cm3) was cooled to - 3 °C and then added portionwise at a rate which 
kept the reaction temperature below 5 °C. The mixture was stirred for 1 h 
and then allowed to stand at the same temperature for 1 h. The dark 
brown slurry was filtered through a Celite bed into a saturated solution of 
potassium chloride (500 g) in water (140 cm3). The solution was cooled 
and yielded an orange crystalline precipitate which was collected by 
vacuum filtration. The solid was washed with saturated potassium 
chloride and ammoniacal methanol (containing 10 % concentrated 
ammonia) and dried under vacuum over calcium oxide, in the presence of 
ammonium carbonate in a separate dish to provide an ammonia 
atmosphere. The product was stored in a refrigerator (107 g, yield 42 %, 
based on sodium bicarbonate).
CAUTION: This salt must not be stored in a sealed vessel; 
decomposition may cause a pressure explosion.
Attempted Preparation of 4-Isopropyl-l,2-benzoquinone (139)
A solution of sodium dihydrogen phosphate (1.5 g) in water (500 cm3) 
was placed in a conical flask. To this solution was added potasssium 
nitrosodisulfonate (Fremy’s salt) (9 g, 34 mmol) and the mixture was 
shaken to dissolve the inorganic radical. A solution of 4-isopropylphenol 
(137) (1.6 g, 11.8 mmol) in ether (35 cm3) was added quickly to the 
purple solution and the mixture was stirred vigorously for 20 min. The 
colour of the solution changed to red - brown and the solution was 
extracted with chloroform (3 x 200 cm3). The combined organic layers 
were dried over anhydrous sodium sulfate for 5 min, filtered, and
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evaporated under reduced pressure at 20 - 23 °C (higher temperatures 
may accelerate dimerization of the product) to give an oil. The oil was 
slurried twice with ether (2x15  cm3) at 0 °C and the orange /  yellow 
crystals produced collected by filtration (0.5 g). The 1H NMR spectrum 
was complex and could not be interpreted.
4-Isopropylpyrocatechol (120)
A solution of 4-isopropyl-1,2-benzoquinone (139) in chloroform (600 
cm3) was prepared as before. Potassium iodide (3 g, 18.1 mmol) in acetic 
acid (200 cm3) was added to the dark red solution and the mixture stirred 
for 2 min. The resultant mixture was washed with sodium bisulfite 
solution (100 cm3 of 5 % w/v). The chloroform layer was washed once 
with water (500 cm3), dried with sodium sulfate, filtered and evaporated 
under reduced pressure to give a dark red oil which was a mixture of the 
desired 4-isopropylpyrocatechol (120) and 4-isopropylphenol (137), as 
judged by TLC. The mixture was purified by column chromatography on 
basic alumina and elution with diethyl ether : light petrol (b.p. 40 - 60 °C) 
(1:5). The product (120) was obtained as a dark red oil which was 
Kugelrohr distilled to produce a pale yellow crystalline solid (0.6 g, yield 
36 %), m.p 75-76 °C (lit.,135 78 °C); vmax (KBr disc) 3425,3305,2958, 
1519,1376 and 1281 c m 1; 5h (200 MHz) (CDC13) 1.12 (6H, d , / 7  Hz, 
Me2), 2.7 (1H, septet, J  7 Hz, CHMe2) and 6.57 - 6.80 (3H, m, A r-H );
6C (50 MHz) (CDC13) 23.9 (Me2), 33.2 (CHMe2), 113.8, 115.6,118.7 
(Ar-H), 141.1 (C-4) and 142.2 and 143.2 (C-l and C-2); m/z 152 (M+) 
(Found: M+ 152.0836. C9H12O2 requires 152.0837)
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4-IsopropyI-2-nitrophenol (151)
4-Isopropylphenol (137) (2.8 g, 20.6 mmol) was dissolved in glacial 
acetic acid (50 cm3) and the mixture cooled to 18 - 20 °C. Nitric acid (2.5 
cm3, sp.gr 1.42) was dissolved in acetic acid (10 cm3) and the resultant 
solution was added dropwise with stirring. After the addition the reaction 
mixture was allowed to stand for 15 min at 18 - 20 °C. Water (500 cm3) 
was added and the solution neutralised with sodium hydroxide (20%).
The aqueous solution was extracted with ether (3 x 250 cm3). The organic 
layer was washed with water (2 x 400 cm3), dried with sodium sulfate, 
filtered and evaporated under reduced pressure to give a dark yellow oil 
(2.9 g) which was a mixture of the desired 4-isopropyl-2-nitrophenol 
(151) and the by-product 4-isopropyl-2,6-dinitrophenol. The mixture was 
purified by column chromatography on basic alumina and elution with 
ethyl acetate - light petrol (b.p. 40 - 60 °C) (1:5). The product (151) was 
obtained as a dark yellow oil which was then Kugelrohr distilled to 
produce a pale yellow oil (2.2 g, yield 59 %); vmax (thin film) 3252, 2964, 
2932,2872,1630 and 1537 cm'1; 5h (200 MHz) (CDC13) 1.22 (6H, d, J  7 
Hz, Me2), 2.9 (1H, septet, J  7 Hz, CHMe2), 7.04 (1H, d, J  8.6 Hz, 6-H), 
7.44 (1H, d with fine splitting, J  8.6 Hz, 5-H), 7.89 (1H, s with fine 
splitting, 3-H) and 10.4 (1H, s, OH,); 5C(50 MHz) (CDC13) 23.6 (Me2), 
33.0 (CHMe2), 119.6 (C-6), 121.7 (C-5), 136.4 (C-3), 133.1 (C-4), 141.1 
(C-l) and 153.2 (C-2); m/z 181 (M+) (Found: M+ 181.0735. C9H n 0 3N 
requires 181.0739). The by-product 2,6-dinitro-4-isopropylphenol (0.7 g, 
yield 15 %) was obtained as a dark red oil; 5h (200 M Hz) (CDC13) 1.29 
(6H, d, /  7 Hz, Me2), 3.00 (1H, septet, J 7 Hz, CHMe2) and 8.17 (2H, s,
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3-H and 5-H); 5C(50 MHz) (CDCI3) 23.4 (Me2), 33.1 (CHMe2), 129.4 
(C-3 and C-5), 137.5 (C-4), 140.3 (C-l) and 147.5 (C-2 and C-6).
(±)-3-Isopropylmucolactone (152)
4-Isopropyl-2-nitrophenol (151) (4.4 g, 24 mmol) was added in portions 
to concentrated sulfuric acid (15 cm3) at 110 -115 °C over 2 h with 
stirring. The black mixture was stirred for a further 30 min at 110 -115 
°C, then cooled to room temperature and carefully poured onto crushed 
ice (200 g). When the ice had melted, the aqueous solution was saturated 
with sodium chloride and extracted continuously with ether for 48 h. The 
ethereal extract was dried over sodium sulfate, filtered and evaporated to 
give the lactone (152) as a dark red oil (2.5 g, yield 56 %); vmax (thin 
film) 2972, 1746, 1634, 1364, 1273, 1233 and 1172 cm'1; 5H(200 MHz) 
(CDCI3) 1.10 (3H, d, /  7 Hz, Me), 1.17 (3H, d, J 1 Hz, Me), 2.00 (1H, 
septet, CHMe2), 2.86 (1H, dd, J  16.4 and 3.7 Hz, 5-H), 2.47 (1H, dd, J
16.4 and 8.6 Hz, 5-H), 5.31 (1H, d d d ,/ 8.6, 3.7 and 1.5 Hz, 4-H), 5.76 
(1H, s with fine splitting, 2-H), 10.4 (1H, s, OH); 6C (50 MHz) (CDC13)
19.5 and 20.8 (Me2), 26.7 (CHMe2), 36.3 (C-5), 78.5 (C-4), 113.7 (C-2),
172.3 (C=0) and 177.4 (C=0); m!z 184 (M+) (Found: M+ 184.0735. 
C9Hi204 requires 184.0736).
(+) -l-Isopropyl-8-bromomuconodilactone (153)
(+)-3-Isopropylmuconolactone (152) (1.84g, 10 mmol) was dissolved in 
aqueous sodium hydrogen carbonate (30 cm3, 0.33 M). Bromine (1.6 g,
10 mmol) in dichloromethane (50 cm3) was added to the solution at 0 °C 
with stirring. The mixture was warmed to ambient temperature and stirred
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for 7 h. Aqueous sodium thiosulfate was added to remove traces of 
bromine. The mixture was extracted with dichloromethane (3 x 100 cm3) 
and the combined extracts were dried with magnesium sulfate. 
Evaporation of the solvents gave the bromodilactone (153) as a brown 
oily solid, which failed to crystallise from chloroform - hexane, (2.3 g, 
yield 87 %); vmax(CHCl3) 3026,1799,1226 and 1205 cm 1; 6H(200 
MHz) (CDCI3) 0.96 (3H, d, J  6.7 Hz, Me), 1.09 (3H, d, J  6.7 Hz, Me), 
2.65 (1H, septet, J 7 Hz, CHMe2), 2.90 (1H, d, J  19.2 Hz, 4-H), 3.10 
(1H, dd, J  19.2 and 5.0 Hz, 4-H), 4.55 (1H, s, 8-H) and 5.20 (1H, d, J  4.8 
Hz, 5-H); 6C (50 MHz) (CDCI3) 15.9 and 16.0 (Me2), 31.7 (CHMe2),
35.7 (C-4), 42.1 (C-8), 80.2 (C-5), 92.8 (C-l), 169.5 (C=0) and 172.0 
(C=0); m/z 264 (M+,81B r ), 262 (M+, 79Br) (Found: M+ 263.9816. 
C9H11O4 slBr requires 263.9821) (Found: M+ 261.9839. C9H n 0 479Br 
requires 261.9841).
(±)-l-IsopropyImuconodi!actone (154)
To a suspension of the bromodilactone (153) (263 mg, 1.0 mmol) in dry 
benzene (4 cm3) was added azoisobutyronitrile (14 mg, 0.1 mmol) under 
nitrogen and the flask sealed with a subaseal. Tributyltin hydride (0.54 
cm3, ca. 1.2 mmol) was introduced with syringe, and the mixture was 
warmed to 30 - 40 °C to give a clear solution. The mixture was heated for 
another 15 min and then kept at room temperature for 1 h with stirring. 
Hexane (3 cm3) was added and a white precipitate formed, which was 
filtered off to give the dilactone (154) as an off-white wax, which failed 
to recrystallise from chloroform-hexane (0.04 g, yield 22 %). vmax (thin 
film) 2972, 1787, 1392, 1282, 1235, 1159, 1123 and 1026 c m 1; 6H(200
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MHz) (CDCI3) 0.98 (3H, d, J  6.8 Hz, Me), 1.05 (3H, d, J  6.8 Hz, Me),
2.02 (1H, septet /  6.8 Hz, CHMe2), 2.62 - 3.00 (4H, m, 4-H2and 8-H2) 
and 4.96 (1H, d with fine splitting, J  4.9 Hz, 5-H); 6c (50 MHz) (CDCI3)
16.6 and 17.4 (Me), 34.1 (CHMe2), 35.9 and 37.4 (C-4 and C-8), 80.2 
(C-5), 93.3 (C-l), 172.8 (C=0) and 173.0 (C=0); mlz 184 (M+); (Found: 
M+ 184.0738. C9Hi20 4 requires 184.0736).
Silver (I) Oxide
Silver nitrate (10 g, 0.059 mmol) was dissolved in water (25 cm3). 
Sodium hydroxide pellets (2.5 g, 0.063 mmol) were dissolved in water 
(20 cm3) and the solution was added to the silver nitrate solution. A 
brown precipitate was produced immediately which was filtered off, 
washed with hot water ( 2 x 1 0  cm3), acetone (10 cm3) and dry ether (3 x 
10 cm3) and stored in a desiccator over phosphorus pentoxide for 1 h (7.7 
g, yield 56 %).
4-Isopropyl-l,2-benzoquinone (139)
4-Isopropylpyrocatechol (102) (0.1 g, 0.66 mmol) was dissolved in dry 
ether (5 cm3) and placed in a dry flask fitted with a silica gel guard tube. 
To this solution was added an ethereal suspension (10 cm3) of silver (I) 
oxide (0.85 g, 3.66 mmol) followed by anhydrous magnesium sulfate 
(0.85 g, 7.08 mmol). This mixture was stirred for 1 h in the dark. The 
solution was filtered through Celite and dry sodium sulfate. The filtrate 
was concentrated to ~ 20 cm3 and refrigerated in the dark for 16 h. The 
solution appeared dark red - green and no crystals were observed. The 
solution was evaporated to dryness in vacuo without heating. The o-
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quinone (139) was produced as a dark red oil, which was unstable when 
stored at -5 °C (0.07 g, yield 71 %); 6H(200 MHz) (CDC13) 1.09 (6H, d, 
J 7 Hz, Me2), 2.51 (1H, septet, /  7 Hz, CHMe2), 6.07 (1H, s with fine 
splitting, 3-H), 6.27 (1H, d, J  10.2 Hz, 6-H ) and 6.94 (1H, d with fine 
splitting, J  10.2 Hz, 5-H ); 5C (50 MHz) (CDC13) 20.0 (Me2), 33.9 
(CHMe2), 124.0 (C-3), 129.5 (C-6), 141.6 (C-5), 160.5 (C-l), 179.6 
(C=0) and 180.1 (C=0).
3.2.2 4-AIkyI Substituted Pyrocatechols
4-AlIylpyrocatechol (125)
Anhydrous aluminium chloride (9.7 g, 72.7 mmol) was suspended in a 
solution of eugenol (123) (10.8 g, 65.9 mmol) in dry dichloromethane 
(100 cm3), in an apparatus protected from atmospheric moisture. Pyridine 
(22.9 g, 0.29 mol) was added slowly while the reaction was cooled to 
maintain the temperature at 30 - 45 °C. The mixture was then heated to 
reflux for 24 h. The solution was cooled to 25 °C and dilute hydrochloric 
acid added until the mixture was acidic to Congo Red indicator. The two 
layers were separated and the aqueous phase was washed with ether. The 
organic layers were dried over sodium sulfate, filtered and evaporated. 
The crude product was purified by column chromatography on a silica 
column using ether- light petrol (b.p. 40-60 °C) (1:5) to give equal 
amounts of eugenol (123) and the desired 4-allylpyrocatechol (125). The 
title compound was Kugelrhor distilled to give a clear oil which failed to 
crystallise (2.3 g, yield 26 %), (lit.,179 m.p. 48 °C); vmax(thin film) 3352, 
3080,1518,1444, and 1282 c m 1; 6h (200 MHz) (CDCI3) 3.21 (2H, d, J
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7 Hz, CH2CH=CH2), 4.96 - 5.06 (2H, m, CH2CH=CH2), 5.77 - 5.97,
(1H, m, CH2CH=CH2) and 6.54-6.78 (3H, m, A r-H ); 6C (50 MHz) 
(CDC13) 39.4 (CH2CH=CH2), 115.6 (CH2CH=CH2), 115.6 and 115.8 (C- 
3 and C-6), 121.1 (C-5), 134.0 (C-4), 137.6 (CH2CH=CH2), 141.3 and
143.4 (C-l and C-2); m/z 150 (M+) (Found: M+ 150.0673. C9Hi0O2 
requires 150.0681).
4-n-PropyIpyrocatechol (124)
4-Allylpyrocatechol (125) (2.19 g, 14.6 mmol) was dissolved in ethanol 
(30 cm3) and hydrogenated in the presence of palladium on carbon 
catalyst (0.7 g, 10 % Pd /C). Hydrogen uptake ceased after 90 min. The 
solution was filtered through Celite and evaporated to give a dark oil. 
Kugelrohr distillation gave the title compound as a white crystalline solid 
(2.07 g, yield 93 %), m.p 59-60 °C (lit.,144 60 °C); vmax (KBr disc) 3389, 
1604,1525,1522,1518 and 1286 c m 1; 6H(200 MHz) (CDC13) 0.91 (3H, 
t, /  7 Hz, CH2CH2CH2), 1.57 (2H, sextet, J 1 Hz CH2CH2CH3), 2.45 
(2H, t, J 7 Hz CH2CH2CH3), 5.86 (2H, br.s, OH exch. with D20 ), 6.57 
(1H, d with fine splitting, J  8 Hz, 5-H), 6.68 (1H, s with fine splitting, 3-
H) and 6.76 (1H, d, /  8 Hz, 6-H); 6C (50 MHz) (CDC13) 13.7 
(CH2CH2CH2), 24.6 ( C K 2 C H 2 C K 3 ) ,  37.2 (CH2CH2CH3), 115.4, 115.7,
121.0 (Ar-H), 136.2 (C-4), 141.0 and 143.1 (C-l and C-2); m/z 152 (M+) 
(Found: M+ 152.0847. C9Hi20 2 requires 152.0837). (Found : C, 71.2; H,
7.9 %. C9Hi20 2 requires C, 71.05; H, 7.9 %).
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4-(2-bromoprop-l-yl)pyrocatechol (142)
Eugenol (123) (1.0 g, 6.10 mmol) was dissolved in dichloromethane (40 
cm3) and cooled to - 78 °C in an acetone / dry ice bath. To this solution 
was added boron tribromide (neat) (1 cm3, 9.22 mmol). The dry ice / 
acetone bath was removed and the mixture warmed to ambient 
temperature and stirred for 24 h. The solution was then cooled in an ice 
bath and ether (50 cm3) added with care. Water (50 cm3) was added to 
the reaction mixture. Two layers formed and the ether layer was removed 
and was washed with water (3 x 50 cm3). The organic layer was 
separated, dried with sodium sulfate, filtered and the filtrate evaporated in 
vacuo to leave a dark brown oily solid (0.56 g, yield 40 %); vmax (thin 
film) 3476, 3348, 1531, 1452, 1444, 1363, 1286, 1259, 1203 and 1172 
cm*1; SH (200 MHz) (CDC13) 1.64 (3H, d, /  7 Hz, CH2CHBrCH2), 2.97 
(2H, ddd, J 1 Hz CHaCHBrCHs), 4.20 (1H, sextet, /  7 Hz 
CH2CHBrCH3), 6.60 (1H, d with fine splitting, J  8 Hz, 5-H), 6.62 (1H, s, 
with fine splitting, 3-H) and 6.78 (1H, d, /  8 Hz, 6-H); 6c (50 MHz) 
(CDCI3) 25.6 (CH2CHBrCH3), 46.6 (CH2CHBrCH3), 51.3 
(CH2CHBrCH3), 115.6, 116.5,122.0 (Ar-CH), 131.9 (C-4), 142.1 and
143.2 (C-l and C-2); mtz 232 (M+,81Br) (Found: M+ 231.9923. 
C9H n 0 281Br requires 231.9923).
2-methoxy-4-propyIphenol (143)
Eugenol (123) (1.0 g, 6.10 mmol) was dissolved in ethanol (30 cm3) and 
the solution was hydrogenated in the presence of palladium on carbon 
catalyst (0.7 g, 10 % Pd /C) under 1 atmosphere of hydrogen. Uptake of 
hydrogen ceased after 4 h. The solution was filtered through Celite and
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the filtrate evaporated to give a dark oil. Kugelrohr distillation gave 2- 
methoxy-4-propylphenol (143) as a clear oil (0.92 g, Yield 91 %); vmax 
(thin film) 2959,2932, 1516, 1269,1234 and 1207 cm*1; 6H(200 MHz) 
(CDC13) 0.92 (3H, t, J  7 Hz, CH2CH2CH3), 1.58 (2H, sextet, J 7 Hz 
CH2CH2CH3), 2.49 (2H, t, J  7 Hz CH2CH2CH3), 3.78 (3H, s, OCH3),
5.76 (1H, br.s, OH exch. with D20 )  and 6.61 - 6.84 (3H, m, Ar-H); 6C 
(50 MHz) (CDCI3) 13.6 (CH2CH2CH2), 24.7 (CH2CH2CH3), 37.6 
(CH2CH2CH3), 110.9, 114.1, 120.8 (Ar-H), 136.2 (C-4), 143.3 and 146.2 
(C-l and C-2); mlz 166 (M+) (Found: M+ 166.0995. C10H14O2 requires 
166.0994).
4-w-Propylpyrocatechol (124)
2-Methoxy-4-propylphenol (143) (1.0 g, 6.02 mmol) was dissolved in 
dichloromethane (40 cm3) and cooled to - 78 °C in an acetone /  dry ice 
bath. To this solution was added boron tribromide (neat) (1ml, 9.2 mmol). 
The dry ice / acetone bath was removed and the mixture warmed to 
ambient temperature and stirred for 24 h. The solution was then cooled to 
0 °C in an ice bath and ether (50 cm3) was added with care. Water (50 
cm3) was added to the reaction mixture and two layers were formed. The 
upper organic layer was removed and washed with water (2 x 50 cm3). 
The lower aqueous layer was washed with ether (3 x 50 cm3). The 
combined organic layers were dried with sodium sulfate, filtered and the 
filtrate evaporated in vacuo to give a dark oil. Kugelrohr distillation gave 
the title compound as a white crystalline solid (0.82 g, Yield 90 %); m.p 
59-60 °C (lit.,144 60 °C). vmax (thin film) 3355,2959, 2929, 2868, 1605, 
1517, 1444, 1348 and 1279 c m 1; 5H(200 MHz) (CDCI3) 0.90 (3H, t, J 1
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Hz, CH2CH2CH2), 1.55 (2H, sextet, J  7 Hz, CH2CH2CH3), 2.43 (2H, t, J  
7 Hz CH2CH2CH3), 6.59 (1H, d with fine splitting, J  8 Hz, 5-H), 6.69 
(1H, s with fine splitting, 3-H) and 6.76 (1H, d, J  8 Hz, 6-H); 5c (50 
MHz) (CDCI3) 13.7 (CH2CH2CH2), 24.6 (CH2CH2CH3), 37.2 
(CH2CH2CH3), 115.4, 115.7, 121.0 (Ar-H), 136.1 (C-4), 141.0 and 143.0 
(C-l and C-2); mlz 152 (M+) (Found: M+ 152.0832. C9H12O2 requires 
152.0837).
4-n-ButyIpyrocatechoI (126)
90% Zinc powder (2 g, 27.0 mmol) was washed with dilute hydrochloric 
acid (20 cm3) and covered with a solution of mercuric chloride (0.4 g, 1.5 
mmol) in water (10 cm3). Amalgamation was effected by occasional 
agitation during 30 min. The zinc-mercury amalgam was transferred to a 
3 - neck flask (100 cm3) fitted with a mechanical stirrer and reflux 
condenser. Water (10 cm3), concentrated hydrochloric acid (10 cm3, 37 
% w/v) and a solution of A2-butyrlpyrocatechol (127) (1.08 g, 6.0 mmol) in 
ethanol (5 cm3) was added to the amalgam. The mixture was agitated 
vigorously and heated at reflux for 12 h. To the mixture was added 
toluene (12 cm3) and stirring was continued for 2-3 min. The organic 
layer was removed, washed with water (3 x 50 cm3) and evaporated in 
vacuo to give a dark brown oil. Kugelrohr distillation gave a clear oil 
which produced the title compound as a white crystalline solid upon 
standing (0.51 g, yield 51 %), m.p 39-41 °C (lit.,151 39-41 °C); vmax(KBr 
disc) 3379, 2959,2930,1523 and 1284 cm'1; 5H(200 MHz) (CDC13) 0.89 
(3H, t, J  7 Hz, CHsOfeCHzCFb), 1.21 - 1.38 (2H, m, CH2CH2CH2CH3), 
1.43 - 1.57, (2H, m, CH2CH2CH2CH3), 2.44 (2H, t, J 1 Hz,
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CH2CH2CH2CH3), 6.57 (1H, d with fine splitting, J  8 Hz, 5-H), 6.68 
(1H, s with fine splitting, 3-H) and 6.73 (1H, d with fine splitting, J  8.6 
Hz, 5-H); 6C (50 MHz) (CDCI3) 13.9 (CU2CU2CU2CE1I  22.3 
(CH2CH2CH2CH3), 33.7 (CH2CH2CH2CH3), 34.9 (CH2CH2CH2CH3),
115.6, 115.8, 120.9 (Ar-H), 136.3 (C-4), 141.2 and 141.3 (C-l and C-2); 
m/z 166 (M+) (Found: M+ 166.1004. C10H14O2 requires 166.0994).
(Found : C, 72.05; H, 8.4%. Ci0H i4O2 requires C, 72.3; H, 8.4%).
4-EthylpyrocatechoI (119)
A solution of sodium dihydrogen phosphate (1.5 g) in water (500 cm3) 
was placed in a conical flask. To this solution was added potassium 
nitrosodisulfonate (Fremy’s salt) (9.0 g, 34 mmol) and the mixture was 
shaken to dissolve the inorganic radical. A solution of 4-ethylphenol 
(140) (1.6 g, 11.8 mmol) in ether (35 cm3) was added quickly to the 
purple solution and the mixture was stirred vigorously for 20 min. The 
colour of the solution changed to red - brown and the solution was 
extracted with chloroform (3 x 200 cm3). The combined organic extracts 
were placed in a conical flask and potassium iodide (3 g, 18.1 mmol) in 
acetic acid (200 cm3) was added to the dark red solution and the mixture 
stirred for 2 min. The resultant mixture was washed with sodium bisulfite 
solution (100 cm3 of 5 % w/v). The chloroform layer was washed with 
water (500 cm3), dried with sodium sulfate, filtered and evaporated under 
reduced pressure to give a dark red oil which was a mixture of the desired 
4-ethylpyrocatechol (119) and 4-ethylphenol (140). The mixture was 
purified by column chromatography on basic alumina and elution with 
diethyl ether : light petrol (b.p. 40 - 60°C ) (1:5). The product (119) was
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obtained as a dark red oil which was Kugelrhor distilled to produce an 
off-white crystalline solid (0.6 g, yield 33 %), m.p 38-39 °C (lit.,136 39 
°C); vmax (KBr disc) 3384, 2965, 1606, 1525, 1446, 1350, 1283, 1193 
and 1111 cm'1; 6H(200MHz) (CDC13) 1.14 (3H, t , / 7  Hz, Me), 2.48 
(2H, q, J 1 Hz, CHbMe), 6.36 (2H, br.s, OH), 6.60 (1H, d with fine 
splitting, J  8 Hz, 5-H), 6.70 (1H, s with fine splitting, 3-H) and 6.78 (1H, 
d, J  8 Hz, 6-H); 5C (50 MHz) (CDCI3) 15.6 (Me), 28.0 (OfcMe), 115.3,
115.7, 120.3 (Ar-H), 137.7 (C-4), 141.0 and 143.1 (C-l and C-2); m/z 
138 (M+) (Found: M+ 138.0675. C8H10O2 requires 138.0681).
3.2.3 Chloro Substituted Aromatics 
Chlorovanillin (144)152
Vanillin (129) (17 g, 0.11 mmol) was dissolved in glacial acetic acid (150 
cm3) and a stream of dry chlorine gas was bubbled through the solution 
with stirring at ambient temperature. An exotherm was observed during 
the addition. After 15 min, crystals began to separate from the solution 
and the passage of gas was discontinued and the slurry allowed to stand 
at ambient temperature for 6 h. The precipitate was isolated by vaccum 
filtration and recrystallised from glacial acetic acid. The recrystallised 
solid was isolated by filtration. The filtrate was allowed to stand for 2 h 
and produced a second crop of crystals. The title compound was obtained 
as a white solid, crystallizing in square plates (18.1 g, Yield 87 %), m.p 
165 °C (lit.,152 165 °C); vmax(KBr disc) 3300,1676,1591,1504,1427, 
1296 and 1163 cm'1; 6H(200 MHz) [(CD3)2SO] 3.94 (3H, s, Me), 7.41 
(1H, s with fine splitting, Ar-H), 7.60 (1H, s with fine splitting, Ar-H) and
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9.79 (1H, s, CHO); 5C(50 MHz) [(CD3)2SO] 56.4 (Me), 109.1 (C-3),
120.1 (C-2), 125.8 (C-5), 148.9 and 149.0 (C-4 and C-6) and 185.0 
(CHO); m/z 188 (M+, 37C1), 186 (M+, 35C1); (Found: M+ 188.0052 
C8H70 337C1 requires 188.0159), (Found: M+ 186.0065 C8H70 335C1 
requires 186.0189).
2-ChIoro-6-methoxy-4-methyIphenol (145)
Chlorovanillin (144) (2.0 g, 10.7 mmol) was dissolved in ethanol (120 
cm3) containing a catalytic amount of hydrochloric acid in ethanol (0.2 
cm3, 1M, ca. 0.2 mmol HC1) was hydrogenated in the presence of 
palladium / carbon catalyst (174 mg, 10 % Pd/C) with stirring at room 
temperature for 1 h until sufficient hydrogen was absorbed. The mixture 
was filtered through Celite to remove the catalyst and the filtrate was 
neutralised with solid sodium bicarbonate. Ethanol was evaporated under 
reduced pressure and the residue was extracted with ether (200 cm3), 
leaving a mass of inorganic salts. The ether layer was dried over sodium 
sulfate, filtered and evaporated to give the desired product (119) as a light 
coloured oil (0.94 g, yield 51 %); vmax(thin film) 3435, 2938, 1610, 1595, 
1504,1462,1414,1362,1285 and 1236 cm'1; 5h (200 M Hz) (CDC13)
2.15 (3H, s, Me), 3.82 (3H, s, OMe), 5.87 (1H, br.s, OH), 6.55 (1H, s 
with fine splitting, 3-H) and 6.71 (1H, s with fine splitting, 5-H); 5c (50 
MHz) (CDC13) 20.7 (Me), 56.0 (OMe), 110.2 (C-3), 116.8 (C-2), 121.7 
(C-5), 129.6 (C-4), 139.5 and 147.0 (C-l and C-2); m/z 174 (M+,37C1), 
172 (M+,35C1); (Found: M+ 174.0254. C8H90 237C1 requires 174.0262), 
(Found: M+ 172.0277 C8H90 235C1 requires 172.0291).
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3-Chloro-5-methyIpyrocatechol (128)
Anhydrous aluminium chloride (0.49 g, 3.64 mmol) was suspended in a 
solution of 4-methyl-2-chloro-6-methoxyphenol (145) (0.54 g, 3.29 
mmol) in dry dichloromethane (50 cm3), in an apparatus protected from 
atmospheric moisture. Pyridine (1.15 g, 14.5 mmol) was added slowly 
while the reaction mixture was cooled to maintain the temperature at 30 - 
45 °C. The mixture was heated under reflux for 24 h. The solution was 
cooled to 25 °C and dilute (15-20 %) hydrochloric acid added until the 
mixture was acidic to Congo Red indicator. The two layers were 
separated and the aqueous phase was washed with ether. The organic 
layers were dried over sodium sulfate, filtered and evaporated in vacuo. 
The crude product was chromatographed on a silica column eluted with 
ether/ light petrol (b.p. 40-60 °C) (1:5) to give equal amounts of starting 
material (119) and the desired 3-chloro-5-methylpyrocatechol (128) 
(0.10 g, yield 22 %), m.p 58-60 °C; vmax(KBr disc) 3410, 1610, 1512, 
1500 and 1288 c m 1; 5H(200 MHz) (CDC13) 2.21 (3H, s, Me), 5.36 (2H, 
br.s, OH), 6.67 (2H, m, Ar-H); 5C (50 MHz) (CDC13) 20.6 (Me), 115.1 
(Ar-CH), 119.4 (C-3), 120.8 (Ar-H), 131.2 (C-2), 137.0 (C-5), 144.2 (C-
1); mlz 160 (M+,37C1), 158 (M+,35C1) (Found: M+ 160.0118. C7H70 237C1 
requires 160.0105), (Found: M+ 158.0139 C7H70235C1 requires 
158.0135).
2-Chloro-4-methyIphenol (146)153
To melted 4-methylphenol (28) (27 g, 0.25 mol) was added neat sulfuryl 
chloride (20 cm3, 0.28 mmol) slowly. Hydrogen chloride and sulfur 
dioxide were immediately evolved. The reaction mixture was warmed on
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a water bath and then washed with cold aqueous sodium carbonate. The 
residue was dried over fused calcium chloride, filtered and distilled. The 
chlorocresol (146) compound was obtained as a colourless oil, (22 g, 
yield 62 %); vmax (thin film) 3524, 3447, 1500, 1282, 1251, 1215, 1182 
and 1053 cm'1; 5H(200 MHz) (CDC13) 2.20 (3H, s, Me), 6.87 - 7.06 
(3H, m, Ar-H); 6C (50 MHz) (CDC13) 20.12 (Me), 115.87 (C-3), 119.32 
(C-2), 128.82 (C-5), 129.12 (C-6), 130.89 (C-4), 148.87 (C-l); m/z 144 
(M+,37C1), 142 (M+,35C1); (Found: M+ 144.0155. C7H70 37C1 requires 
144.0156), (Found: M+ 142.0186 C7H70 35C1 requires 142.0185).
Potassium Nitrosodisulfonate - Frem y’s S a lt124 
Sodium nitrite (32.5 g, 0.5 mol) was dissolved in water (100 cm3), placed 
in a 21 beaker and cooled to 0 °C in an ice bath. Chopped ice (200 g) 
was added and the solution stirred steadily during the addition of fresh 
sodium metabisulfite (100 ml, 31.92 % w/v), followed by glacial acetic 
acid (20 cm3). Momentary darkening in colour of the reaction mixture 
occcurred after 2-3 min, and a sample was removed. The sample failed to 
decolourise iodine solution indicating the end of the reaction. 
Concentrated ammonia solution (25 cm3, sp gr 0.88) was added and the 
mixture was again cooled to 0 °C in an ice bath. Fresh ice was added 
whenever necessary to keep some present in the reaction mixture 
throughout the next stage. Aqueous potassium permanganate (0.2 M, 400 
cm3) was added dropwise with continued stirring over 1 h.
The precipitated manganese dioxide was removed by filtration at 0 °C 
through a bed of Celite and the filtrate was warmed to ambient 
temperature. A portion of the filtrate (10-15 cm3) was treated with an
151
equal volume of saturated aqueous potassium chloride. A precipitate of 
Fremy’s salt was formed for seeding the main batch. The remainder of 
the filtrate was stirred, while saturated potassium chloride solution (250 
cm3) was added dropwise over a period of about 45 min. Small portions 
of the previously prepared suspension were added at intervals during this 
period until the solid persisted and the precipitate formed was cooled in 
ice for a further 45 min. The orange solid was collected by filtration but 
was not sucked dry. The filter cake was washed with ammoniacal 
saturated potassium chloride solution (containing ca 5 % w/v 0.88 
ammonium hydroxide) (200 cm3), ammoniacal methanol (containing ca 5 
% v/w 0.88 ammonium hydroxide) (2 x 200 cm3) and finally with acetone 
(200 cm3) but not sucked dry. The solid was spread on a watch glass and 
the acetone was allowed to evaporate for 10-15 min. The resultant orange 
crystals were stored in a desiccator over calcium oxide, in the presence of 
ammonium carbonate in a separate dish to provide an ammoniacal 
atmosphere. Yield (82 %) (based upon metabisulfite).
CAUTION: This salt must not be stored in a sealed vessel; 
decomposition may cause a pressure explosion.
3-Chloro-5-methyIpyrocatechol (128)
A solution of sodium dihydrogen phosphate (1.5 g) in water (500 cm3) 
was placed in a conical flask. To this solution was added potassium 
nitrosodisulfonate (Fremy’s salt) (9.0 g, 34 mmol) and the mixture was 
shaken to dissolve the inorganic radical. A solution of 2-chloro-4- 
methylphenol (146) (1.68 g, 11.8 mmol) in ether (35 cm3) was added 
quickly to the purple solution and the mixture was stirred vigorously for
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20 min. The colour of the solution changed to red - brown and the 
solution was extracted with chloroform (3 x 200 cm3). The combined 
organic extracts were placed in a conical flask and potassium iodide (3 g,
18.1 mmol) in acetic acid (200 cm3) was added to the dark red solution 
and the mixture stirred for 2 min. The resultant mixture was washed with 
sodium bisulfite solution (100 cm3 of 5 % w/v). The chloroform layer was 
washed with water (500 cm3), dried with sodium sulfate, filtered and 
evaporated under reduced pressure to give a dark red oil which was a 
mixture of the desired product (128) and unreacted starting material 
(146). The mixture was purified by column chromatography on basic 
alumina and elution with diethyl ether : light petrol (b.p. 40 - 60 °C )
(1:5). The product (128) was obtained as a dark red oil which was 
Kugelrohr distilled to produce an off-white crystalline solid (0.63 g, yield 
34 %), m.p 58-60 °C; vmax(KBr disc) 3410,1610, 1512, 1500 and 1288 
cm 1; 5h (200 M H z) (CDC13) 2.21 (3H, s, Me), 5.36 (2H, br.s, OH), 6.67 
(2H, m, Ar-H); 8C(50 MHz) (CDC13) 20.6 (Me), 115.1 (Ar-CH), 119.4 
(C-3), 120.8 (Ar-H), 131.2 (C-2), 137.0 (C-5), 144.2 (C-l); miz 160 
(M+,37C1), 158 (M+,35C1) (Found: M+ 160.0118. C7H70 237C1 requires 
160.0105), (Found: M+ 158.0139 C7H70 235C1 requires 158.0135).
2-ChIoro-4-methyI-6-nitrophenol (155)
2-Chloro-4-methylphenol (146) (3.50 g, 0.025 mmol) was dissolved in 
acetic acid (30 cm3) and cooled to 0 °C using an ice /  salt bath. To this 
cooled and stirred solution nitric acid (4.5 cm3) in acetic acid (15 cm3) 
was added rapidly. The resultant mixture was diluted immediately with 
water and a yellow precipitate was formed. The solid was filtered and
153
washed with water (200 cm ). The title compound was obtained as a 
yellow crystalline solid (2.8 g, yield 60.8 %), m.p 68 °C (lit.,180 68 °C); 
vmax (KBr disc) 3196,1543, 1464,1406,1311,1255,1217,1155 and 
1101 cm'1; 8h (200 MHz) (CDC13) 2.36 (3H, s, Me), 7.48 (1H, s with fine 
splitting, 3-H), 7.80 (1H, s with fine splitting, 5-H) and 10.80 (1H, br.s, 
OH); 8C(50 MHz) (CDC13) 20.2 (Me), 123.2 (Ar-H), 123.9,129.8 and
133.9 (Ar-C), 138.5 (Ar-H) and 149.2 (Ar-C); m/z 189 (M+,37C1), 187 
(M ^ C l) ;  (Found: M+ 189.0003. C7H<;0 3N37a  requires 189.0007), 
(Found: M+ 187.0038 C7H603N35C1 requires 187.0036).
3-Chloro-5-methyI-l,2-benzoquinone (158)
3-Chloro-5-methylpyrocatechol (128) (0.1 g, 0.53 mmol) was dissolved 
in dry ether (5 cm3) and placed in a dry flask fitted with a silica gel guard 
tube. To this solution was added silver (I) oxide (0.85 g, 3.66 mmol) as a 
suspension in ether (10 cm3) and anhydrous magnesium sulfate (0.85 g,
7.08 mmol). The mixture was stirred for 1 h in the dark. The solution was 
filtered through a bed of Celite and dry sodium sulfate. The filtrate was 
concentrated to ~ 20 cm3 and refrigerated in the dark for 16 h. The 
solution appeared dark red / green and no crystals were observed. The 
solution was evaporated to dryness in vacuo without heating. The 
quinone (158) was produced as a dark red oil, which was unstable when 
stored at -5 °C. (0.04 g, Yield 40 %). SH (200 MHz) (CDC13) 2.20 (3H, s, 
with fine splitting, Me), 6.25 (1H, s with fine splitting, Ar-H), 7.05 (1H, s 
with fine splitting, Ar-H); 5c (50 MHz) (CDCI3) 23.1 (Me), 126.4 (Ar- 
CH), 139.6 (Ar-CH), 151.8 (C-5), 141.6 (C-5), 173.3 (C=0) and 177.9 
(C=0).
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3.2.4 Trifluoromethyl Substituted Pyrocatechol
2-Nitro-4-trifluoromethyIphenoI (149)154
2-Nitro-4-trifluoromethylchlorobenzene (148) (5.63 g, 25 mmol) was 
dissolved in dimethylsulfoxide (7.5 cm3) and finely powdered sodium 
hydroxide (3.0 g, 75 mmol) was added with stirring over an 8 h period. 
The reaction mixture was maintained at 20 - 25 °C throughout the 
addition period. The reaction was left to stand for 16 h without stirring 
then poured into cold water (100 cm3) and shaken to mix. The mixture 
was washed with ether (2 x 50 cm3), separated and the aqueous layer was 
acidified to pH 1 with concentrated hydrochloric acid. The acidified 
solution was extracted with ether (3 x 50 cm3), and the combined dark 
red ether layers were filtered through Decalite and the solvent removed 
from the filtrate under reduced pressure. The title compound was 
obtained as a dark red oil (4.8 g, yield 87 %); vmax (KBr disc) 3263, 1637, 
1589, 1556, 1500, 1435, 1319, 1263, 1176, 1128, 1087 and 1072 c m 1;
5h (200 MHz) (CDC13) 7.32 (1H, d, J  8.8 Hz, 6-H), 7.84 (1H, d with fine 
splitting, J  8.8 Hz, 5-H), 8.42 (1H, s with fine splitting, 3-H) and 10.81 
(1H, br.s, OH); 6c (50MHz) (CDCI3) 121.2 (C-6), 123.1 (CF3), 123.2 
(C-5), 123.5 (C-4), 133.0 (C-2) 133.7 (C-3) and 157.1 (C-l); mlz 207 
(M+) (Found: M+ 207.0140. C7H4O3NF3 requires 207.0143).
2-Amino-4-trifluoromethyIphenol (150)
Method A: 155
A solution of 4-hydroxy-3-nitrobenzotrifluoride (149) (8.0 g, 38.6 mmol) 
in ethanol (100 cm3) was hydrogenated in the presence of Raney nickel
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catalyst (0.5 g), using low pressure hydrogenation apparatus. The reaction 
mixture was filtered through a bed of Celite and evaporated in vacuo to 
give a mid-brown solid. The solid was recrystallised from toluene to 
afford off white crystals of the title compound (5.2 g, yield 76 %), m.p 
120-121 °C (lit.,155 121-122 °C); vmax (KBr disc) 3395,1620, 1346,1331, 
1213,1203, 1169 and 1107 c m 1; 6H (200 MHz) [(CD3)2CO] 6.76- 6.99 
(3H, m, Ar-H); 5C (50 MHz) [(CD3)2CO] 111.7 (C-3), 114.6 (C-6), 114.9 
(C-5), 122.5 (C-5), 126.3 (CF3), 137.8 (C-2) and 147.9 (C-l); m/z 177 
(M+) (Found: M+ 177.0395. C7H6ONF3 requires 177.0401).
Method B: 156
4-Hydroxy-3-nitrobenzotrifluoride (149) (0.3 g, 1.5 mmol) in formic acid 
(98 %, 5 cm3) was stirred with 10 % Palladium on carbon catalyst (10 % 
Pd, 0.89 g) and the mixture was heated to 100 °C on a water bath until 
effervesence ceased (15 min). The mixture was filtered through a Celite 
bed and the Celite bed washed with water. The filtrate was extracted with 
ether (3 x 50 cm3). The combined ether layers were dried over sodium 
sulfate, filtered and the filtrate evaporated in vacuo to afford a brown 
solid. The solid residue recrystallised from toluene to give 2-amino-4- 
trifluoromethylphenol as white crystals (0.21 g, yield 82 %), m.p 120-121 
°C (lit.,156 121-122 °C).
4-Trifluoromethylpyrocatechol (121)
A solution of 4-hydroxy-3-aminobenzotrifluoride (150) (0.65 g, 3.7 
mmol) in acetic acid (300 cm3) was added within 3 mins to a vigorously 
stirred solution of sodium metaperiodiate (10.0 g, 0.04 mol) in a dilute 
solution of hydrochloric acid (0.1 N, 700 cm3) at ambient temperature.
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Stirring was continued for 30 sec and the mixture was then extracted with 
chloroform (3 x 500 cm3). The organic layer was washed with water (2 x 
500 cm3) and potassium iodide (3.0 g, 18 mmol) in acetic acid (200 cm3) 
was added. The mixture was stirred for 2 min, and then washed with 
sodium bisulfite solution (100 cm3, 5 % w/v). The organic layer was 
washed with hydrochloric acid (0.1 N, 500 cm3) to remove any remaining 
starting material. The chloroform layer was washed with water (500 cm3) 
and the combined aqueous extracts back-extracted once with chloroform 
(200 cm3). The combined organic extracts were dried over sodium sulfate 
and filtered. Acetic acid (5 cm3) was added to the filtrate and the solvent 
removed in vacuo. A dark brown oil remained and was Kugelrhor 
distilled to afford 4-trifluoromethylpyrocatechol (121) as an off white oil 
which failed to crystallise on standing (0.11 g, yield 17 %); vmax (KBr 
disc) 3318, 3025, 2989, 1232, 1163 and 1112 cm'1; 5H (200 MHz) 
(CDCI3) 6.52 (2H, br.s, OH, exch. with D2O) and 6.88-7.09 (3H, m, Ar- 
H); 6C (50 MHz) (CDC13) 112.5 (C-3), 115.1 (C-6), 118.5 (C-3), 123.2 
(C-4), 124.0 (CF3), 143.5 and 146.6 (C-l and C-2); m/z 178 (M+) (Found: 
M+ 178.0241. C7H5O3F3 requires 178.0242).
3.2.5 Methyl Substituted Metabolites
4-Methyl-l,2-benzoquinone (59)
4-Methylpyrocatechol (44) (l.Og, 8.1 mmol) was dissolved in dry ether 
(5 cm3) and placed in a dry flask fitted with a silica gel guard tube. To 
this solution was added silver (I) oxide (8.5 g, 36.6 mmol) as a
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suspension in ether (10 cm3) and anhydrous magnesium sulfate (8.5 g,
70.8 mmol). The mixture was stirred for 1 h in the dark. The solution was 
filtered through a bed of Celite and dry sodium sulfate. The filtrate was 
reduced under vacuum at 20 - 23 °C. The residual oily red-brown crystals 
were slurried in ether (15 cm3) and collected by filtration. This gave the 
title compound as dark red crystals (0.7 g, yield 71%), m.p 82-83 °C 
(lit.,181 83-84 °C); 5H(200 MHz) (CDC13) 2.10 (3H, s, Me), 6.15 (1H, s 
with fine splitting, 3-H), 6.26 (1H, d, J  10 Hz, 6-H) and 6.85 (1H, d, J  10 
Hz with fine splitting, 5 -H ); 6C (50 MHz) (CDC13) 22.6 (Me), 127.4 (C- 
3), 129.2 (C-6), 143.2 (C-5), 151.8 (C-4), 178.9 (C=0) and 180.1 (C=0).
Monoperphthalic Add 167
Phthalic anhydride (20 g, 0.1 mol) was heated at reflux in dry benzene 
(200 cm3). The mixture was filtered while hot and the filtrate was cooled 
to ambient temperature. Light petroleum (200 cm3) was added and 
crystallisation occurred. The crystallised phthalic anhydride (10.3 g,
Yield 52 %) was isolated by filtration.
To a solution of sodium carbonate (6.2 g, 50 mmol) in water (25 cm3), 
cooled to 0 °C with stirring was added 30% aqueous hydrogen peroxide 
(6.9 g, 6.3 ml, 60 mmol). To this mixture was added recrystallised 
phthalic anhydride (7.4 g, 50 mmol) and the resultant mixture was stirred 
at -5 °C to 0 °C for 30 min. At the end of this period a clear solution had 
formed, which was transferred to a separating funnel and shaken with 
ether (35 cm3). A solution of concentrated sulfuric acid (10 M, 3 cm3) in 
water (15 cm3) was added slowly over 10 min. The organic layer was 
separated and the aqueous layer extracted with ether (2x15  cm3). The
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combined ether extracts were washed with saturated ammonium sulfate (2 
x 20 cm3) and dried in a refrigerator over anhydrous magnesium sulfate. 
The peracid content of the ethereal solution was determined by adding 
20% aqueous potassium iodide (30 cm3) to the peracid solution (2 cm3) 
and titrating the liberated iodine after 5 min with sodium thiosulphate 
(0.12 M). The yield is 6.3 g in of 65 cm3 ether corresponding to a 64 % 
yield (based on phthalic anhydride).
3-MethyImuconic Anhydride (156)168
To a stirred ice cold solution of 4-methyl-1,2-benzoquinone (59) (0.6 g,
4.9 mmol) in ether (45 cm3) was added an ether solution of 
monoperphthalic acid (2.5 g, 26 cm3, 15.4 mmol) and the mixture was 
stirred at -5 °C to 0 °C for 4 h, then at room temperature for 18 h. The 
solution was filtered and the filtrate evaporated under reduced pressure to 
give (131) as a white solid which was recrystallised from light petrol 
(0.28 g, yield 41 %), m.p 72-73 °C (lit.,168 73-74 °C); vmax(KBr disc) 
1733,1693,1645, 1320 and 1182 cm'1; 6H(200 MHz) ((CD3)2CO] 1.55 
(3H, s, Me) and 7.61 - 7.82 (3H, m, C-H); m/z 138 (M+); (Found: M+ 
138.0313. C7H603 requires 138.0317).
Disodium 3-methyl-cwcw-muconate
To a stirred ice cold solution of aqueous sodium hydroxide (2 mmol, 5 
cm3) was added 3-methylmuconic anhyride (156) (0.1 g, 0.725 mmol). 
This solution was stirred for 10 min, then evaporated to dryness to give 
the disodium 3-methyl-c/s-c/s-muconate as a white powder (0.12 g, yield 
83 %), m.p 350 °C (Decomp); vmax(KBr disc) 3426, 1621, 1568, 1400,
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1345 and 1304 cm'1; 6H(200 MHz) (D20 ) 1.76 (3H, s, Me), 5.60 (1H, s 
with fine splitting, 2-H), 5.77 (1H, d with fine spitting, J  13.0 Hz) and
6.49 (1H, d, J  13.0 Hz, 5-H); 6C (50 MHz) (D20 )  21.5 (Me), 127.7,
128.6,129.3 (C-H), 142.3 (C-4), 176.9 (C=0) and 178.6 (C=0).
3-Methyl-2-cw-4-fraws-muconic Acid (157)168 
To a stirred ice cold aqueous solution of sodium hydrogen carbonate 
(0.121 g, 1.45 mmol, 5 cm3) was added 3-methylmuconic anhyride (156) 
(0.1 g, 0.725 mmol). The solution was stirred for 1 h then evaporated to 
dryness to give the 3-methyl-2-czs-4-rrans-muconic acid (157) as a white 
solid, which was recrystallised from ethanol (0.06 g, yield 53 %), m.p 
178 -179 °C (lit.,168 177-178 °C); vmax(KBr disc) 2966,1690,1628,
1598,1314,1266 and 1191 cm'1; 5h (200 MHz) [(CD3)2SO] 1.99 (3H, s, 
Me), 5.96 (1H, s, 2-H), 6.15 (1H, d, J  16 Hz, 4-H) and 8.45 (1H, d, J  16 
Hz, 5-H); 6C(50 MHz) [(CD3)2SO] 19.9 (Me), 124.1 (C-H), 124.9 (C-H),
139.5 (C-H), 146.7 (C-3), 166.4 (C=0) and 167.3 (C=0).
(±)-3-Methylmuconolactone (51)169
3-Methyl-2-ds-4-rran.s-muconic acid (157) (55 mg, 0.35 mmol) was 
heated at reflux for 12 h with water (20 cm3) containing hydrochloric acid 
(0.2 cm3, 10 M). The solution was evaporated to dryness and (±)-3- 
methylmuconolactone (51) was obtained as a white solid which was 
recrystallised from ethyl acetate (47 mg, yield 85 %), m.p 127-128 °C 
(lit.,169 127-128 °C); vmax (KBr disc) 1732,1693,1645,1320,1179 and 
1157 cm'1; 5h (200 MHz) [(CD3)2CO] 2.13 (3H, s, Me), 2.52 (1H, dd, J
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16.4 and 8.5 Hz, 5-H), 3.01 (1H, dd, /  16.4 and 3.8 Hz, 5-H), 5.25 - 5.31 
(1H, m, 4-H) and 5.81 (1H, s with fine splitting, 2-H); 5C (50 MHz) 
[(CD3)2CO] 14.1 (Me), 37.6 (C-5), 81.9 (C-4), 117.7 (C-2), 170.0 (C-3),
171.4 (C=0) and 173.3 (C=0); m/z 156 (M+); (Found: M+ 156.0422. 
C7H8O4 requires 156.0422).
(±) -l-MethyI-8-bromomuconodilactone (158)
To a solution of (±)-3-methylmuconolactone (51) (40 mg, 0.26 mmol) 
was added sodium hydrogen carbonate (25 mM, 5 cm3). To the resultant 
solution was added bromine (0.04 g, 0.25 mmol) in dichloromethane (10 
cm3) at 0 °C with stirring. The mixture was warmed to ambient 
temperature and was stirred for 7 h. The resultant mixture was washed 
with aqueous sodium thiosulfate (2.0 M, 20 cm3). The mixture was 
extracted with dichloromethane (3 x 25 cm3) and the extracts dried with 
magnesium sulfate and filtered. Evaporation of the solvents gave the 
bromodilactone (158) as a white solid, which crystallised from 
chloroform - hexane (53 mg, yield 88 %), m.p 89-90 °C (lit.,172 88-89 
°C); vmax (KBr disc) 1285, 1242, 1187, 1113, 1077 and 1028 c m 1; 6H 
(200 MHz) [(CD3)2CO] 1.78 (3H, s, Me), 2.92 (1H, d, J  18.8 Hz, 4-H), 
3.37 (1H, dd, J  18.8 and 4.9 Hz, 4-H), 4.86 (1H, s with fine splitting, 8- 
H) and 5.32 (1H, d, J  4.9 Hz, 5-H); 6C (50 MHz) [(CD3)2CO] 19.8 (Me),
35.0 (C-4), 43.5 (C-8), 82.6 (C-5), 89.5 (C-l), 171.0 (C=0) and 172.7 
(C=0); m/z 234 (M+, 79Br) (Found: M+ 233.9523. C9H n 0 479Br requires 
233.9528).
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(±)-l-MethyImuconodilactone (159)
To a suspension of the bromodilactone (158) (50 mg, 0.2 mmol) in dry 
benzene (2 cm3) was added azoisobutyronitrile (3 mg, 0.1 mmol) under 
nitrogen. Tributyltin hydride (0.12 cm3, ca. 0.3 mmol) was added to this 
mixture via syringe, and the resultant mixture then warmed to 30 - 40 °C 
to give a clear solution. The mixture was heated for another 15 min and 
then cooled to room temperature over 1 h with stirring. Hexane (3 cm3) 
was added and a white precipitate formed, which was isolated by 
filtration to give a white solid (159) which was recrystallised from 
chloroform-hexane (21 mg, yield 63 %), m.p 87-88 °C (lit.,172 90-91 °C); 
vmax (KBr disc) 1780, 1306, 1258, 1231, 1212, 1200, 1125, 1089 and 
1043 c m 1; 5H(200 MHz) (CDC13) 1.58 (3H, s, Me), 2.68 - 3.04 (4H, m,
4-H2 and 8-H2) and 4.86 (1H, d with fine splitting, J  4.8 Hz, 5-H); 5c (50 
MHz) (CDCI3) 21.9 (Me), 34.8 (C-4), 40.2 (C-8), 82.1 (C-5), 87.5 (C-l),
172.49 (C=0) and 172.69 (C=0); m/z 156 (M+) (Found: M+ 156.0422. 
C7H8O4 requires 156.0422.)
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3.3 METABOLISM
3.3.1 Pseudomonas putida 
Maintenance:
Pseudomonas putida (ATCC 12633) (Ornston & Stanier, 1966) was a 
stock culture originally obtained from Torry Research Station. It was 
maintained on 1% yeast extract agar slope test-tube at 4°C.
Chemicals:
4-Methylpyrocatechol and 4-t-butylpyrocatechol were purchased from 
BDH company. All other substrates were prepared by the author.
Culture Conditions:
The nutrient medium was prepared as described by Ornston and Stanier 
with some modifications.
Nitriloacetic acid 220 mg
Magnesium sulfate heptahydrate 580 mg
Calcium chloride dihydrate 88.5 mg
Ferrous sulfate 7 mg
Ammonium sulfate 1.0 g
Potassium dihydrogen orthophosphate 6.8 g
Disodium hydrogen orthophosphate 7.1 g
Sodium benzoate 1.44 g
Hunter’ metal solution ‘44’ * 1 cm3
Deionised water 1 litre
163
* Hunter’ metal solution ‘44’ Solution for Ornston and Stanier medium
Ethylenediamine Tetraacetate, Disodium Salt 318 mg
(E.D.T.A. Na2.2H20)
Zinc Sulfate Hydrate 1095 mg
Manganese Sulfate Hydrate 154 mg
Copper Sulfate Hydrate 39.2 mg
Cobalt Nitrate Hydrate 24.8 mg
Sodium Tetraborate 17.7 mg
Ammonium Molybdate 20 mg
Deionised water 100 cm3
Procedures:
The Pseudomonas putida (ATCC 12633) slants were maintained on 1 % 
yeast extract agar for 3 days at 25 °C. A water suspension of the bacteria 
was prepared by adding sterile water (2 cm3) to the slope and scratching 
the surface gently to form a suspension. The suspension was used to 
inoculate 3 conical flasks each containing 100 cm3 of the Ornston and 
Stainer medium. The flasks were incubated at 30 °C with the same 
shaking speed for 18 h. The first batch of the pyrocatechol in sterile 
deionised water was fed to these flasks. The flasks were shaken for 4 h at 
30 °C. A ferric chloride test showed that all the pyrocatechol had been 
metabolised. A second batch of the pyrocatechol was then fed. The flasks 
were left shaking for 18 h. The ferric chloride test was again negative 
after this second addition, and a third batch of pyrocatechol in water was
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fed. After a further 24 h, the cultures were combined, the pH adjusted to 
pH 7.5 with aqueous sodium hydroxide and the mixture extracted with 
ether to remove non-acidic material. The pH of the culture medium was 
then adjusted to pH 2.5 with orthophosphoric acid, saturated with sodium 
chloride, and extracted with ether to obtain the 4-substituted 
muconolactone. The remaining aqueous extract was then continuously 
extracted with ether for 48 h to remove any remaining metabolites. The 
ether extracts were filtered through Celite, dried over sodium sulfate and 
evaporated in vacuo.
Metabolism of 4-methylpyrocatechol (44)
This pyrocatechol was used as a control each time. Examination of the 
ether extracts of the medium at pH 7.5 yielded any unmetabolised 4- 
methylpyrocatechol (44). Ether extracts of the medium at pH 2.5 yielded 
an oily solid which by !H NMR spectroscopy of the total extract in 
[(CD3)2SO] was shown to contain 4-methylmuconolactone (50) as the 
major metabolite, with 3-methylmuconolactone (51) and 3-methyl-2-c/s- 
A-trans-mucomc acid (157) also being present. The 3-methyl-2-cw-4- 
rra/w-muconic-acid (132) was separated by centrifrugation with acetone. 
Preparative TLC on silica plates developed with diisopropyl ether - 
formic acid - water (200 : 7 : 3 ) successfully separated the remaining oil 
to give (S)-(+)-4-methylmuconolactone (50), R? 0.4, and (+)-3- 
methylmuconolactone (51), R? 0.2. The feeding data for these 
experiments are contained in Tables 1 to 5 on pages 177 to 181.
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(S)-(+)-4-MethyImuconoIactone (50)
Preparative TLC gave the (S)-(+)-4-methylmuconolactone (50) as an oil 
which failed to crystallise, [ cc] d  + 3 1  ° (c, 0.9 in methanol)
(lit.,175 + 31 °); vmax (KBr disc) 3111,2984,2934,1743,1176 and 1107 
cm 1; 5h (200 MHz) (CDC13) 1.52 (3H, s, Me), 2.69 and 3.04 (2H, ABq,
J  15.9 Hz, 5-H2), 6.03 (1H, d, J  5.7 Hz, 2-H) and 7.65 (1H, d, 5.7 Hz, 3- 
H); 8c (50 MHz) (CDCI3) 23.7 (Me), 42.7 (C-5), 85.9 (C-4), 120.4 (C-2),
160.0 (C-3), 172.4 (C=0) and 173.0 (C=0); m/z 156 (M+) (Found: M+ 
156.0415. C7H8O4 requires 156.0422).
(±)-3-MethyImuconoIactone (51)
Preparative TLC of the ether extract of the medium at pH 2.5 gave (±)-3- 
methylmuconolactone (51) as an oil which failed to crystallise; 
vmax (KBr disc) 3111, 3047, 2990, 1736, 1645, 1414, 1398, 1319 and 
1186 cm'1; 5h (200 MHz) [(CD3)2CO] 2.02 (3H, s, Me), 2.52 (1H, dd, J
16.3 and 8.5 Hz, 5-H), 3.00 (1H, dd, J  16.3 and 3.8 Hz, 5-H), 5.13 - 5.19 
(1H, m, 4-H) and 5.94 (1H, s with fine splitting, 2-H); 6c (50 MHz) 
[(CD3)2CO] 13.7 (Me), 37.5 (C-5), 81.6 (C-4), 117.4 (C-2), 169.6 (C-3),
171.2 (C=0) and 172.8 (C=0); m!z 156 (M+) (Found: M+ 156.0437. 
C7H8O4 requires 156.0422).
3-Methyl-2-cis-4-fra7M,-muconic Acid (157)
Separation of 3-methyl-2-cw-4-frans-muconic acid (157) from the total 
extract of the medium at pH 2.5 was achieved by centrifugation to give a 
white crystalline solid with m.p 176-177 °C (lit.,168 177-178 °C); vmax
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(KBr disc) 2966, 1690, 1628,1598,1314, 1266 and 1191 cm'1; 6H(200 
MHz) [(CD3)2SO] 1.99 (3H, s, Me), 5.96 (1H, s, 2-H), 6.15 (1H, d, J  16 
Hz, 5-H) and 8.45 (1H, d, J  16 Hz, 4-H); 6C (50 MHz) [(CD3)2SO] 19.9 
(Me), 124.1 (CH), 124.9 (CH), 139.5 (CH), 146.7 (C-3), 166.4 (C=0) 
and 167.3 (C=0).
(-)-l-Methyl-4-bromomuconodiIactone (170)
(£)-(+)-4-Methylmuconolactone (50) (78 mg, 0.5 mmol) was brominated 
using the standard procedure to give (-)-l-methyl-4- 
bromomuconodilactone (170) (97 mg, yield 83 %) as a white crystalline 
solid, m.p 123-124 °C, [ c c ] d  - 68 ° (c , 0.9 in methanol); vmax (KBr disc) 
1785,1293,1265,1202,1117,1085 and 1015 cm'1; 8h (360 MHz) 
(CDC13) 1.88 (3H, s, Me), 2.78 and 3.06 (1H, ABq, J  18.8 Hz, 8-H2), 
4.47 (1H, s, 5-H) and 4.97 (1H, s, 4-H); 5C (50 MHz) (CDCI3) 22.7 
(Me), 36.8 (C-4), 40.5 (C-8), 86.2 (C-5), 87.7 (C-l), 169.3 (C=0) and
171.0 (C=0); m /z 234 (M+,79Br); (Found: M+ 233.9587. C7H779Br O 4 
requires 233.9528).
(-)-l-Methylmuconodilactone (54)
(-)-l-Methyl-4-bromomuconodilactone (170) (59mg, 0.25 mmol) was 
debrominated by the standard procedure to give (-)-l- 
methylmuconodilactone (54) (21 mg, yield 53 %) as a white crystalline 
solid, m.p. 108-109 °C (lit.,175 108 °C), [oc]D - 132 0 (c, 0.2 in methanol) 
(lit.,163 -131 °); vmax (KBr disc) 1784,1296,1259,1199,1127,1090 and 
1033 cm'1; 5h (200 MHz) (CDC13) 1.55 (3H, s, Me), 2.68 - 2.99 (4H, m,
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4-H2 and 8-H2) and 4.85 (1H, d, J  4.4 Hz, 5-H); 5C (50 MHz) (CDC13)
21.5 (CH3), 34.6 (C-H2), 40.0 (C-H2), 82.0 (C-5), 87.5 (C-l), 172.6 
(C=0) and 172.8 (C=0); m h  156 (M+) (Found: M+ 156.0419. C7H80 4 
requires 156.0422.)
Metabolism of 4-isopropyIpyrocatechoI (120)
Examination of the ether extracts at pH 7.5 recovered unmetabolised 4- 
isopropylpyrocatechol (120). At pH 2.5 evaporation of the ether extracts 
produced a dark red gum which when examined by lU NMR 
spectroscopy showed the presence of 4-isopropylmuconolactone (165) as 
the major metabolite with 3-isopropylmuconolactone (152) and 3- 
isopropyl-2-pyrone-5-carboxylic acid (166) also present. Preparative TLC 
on silica plates with diisopropyl ether - formic acid - water (200 : 7 : 3) as 
eluent, successfully separated (165) and (152) with Rf 0.4 and 0.2 
respectively. 3-Isopropyl-2-pyrone-5-carboxylic acid (166) was not 
recovered. The feeding data for these experiments are contained in Table 
1 on page 177.
(+)-4-IsopropyImuconoIactone (165)
Preparative TLC gave the (+)-4-isopropylmuconolactone (165) as an oil 
which failed to crystallise, [ oc] d  + 21 0 ( c ,  0.7 in methanol); vmax (KBr 
disc) 3431, 3200, 3096, 2974, 2941, 2885, 1745, 1736, 1701 and 1390 
cm 1; 5h (200 MHz) [(CD3)2CO] 0.92 (3H, d, /  6.9 Hz, Me), 0.96 (3H, d, 
J  6.9 Hz, Me), 2.22 (1H, m, CHMe2), 2.79 and 2.97 (2H, ABq, J  15.9 
Hz, 5-H2), 6.12 (1H, d , / 5 .7  Hz, 2-H), 7.76 (1H, d , / 5 .8  Hz, 3-H); 6C 
(50 MHz) [(CD3)2CO] 17.0 (Me),17.5 (Me), 34.7 (CHMe2), 40.1 (C-5),
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90.9 (C-4), 122.0 (C-2), 159.3 (C-3), 170.5 (C=0), 172.5 (C=0); m/z 
184 (M+); (Found: M+ 184.0751 C9Hi20 4 requires 184.0736).
(±)-3-IsopropylmuconoIactone (152)
Preparative TLC recovered (±)-3-isopropylmuconolactone (152) as an oil 
which failed to crystallise; vmax(CHCl3) 3010, 3000, 1800, 1760, 1720, 
1240,1180 and 1100 c m 1; 6h (200 MHz) [(CD3)2CO] 1.17 (3H, d, J  6.7 
Hz, Me), 1.21 (3H, d, J  6.7 Hz, Me), 2.25 (1H, m, CHMe2), 2.45 - 3.12 
(2H, m, 5-H2), 5.35 - 5.45 (1H, m, 4-H) and 5.86 (1H, s with fine 
splitting, 2-H); 6C (50 MHz) [(CD3)2CO] 20.7 and 22.0 (Me)2, 28.0 
(CHMe2), 37.6 (C-5), 80.1 (C-4), 114.8 (C-2), 171.0 (C=0), 172.8 
(C=0) and 179.2 (C-3); m/z 184 (M+) (Found: M+ 184.0722. C9H120 4 
requires 184.0736).
(-)-l-IsopropyI-4-bromomuconodi!actone (169) 
(+)-4-Isopropylmuconolactone (165) (100 mg, 0.54 mmol) was 
brominated using the standard procedure to give (-)-l-isopropyl-4- 
bromomuconodilactone (169) (131 mg, yield 91 %) as an oil which failed 
to crystallise, [a]o - 49 ° (c, 0.6 in methanol); vmax (CHCI3) 3317, 3029, 
2984,2406, 2355 and 1798 c m 1; 5h (200 MHz) (CDC13) 1.10 (3H, d, J
6.8 Hz, Me), 1.20 (3H, d, J  6.8 Hz, Me), 2.41 (1H, septet, J  6.8 Hz, 
CHMe2), 2.72 - 3.00 (2H, m, 8-H2), 4.49 (1H, s, 5-H) and 5.08 (1H, s, 4-
H); 5C (50 MHz) (CDC13) 17.7 and 17.9 (Me2), 33.2 (CHMe2), 34.4 (C- 
8), 37.3 (C-4), 84.1 (C-5), 94.3 (C-l), 171.0 (C=0) and 173.0 (C=0); 
m/z 264 (M+,81Br), 262 (M+,79Br); (Found: M+ 263.9847. C9Hn 0 481Br
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requires 263.9821), (Found: M+ 261.9842. C gH nO ^B r requires 
261.9841).
(-)-l-Isopropylmuconodilactone (168)
(-)-l-Isopropyl-4-bromomuconodilactone (169) (120 mg, 0.45 mmol) was 
debrominated by the standard procedure to give (-)-l- 
isopropylmuconodilactone (168) (29 mg, yield 41 %) as an oil which 
failed to crystallise, [ cc] d  -1 1 7 °  ( c ,  0.3 in methanol); vmax (CHCI3) 3316, 
3022, 2983, 2402, 2352, 1788, 1632 and 1394 cm'1; 5H(200 MHz) 
[(CD3)2CO] 0.99 (3H, d, J  6.8 Hz, Me), 1.07 (3H, d, J  6.8 Hz, Me), 2.24 
(1H, septet, CHMe2), 2.72 - 3.22 (4H, m, 4-H2and 8-H2), 5.23 (1H, br.d, 
/ 5 . 8  Hz, 5-H); 5C(50 MHz) [(CD3)2CO] 16.4 and 17.7 Me2), 34.2 
(CHMe2), 34.2 (C-9), 36.2 and 37.7 (C-4 and C-8), 81.2 (C-5), 94.2 (C-
1), 173.8 (C=0) and 174.0 (C=0); mlz 184 (M+) (Found: M+ 184.0746. 
C9Hi204 requires 184.0736).
Metabolism of 4-Ethylpyrocatechol (119)
4-Ethylpyrocatechol (119) was recovered in small quantities by manual 
extraction of the aqueous broth with ether at pH 7.5. Examination of the 
ether extracts at pH 2.5 by XH NMR confirmed the presence of 4- 
ethylmuconolactone (171) as the major metabolite, with 3- 
ethylmuconolactone (172) and 3-ethyl-2-c is-4-trans-muconic acid (173) 
also present as minor metabolites. Centrifugation of the total extract at pH
2.5 was successful in separating 3-ethy\-2-cis-4-trans-mucomc acid 
(173); however the extract was contaminated with the 4-ethyl and 3- 
ethylmuconolactones. The *H NMR spectrum of the remaining extract
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displayed all the proton signals of both 4-ethylmuconolactone (171) and
3-ethylmuconolactone (172). The feeding data for this experiment are 
shown in Table 4 on page 180.
4-EthyImuconolactone (171)
Examination of the extract at pH 2.5 by *H NMR spectroscopy showed 
the presence of 4-ethylmuconolactone (171); 5h (200 MHz) (CDCI3) 0.77 
(3H, t, J  7.34 Hz, CH2CH2), 1.86 (2H, q, J  7.34 Hz, CH2CH3), 2.68 and 
2.89 (2H, ABq, J  15.7 Hz, 5-H2), 6.05 (1H, d, /5 .7  Hz, 2-H) and 7.56 
(1H, d, J  5.7 Hz, 3-H); 6C (50 MHz) (CDC13) 7.3 (CH2CH2), 29.1 
(CH2CH3), 41.1 (C-5), 88.4 (C-4), 121.3 (C-2), 158.8 (C-3), 172.3 
(C=0) and 173.2 (C=0).
3-EthyImuconolactone (172)
Examination of the extract of the medium at pH 2.5 by XH NMR 
spectroscopy confirmed the presence of 3-ethylmuconolactone (172); 5h 
(200 MHz) (CDCI3) 1.14 (3H, t, J  8 Hz, CH2CH2), 1.86 (2H, q, J  8 Hz, 
CH2CH3), 2.60 (1H, dd, J  16.5 and 8.4 Hz, 5-H), 2.94 (1H, dd, J  16.5 
and 4.1 Hz, 5-H), 5.19 - 5.25 (1H, m, 4-H) and 5.80 (1H, s with fine 
splitting, 2-H); 6C(50 MHz) (CDC13) 10.9 (CH2CH2), 21.1 (CH2CH3),
36.7 (C-5), 79.9 (C-4), 115.1 (C-l), 172.7 (C-3), 173.6 (C=0) and 174.1 
(C=0).
Metabolism of 4-Allylpyrocatechol (125)
Examination of the ether extracts of the medium at pH 7.5 showed the 
presence of unmetabolised 4-allylpyrocatechol (125). The total extract of
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the medium at pH 2.5 was examined by XH NMR spectroscopy to show a 
complex mixture of metabolites. 4-Allylmuconolactone (174), and 3-ally 1-
2-cis-4-trans muconic acid (175) were found to be present in 
approximately equal quantities. This mixture was subjected to preparative 
TLC on silica plates with diisopropyl ether - formic acid - water (200 : 7 : 
3) as eluent, which recovered (+)-4-allylmuconolactone (174) with Rp 
0-4. (+)-3-Allylmuconolactone and 3-allyl-2-c/s-4-rra/w-muconic acid 
(175) were not isolated. The feeding data for these experiments are 
contained in Table 2 on page 178.
(+)-4-Allylmuconolactone (174)
Preparative TLC yielded (+)-4-allylmuconolactone (174) as an oil which 
failed to crystallise, [a]D + 10 ° (c, 0.5 in methanol); vmax(CHCl3) 3005, 
1760, 1700, 1235, 1225, 1110 and 1100 cm*1; 5r (200 MHz) (CDC13) 
2.58 - 2.64 (2H, m, CH2-CH=CH2), 2.69 - 3.01 (2H, m, 5-H2), 5.11 - 
5.27 (2H, m, CH2-CH=CH2), 5.55 - 5.75 (1H, m, CH2-CH=CH2), 6.12 
(1H, d, J  5.5 Hz, 2-H), 7.61 (1H, d, J  5.6 Hz, 3-H) and 9.97 (1H, br.s, 
OH); 6C (50 MHz) (CDC13) 40.1 (C-5 and C-7), 87.2 (C-4), 121.8 (CH2- 
CH=CH2), 121.9 (C-2), 130.0 (C-8), 158.4 (C-3), 172.0 (C=0) and 174.1 
(C=0); m/z 182 (M+) (Found: M+ 182.0575. C9Hi0O4 requires 182.0579).
(-)-l-AHylmuconodilactone (176)
(+)-4-Allylmuconolactone (174) cyclised upon storage at ambient 
temperature to give (-)-l-allylmuconodilactone as a white crystalline 
compound, m.p. 114-115 °C, [ o c ] d  - 82 ° (c , 0.3 in methanol); vmax (KBr 
disc) 3441,1783,1257 and 1210 cm'1; 5h(200 MHz) [(CD3)2CO] 2.73 -
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2.77 (2H, m, CH2-CH=CH2), 2.89 - 3.25 (4H, m, 4-H2and 8-H2), 5.16 - 
5.18 (1H, br.d, J  5.6 Hz, 5-H), 5.20 - 5.34 (2H, m, CH2-CH=CH2) and
5.78 - 6.0 (1H, m, CH2-CH=CH2); 6C(50 MHz) [(CD3)2CO] 35.1 (CH2- 
CH=CH2) 38.5 and 39.4 (C-4 and C-8), 81.2 (C-5), 89.8 (C-l), 120.3 
(CH2-CH=CH2), 131.2 (CH2-CH=CH2), 173.0 (C=0), 173.1 (C=0); mlz 
182 (M+) (Found: M+ 182.0574. C9Hi0O4 requires 182.0579).
Metabolism of 4-PropylpyrocatechoI (124)
Examination of the ether extracts at pH 7.5 showed the presence of 
unmetabolised 4-propylpyrocatechol (124).The ether extracts at pH 2.5, 
when examined by lH NMR, showed 4-propylmuconolactone (177), 3- 
propylmuconolactone (178) and 3-propyl-2-cisA-trans- muconic acid 
(179) present in approximately equal quantities. The total extract was 
separated by preparative TLC on silica plates (diisopropyl ether - formic 
acid - water (200 : 7 : 3) as eluent. (+)-4-Propylmuconolactone (177) and 
(±)-3-propylmuconolactone (178) with /?F 0.4 and 0.2 respectively were 
recovered. 3-Pvopyl-2-cis-4-trans-nmcomc acid (179) was not 
recovered. The feeding data for these experiments are contained in Table 
3 on page 179.
(+)-4-Propylmuconolactone (177)
Preparative TLC recovered the target lactone (+)-4-propylmuconolactone 
{111) as an oil which failed to crystallise. [ cc] d  + 11 0 ( c , 0.7 in 
methanol); vmax(CHCl3) 3020,2960, 2900, 1750, 1700, 1360, 1350,
1310,1120 and 1100 cm'1; 5H (200 MHz) (CDC13) 0.90 (3H, t, J  7.3 Hz, 
CH2CH2CH3), 1.19-1.35 (2H, m, CH2CH2CH3), 1.71-1.94
173
(CH2CH2CH3), 2.16 and 3.04 (2H, ABq J  15.8 Hz, 5-H2), 6.10 (1H, d, J
5.7 Hz, 2-H), 7.60 (1H, d, J 5.7 Hz, 3-H); 5C (50 MHz) (CDCI3) 13.9 
(CH2CH2CH3), 16.6 (CH2CH2CH3), 38.4 (CH2CH2CH3), 41.9 (C-5), 88.0 
(C-4), 121.5 (C-2), 158.6 (C-3), 172.2 (C=0) and 174.2 (C=0); ml 2 184 
(M+) (Found: M+ 184.0745. C9H12O4 requires 184.0735).
(±)-3-PropyImuconoIactone (178)
Preparative TLC afforded (±)-3-propylmuconolactone (178) as an oil 
which failed to crystallise. vmax (thin film) 2963,2932,2876,1738,1635 
and 1178 cm'1; 5H (200 MHz) (CDC13) 0.98 (3H, t, J 1 2  Hz, 
CH2CH2CH3), 1.53 - 1.72 (2H, m, CH2CH2CH3), 2.25 - 2.33 (2H, m, 
CH2CH2CH3), 2.48 - 2.92 (2H, m, 5-H2), 5.25 - 5.27 (1H, m, 4-H), 5.84 
(1H, br.s, 2-H); 5c (50MHz) (CDCI3) 13.7 (CH2CH2CH3), 20.3 
(CH2CH2CH3), 29.9 (CH2CH2CH3), 37.2 (C-5), 80.0 (C-4), 116.1 (C-2), 
172.3 (C=0), 173.0 (C=0) and 174.1 (C-3); m/z 184 (M+) (Found: M+ 
184.0726. C9H12O4 requires 184.0735).
(-)-l-Propylmuconodilactone (180)
(+)-4-Propylmuconolactone (177) cyclised upon storage at ambient 
temperature to give (-)-l-propylmuconodilactone (180) as an oil which 
failed to crystallise, [ oc] d  - 98 0 (c, 0.5 in methanol); vmax (CHCI3) 3026, 
1968,1789,1225,1203 and 1110 c m 1; 5h(200 MHz) [(CD3)2CO] 0.97 
(3H, t, J  7.3 Hz, CH2CH2CH3), 1.50 (2H, sextet, J  7.3 Hz, CH2CH2CH3), 
1.91 (2H, t /  7.3 Hz, CH2CH2CH3), 2.72 - 3.25 (4H, m, 4-H2and 8-H2) 
and 5.12 (1H, d /  5.5 Hz, 5-H); 6C(50 MHz) [(CD3)2CO] 14.3
174
(CH2CH2CH3), 18.0 (CH2CH2CH3), 35.6 (CH2CH2CH3), 38.1 and 39.2 
(C-4 and C-8), 82.5 (C-5), 91.4 (C-l), 173.1 (C=0) and 174.0 (C=0); 
m!z 184 (M+) (Found: M+ 184.0728. C9H12O4 requires 184.0735).
Metabolism of 4-w-butyIpyrocatechol (126)
4-ft-Butylpyrocatechol (126) was recovered by manual extraction with 
ether at pH 7.5. Examination of the total ether extract at pH 2.5 by *H 
NMR spectroscopy showed that the major components present were 3 - a z -  
butylmuconolactone (181) and 'i-n-butyl-l-cis-A-trans-mucomc acid 
(182). Also present were trace levels of 4-Ai-butylmuconlactone (183). 
This extract was not purified but approximate quantities of metabolites 
produced were determined by *H NMR spectroscopy. The feeding data 
for this experiment are contained in Table 4 on page 180.
Metabolism of 4-f-butylpyrocatechoI (161)
Examination of the ether extracts at pH 7.5 showed the presence of 4-t- 
butylpyrocatechol. Examination by lH NMR of the total ether extract at 
pH 2.5 showed that few metabolites were present. Preparative TLC on 
silica plates (diisopropyl ether/ formic acid/water at 200 : 7 : 3, v/v), 
allowed successful recovery of 3-?-butyl-2-pyrone-5-carboxylic acid 
(184) with /?F 0.25. The feeding data for these experiments are contained 
in Table 4 on page 180.
3-f-Butyl-2-pyrone-5-carboxylic acid (184)
Preparative TLC gave 3-t-butyl-2-pyrone-5-carboxylie acid (184) as an 
oil which failed to crystallise. vmax (CHCI3) 2970, 1724,1252, 1123 and
175
1091 cm'1; 5H(200MHz) [(CD3>2CO] 1.29 (9H, s,M e3),6.33 (1H, s 
with fine splitting, /  1.7 Hz, 4-H) and 7.24 (1H, s with fine splittting J  1.1 
Hz, 2-H); 5C (50 MHz) [(CD3)2CO] 28.7 (Me3), 110.1 (C4-H), 114.2 
(C2-H), 149.9 (CMe3), 161.0 (C=0), 161.4 (C=0), 166.8 (C-3) and
194.5 (C-5); m/z 196 (M+) (Found: M+ 196.0744. Ci0Hi2O4 requires 
196.0736).
Metabolism of 4-trifluoromethylpyrocatechoI (121)
Examination of the ether extracts at pH 7.5 showed the presence of 
unmetabolised 4-trifluoromethylpyrocatechol (121). Examination of the 
total ether extract at pH 2.5 by *H NMR showed few metabolites were 
present. Preparative TLC on silica plates (diisopropyl ether - formic acid - 
water (200 : 7 : 3)), did not enable recovery of any metabolites. The 
feeding data for this experiment are contained in Table 5 on page 181.
Metabolism of 3-chIoro-5-methylpyrocatechol (128)
3-Chloro-5-methylpyrocatechol (128) was recovered by manual 
extraction with ether at pH 7.5. Examination by of the total ether extract 
at pH 2.5 by *H NMR spectroscopy showed that few metabolites were 
present. Preparative TLC on silica plates (diisopropyl ether - formic acid - 
water (200 : 7 : 3)) did not enable recovery of any metabolites. The 
feeding data for these experiments are contained in Table 5 on page 181.
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3.3.2 ASPERGILLUS NIGER
Maintenance:
Aspergillus niger EM 32 mutant was orginally obtained from University 
of Newcastle-Upon-Tyne. It was maintained at 4 °C on Difco bact potato 
dextrose slopes in 10 ml rubber - sealed bottles. Strains of Aspergillus 
niger were subcultured every six months after which time conidial 
viability was observed to decrease significantly.
Chemicals:
4-Methylpyrocatechol was purchased from BDH company. All other 
substrates were prepared by the author.
Culture Conditions:
Fungi were grown in liquid culture in a basal salts medium containing 
Ammonium sulfate
Potassium dihydrogen orthophosphate 
Magnesium sulfate heptahydrate 
Trace elements solution *
Deionised water 
Glucose
* Trace elements solution:
0.5 g 
1.0 g 
50 mg 
1 cm3 
1 litre 
1.8 g
182
Ferrous sulfate heptahydrate 54 mg
Manganous sulfate tetrahydrate 40 mg
Zinc sulfate heptahydrate 20 mg
Copper sulfate pentahydrate 4 mg
Cobaltous chloride hexahydrate 4 mg
Potassium iodide 30 mg
Sodium molybdate dihydrate 5 mg
Calcium chloride dihydrate 0.662 g
Sodium chloride 1.0 g
Deionised water 100 cm3
The basal salts medium, made up to volume with deionised water, was 
adjusted to pH 5.5 with 1M sodium hydroxide solution and autoclaved at 
15 lb/in2, 120 °C.
Procedures:
Fresh conidia were obtained by inoculating slope cultures stored onto the 
surface of the fresh potato dextrose agar at 21 °C for 3 d. The conidia 
were washed off with Tween 80 solution and suspended in sterile 
deionised water. The water suspension was used to inoculate. A 1.0 cm 
inoculum was put into each flask which contained 100 cm3 of the 
medium. The flasks were incubated at 30 °C for 46 h with a shaking 
speed of 160 r.p.m. The utilization of glucose was monitored by U.V. 
spectrometry. When the glucose was almost completely utilized, the first 
batch of pyrocatechol was fed. The pH of the broth was maintained at pH
183
5.5 by the addition of sterile dipotassium hydrogen orthophosphate. The 
flasks were kept at 30 °C for 18 h with the same shaking speed. A ferric 
chloride test showed that all the pyrocatechol had been metabolised. A 
second batch of the pyrocatechol was fed and the pH adjusted tp pH 5.5 
as before and left shaking for further 24 h. The cultures were combined 
and the pH of the combined mixture adjusted to pH 7.2 with saturated 
sodium bicarbonate and extracted with ether to remove non-acidic 
material. The pH of the cultures was adjusted to pH 2.0 with 
orthophosphoric acid, saturated with sodium chloride, and extracted with 
ether to obtain the target lactone. The remaining aqueous extract was then 
continuously extracted with ether for 48 h to remove any remaining 
metabolites. The ether extracts were filtered through Celite, dried over 
sodium sulfate and concentrated in vacuo.
Metabolism of 4-methyIpyrocatechoI (44)
Feeding of 4-methylpyrocatechol (44) was used as a control each time. 
Examination of the ether extracts at pH 7.2 showed evidence of 
unmetabolised 4-methylpyrocatechol (44). Ether extracts at pH 2.0 and 
continuous extraction gave (-)-(S)-3-methylmuconolactone (48). This 
extract was purified by preparative TLC on silica plates (diisopropyl ether 
- formic acid - water (200 : 7 : 3)), to give the target lactone (48) Rf 0.2. 
The feeding data for this experiment is contained in Table 6 on page 188.
184
(5)-(-)-3-MethyImuconolactone (48)
Preparative TLC gave the title lactone (S)-(-)-3-methylmuconolactone 
(48) as an oil which failed to crystallise, [ cc] d  - 26 ° (c, 0.8 in methanol) 
(lit.,177 - 35.8 °); vmax (KBr disc) 1732,1693,1645,1320 and 1179 cm'1; 
6h (200 MHz) (D20 , t-butanol as int.ref std) 2.17 (3H, s, Me), 2.63 (1H, 
dd, /  16.7 and 8.5 Hz, 5-H), 3.16 (1H, dd, J  16.7 and 3.7 Hz, 5-H), 5.42 - 
5.48 (1H, m, 4-H) and 6.00 - 6.01 (1H, m, 2-H); 8C (50 MHz) (D20 )  13.9 
(Me), 36.9 (C-5), 82.9 (C-4), 116.7 (C-2), 172.7 (C-3), 174.5 (C=0) and 
177.2 (C=0); mlz 156 (M+) (Found: M+ 156.0419. C7H80 4 requires 
156.0422).
(-)-l-Methyl-8-bromomuconodiIactone (53)
(S)-(-)-3-Methylmuconolactone (48) (30 mg, 0.2 mmol) was brominated 
using the standard procedure to give (-)-l-methyl-8- 
bromomuconodilactone (53) (34 mg, yield 80 %) as a white crystalline 
solid, m.p 83-85 °C (lit.,79 84.5-86 °C), [a]D - 82° (c, 0.3 in methanol) 
(lit.,80 - 86.5 °); vmax (KBr disc) 1796,1778,1284,1187,1112,1076 and 
1029 c m 1; 5h (200 MHz) (CDC13) 1.68 (3H, s, Me), 2.85 (1H, d, J  18.8 
Hz, 4-H), 3.00 (1H, dd, J  18.8 and 4.4 Hz, 4-H), 4.46 (1H, s, 8-H) and 
4.99 - 5.01 (1H, d, J  3.8 Hz, 5-H); 8C (50 MHz) (CDCI3) 19.7 (Me), 34.3 
(C-4), 41.9 (C-8), 81.2 (C-5), 88.7 (C-l), 169.7 (C=0), 171.4 (C=0); 
mlz 236 (M+,81Br), 234 (M+,79Br); (Found: M+ 235.9525. C7H70 481Br 
requires 235.9508).(Found: M+ 233.9521. C7H70 479Br requires 
233.9528).
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(-)-l-Methylmuconodilactone (54)
(-)-l-Methyl-8-bromomuconodilactone (53) (30 mg, 0.13 mmol) was 
debrominated by the standard procedure to give (-)-l- 
methylmuconodilactone (54) as a white crystalline solid (12 mg, yield 60 
%), m.p. 107 °C (lit.,175 129 °C), [a]D -130 ° (c, 1.2 in methanol) (lit.,163
- 131 °); vmax (KBr disc) 1781,1306,1258,1231,1200,1134,1125,
1089 and 1043 cm'1; 8h (200 MHz) (CDCI3) 1.59 (3H, s, Me), 2.69 - 3.06 
(4H, m, 4-H2 and 8-H2) and 4.85 (1H, d with fine splitting, J  4.7 Hz, 5- 
H); 6C (50 MHz) (CDC13) 21.9 (Me), 34.8 (C-4), 40.3 (C-8), 82.1 (C-5),
87.5 (C-l), 172.5 (C=0) and 172.7 (C=0); mlz 156 (M+) (Found: M+ 
156.0416. C7H80 4 requires 156.0422.)
Metabolism of 4-isopropylpyrocatechol (120)
Examination of the ether extracts at pH 7.2 showed the presence of 
unmetabolised 4-isopropylpyrocatechol (120). Ether extracts at pH 2.0 
and continuous extraction gave the 3-isopropylmuconolactone (163). This 
extract was purified by preparative TLC on silica plates (diisopropyl ether
- formic acid - water (200 : 7 : 3 )), to give the title lactone with RF 0.2. 
The feeding data for this experiment are shown in Table 6 on page 188.
(-)-(S)-3-Isopropylmuconolactone (189)
Preparative TLC gave the title lactone 3-isopropylmuconolactone (189) 
as an oil which failed to crystallise: vmax (thin film) 3027,2975,1757, 
1723,1226and 1092cm'1; 6h (200MHz)(CDCI3) 1 .1 8 (3 H ,d ,/7 .0 H z , 
Me), 1.25 (3H, d, /  7.0 Hz, Me), 2.00 (1H, m, CHMe2), 2.57 (1H, dd, J
16.5 and 8.5 Hz, 5-H ),), 3.00 (1H, dd, J  16.4 and 4.0 Hz, 5-H), 5.36
186
(1H, ddd, J  8.5, 3.9 and 1.6 Hz, 4-H) and 5.85 (1H, s with fine splitting, 
2-H); mlz 184 (M+) (Found: M+ 184.0727. C9H12O4 requires 184.0736).
Metabolism of 4-w-propylpyrocatechol (124)
4-n-Propylpyrocatechol (124) was recovered by manual ether extraction 
of the aqueous broth at pH 7.2. Examination by *H NMR spectroscopy of 
both the manual and continuous extractions with ether at pH 2.0 failed to 
show any metabolites. The feeding data for this experiment are shown in 
Table 6 on page 188.
Metabolism of 3-chIoro-5-methyIpyrocatechol (128)
Examination of the ether extracts at pH 7.2 showed the presence of 3- 
chloro-5-methylpyrocatechol (128). Examination of both manual and 
continuous ether extracts at pH 2.0 by XH NMR spectroscopy did not 
show any metabolites having been produced. The feeding data for this 
experiment are shown in Table 6 on page 188.
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